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Zusammenfassung 
Geschlechtsbestimmung in Drosophila geht, wie auch in Säugetieren, einher mit der 
ungleichen Verteilung von Geschlechtschromosomen. Männliche Fruchtfliegen tragen ein X 
und ein Y Chromosom, im Gegensatz zu zwei X Chromosomen in Weibchen. Um die 
negativen Konsequenzen chromosomaler Aneuploidie zu verhindern haben Fruchtfliegen im 
Verlauf der Evolution ein Dosiskompensationssystem entwickelt, welches die Transkription 
vom männlichen X Chromosom zweifach erhöht und somit das Transkriptionsniveau der zwei 
weiblichen X Chromosomen erreicht. Diese Aktivierung wird durch den „dosis compensation 
complex“ (DCC) bewirkt, ein Ribonucleoproteinkomplex bestehend aus fünf „male specific 
lethal“ (MSL) Proteinen und zwei nicht kodierenden „RNAs on the X“ (roX). Der DCC 
bindet an hunderte von Zielorten auf dem männlichen X Chromosom, wo er die 
Hyperazetylierung von X chromosomalem Chromatin an Lysin 16 von Histon H4 (H4K16ac) 
vermittelt. Diese Histonmodifikation ist mit einer offenen, permissiven Chromatinstruktur 
assoziiert, und es wird angenommen dass ihre Anreicherung auf dem männlichen X 
Chromosom für die zweifache Aktivierung der X chromosomalen Transkription wärend der 
Dosiskompensation notwendig ist. Ungeachtet dessen ist der exakte Mechanismus durch den 
X chromosomale Transkription in Männchen aktiviert wird unbekannt.  Verantwortlich für 
die Hyperazetylierung des männlichen X Chromosoms ist die Histonazetyltransferase „males 
absent on the first“ (MOF), welche Teil des DCC ist. Es wurde kürzlich gezeigt dass MOF 
eine zusätzliche Funktion in autosomaler Genregulation hat, da es an tausenden von 
Genpromotoren als Teil des „non specific lethal“ (NSL) Komplex gefunden wurde. Zu 
welchem Grad H4K16ac an autosomalen Genen allerdings von MOF abhängig ist, und wie 
die Verteilung von MOF zwischen den beiden Komplexen reguliert wird ist nicht bekannt. 
 Im Verlauf meiner Promotion habe ich genetische, biochemische und genomweite 
Verfahren verwendet um einen weiten Bereich von Fragen bezüglich der Funktion von MOF 
in autosomaler Genregulation und Dosiskompensation, der Bindung des DCC an X 
chromosomale Gene, und des Mechanismus der transkriptionellen Aktivierung X 
chromosomaler Gene wärend der Dosiskompensation zu beantworten. Neben Beiträgen zu 
anderen Arbeiten, darunter Untersuchungen zur Rolle der H3K36 spezifischen 
Methyltransferase HypB/Set2 in der Dosiskompensation, sowie zur Rolle von MOF  für die 
Funktion von NSLs, habe ich diese Fragen im Kontext zweier Projekte adressiert. 
 Im Verlauf dieser Arbeiten konnte ich zunächst zeigen dass MOF in männlichen und 
weiblichen Fliegen genomweit für H4K16ac verantworlich, und ein essentielles Gen in 
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Weibchen ist. Ich zeige dass der Drosophila spezifische unstrukturierte N-terminus von MOF 
für den Aufbau des DCC auf dem männlichen X Chromosom erforderlich ist und gleichzeitig 
die enzymatische Aktivität von MOF hemmt. Der N-terminus kontrolliert daher MOFs 
Funktion für die Kompensation des X Chromosoms. Weiterhin habe ich die biologische 
Funktion der von Hefe bis Mensch konservierten Chromobarrel Domäne im MOF protein 
aufgezeigt. Überraschenderweise führt die Mutation der Chromobarrel Domäne, welche für 
die Interaktion von MOF mit roX RNA nötig ist, zu einer dramatischen Abnahme von 
H4K16ac auf allen Chromosomen. Ich konnte somit zum ersten Mal eine biologische 
Funktion der MOF Chromobarrel Domäne in vivo zeigen, welche darin besteht H4K16ac nach 
der Rekrutierung von MOF zum Chromatin auszulösen.  
In einem parallelen Projekt, welches darauf abzielt den Mechanismus der 
Dosiskompensation zu erhellen, wollte ich bestimmen an welchem Schritt des RNA 
Polymerase II Transkriptionszyklus Dosiskompensation in Fliegen agiert. Hiefür habe ich 
genomweite Bindungsprofile von RNA Polymerase II in Speicheldrüsen von männlichen und 
weiblichen Larven, und von Larven mit beeinträchtigter Dosiskompensation hergestellt. Diese 
Analyse zeigt dass RNA Polymerase II auf dem männlichen X Chromosom ungefähr 
zweifach angereichert ist, einschliesslich an Genpromotoren. Dieses Ergebnis legt nahe dass 
Dosiskompensation auf der Ebene der Transkriptionsinitiation arbeitet, was einen 
bedeutenden Fortschritt für unser Verständniss der Dosiskompensation darstellt. 
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Summary 
Like in mammals, sex determination in Drosophila melanogaster involves an unequal 
distribution of sex chromosomes, with male flies carrying an X and a Y chromosome, as 
compared to two Xs in females. To prevent the deleterious effects of chromosomal 
aneuploidy, flies have evolved a dosage compensation system, which upregulates 
transcription from the single male X chromosome to match transcript levels produced from 
the two female Xs. This transcriptional activation is achieved by the dosage compensation 
complex (DCC), a ribonucleoprotein complex consisting of five male specific lethal proteins 
(MSL) and two non coding RNAs on the X (roX). The DCC is physically tethered to 
hundreds of target loci along the male X chromosome, where it promotes hyper-acetylation of 
X-linked chromatin at Lysine 16 of histone H4 (H4K16ac). This histone mark is associated 
with an open, permissive chromatin structure, and its enrichment on the male X chromosome 
is thought to be required for the twofold increase in X-linked transcription during dosage 
compensation. However, the exact mechanism by which X-linked transcription is activated in 
males is still unknown. Responsible for hyper-acetylation of the male X chromosome is the 
histone acetyltransferase males absent on the first (MOF), which is part of the DCC. Recent 
studies have shown that MOF plays an additional role in autosomal gene regulation, as it has 
been found at thousands of autosomal gene promoters as part of the non specific lethal (NSL) 
complex. However, to what extent H4K16ac at autosomal genes is MOF-dependent, and how 
MOF is differentially distributed between the two complexes is currently unknown.   
 During the course of my PhD, I used genetic, biochemical, and genomewide 
approaches to address a wide range of questions, concerning MOF functions in autosomal 
gene regulation and dosage compensation; the DCC recruitment process to X-linked target 
genes; and the mechanism of transcriptional upregulation of X-linked genes during dosage 
compensation. Besides other contributions, investigating the role of the H3K36 specific 
methyltransferase HypB/Set2 during MSL targeting and dosage compensation, as well as the 
role of MOF for NSL function at autosomal promoters, I was addressing these questions in 
the context of two main projects. 
During the first one of these, I have been able to show that MOF is responsible for 
genomewide H4K16ac in male and female flies, and that MOF is an essential gene in females. 
I demonstrated that the Drosophila specific unstructured N-terminus of the MOF protein is 
required for assembly of the DCC on the male X chromosome, and at the same time 
constrains MOFs HAT activity. The N-terminus therefore controls MOFs function in X 
Summary 
10 
 
chromosome compensation. I was furthermore able to reveal the biological role of the 
chromobarrel domain, which is conserved from yeast to human. Unexpectedly, disruption of 
the MOF chromobarrel domain, which has been shown previously to be required for MOF 
interaction with roX RNAs, led to a dramatic loss of H4K16ac from all chromosomes. 
Accordingly, I showed that the chromobarrel domain serves to trigger H4K16ac after the 
recruitment of MOF to its chromatin targets, revealing for the first time a biological role of 
this domain in vivo.  
In a parallel project, to work towards unraveling of the dosage compensation 
mechanism, I wanted to identify the step in the RNA PolII transcription cycle at which dosage 
compensation operates in flies. To this end, I generated genomewide profiles of RNA PolII in 
3rd instar larva salivary glands from male and female flies, and from male flies with disrupted 
dosage compensation. Strikingly, we find that the density of PolII is approximately twofold 
elevated on the male X chromosome as compared to autosomes, including X-linked 
promoters. This data suggests that dosage compensation operates via enhanced transcription 
initiation, which constitutes a major advance in our understanding of the dosage compensation 
process.  
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Preface 
In metazoans, the same genetic information stored inside the nucleus of each somatic 
cell can give rise to highly specialized cell types, specific for certain tissues and/or 
developmental stages. These functional states are the result of distinct patterns of gene 
expression. Accordingly, at any given time point during its life cycle, each cell only realizes a 
subset of the transcriptional and developmental potential encoded in the genome as a whole. 
A fundamental requirement for the formation of a multicellular organism is therefore the 
ability to read the genetic code in a context dependent manner, and to faithfully maintain 
transcriptional states from one cell generation to the next. At the basis of this “epigenetic” 
memory lies the compaction of the genomic sequence into “chromatin”. This nucleoprotein 
complex allows for the activation or inactivation of any genomic locus through an alteration 
in chromatin structure, mediated by a complex interplay of transcription factors, noncoding 
RNAs, and histone modifications. This introduction will give a brief overview over the 
principles that underlie this sophisticated process. 
 
1.1 Chromatin 
1.1.1 The nucleosome 
The fundamental unit of chromatin is the nucleosome with 147bp of DNA wrapped 
around an octamer of histone proteins in 1 3/4 left-handed superhelical turns [1], leading to a 
5- to 10-fold compaction of the DNA. The center of the octamer consists of two dimers of 
histone H3 and H4 while a dimer of H2A and H2B lies on either side of the nucleosome, as 
depicted in Figure 1 [2].  Common to all four histones is the central histone fold domain 
(HFD), consisting of three α-helices (α1, α2 and α3) separated by two loops (L1 and L2), 
which is conserved throughout eukaryotic and archeal lineages (for a review see [3]). The 
core histone octamer is only stable in the presence of DNA or at very high salt concentrations, 
due to the highly basic charge of all four core histones. Core nucleosomes are arranged on the 
DNA like “beads on a string” with 10-80pb of linker DNA between them [4], and one copy of 
the linker histone H1 can bind to and protect 20bp of this linker DNA against micrococcal 
nuclease digestion [5]. Histone H1 is not required for the assembly of the core nucleosome 
itself but is thought to facilitate formation of the next higher level of chromatin structure, the 
30nm fiber [6, 7]. In vivo, depletion of H1 leads to reduced nucleosome repeat length and 
defects in the compaction of mitotic chromosomes, and severe depletion of H1 is fatal in mice 
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and Drosophila [8, 9]. The unstructured tails of the four core histones are not required for the 
formation of the mononucleosome but do affect inter-nucleosomal interactions and the folding 
of the 30nm fiber, as well as the recruitment of chromatin modifying factors and the 
transcriptional machinery. All of these functions are extensively modulated by covalent 
posttranslational modifications of the histone tails, as will be discussed in more detail below. 
 
 
 
 
Figure 1. Organization of DNA in the eukaryotic nucleus.  
The crystal structure of the mononucleosomes with histone H2A, H2B, H3 and H4, adapted from [10], 
and the suggested 30 nm fiber structure from [11]. 
 
1.1.2 Higher order chromatin structure 
Higher order chromatin structure may be defined as any group of nucleosomes that 
adopt a reproducible conformation in 3D [12]. In analogy to protein structures, the chain of 
nucleosomes might form secondary and tertiary structures mediated by inter-nucleosomal 
interactions. Although the primary structure of chromatin is a simple repetition of 
nucleosomes, the situation is complicated by the existence of histone variants, by post-
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translational modifications of the unstructured histone tails and by variable spacing between 
nucleosomes, which all might impact on chromatin secondary structures. To directly prove 
the existence of such structures has so far proven difficult, and recent attempts using cryo-
electron microscopy have failed to support the existence of a 30nm fiber in vivo [13]. 
However, extensive work over the last decades on isolated and reconstituted chromatin has 
revealed some reoccurring patterns of secondary structure formation. Free DNA is highly 
negatively charged and self-repulsive, and this charge is not fully compensated by the basic 
histone proteins. Chromatin structure in vitro is therefore highly responsive to changes in the 
ionic environment [14]. With increasing ionic strength, the beads on a string conformation 
visible in electron micrographs is getting progressively compacted into a fiber with ~30nm in 
diameter (Figure 1). Two alternative nucleosomal arrangements have been proposed for the 
30nm fiber. In the solenoid one-step helix model, the linker histone H1 is placed inside the 
helix and the linker DNA connects two consecutive nucleosomes within the same stack. Per 
turn, 6-8 nucleosomes coil around a central cavity constituting the superhelix [15]. In contrast, 
in the two-start model the linker DNA is found on the outside of the superhelix, connecting 
nucleosomes of consecutive stacks [16]. The two-start model has been supported by a study 
that used the interaction between an acidic patch within the flat face surface of the H2A-H2B 
dimer and the N-terminal tail of histone H4 for di-sulfite crosslinking of corresponding 
cysteine replacement mutants [10, 17].  The crosslinked fibers were prone to digestion by 
restriction enzymes specific for the linker DNA sequences, suggesting an orientation towards 
the outside of the fiber. In further support for a two-start helix, the recent successful 
crystallization of a tetranucleosome revealed a complex that assumed a zigzag arrangement 
with interactions between nucleosomes 1 and 3 and between 2 and 4, with the linker 
extending between them [11]. Finally, a new technique termed EMANIC (EM-assisted 
nucleosome interaction capture), in which formaldehyde crosslinked chromatin fibers are 
dispersed in low salt and analyzed by electron microscopy, has provided evidence for a mixed 
fiber architecture predominated by the zigzag configuration and interrupted by senoidal 
segments [18]. Interestingly, computer modeling has shown that mixed conformations allow 
for a higher degree of compaction, and better match the calculated nucleosome packaging in 
vivo. The existence and form of hierarchical structures above the 30nm fiber are a matter of 
intensive study and, due to the ~250nm resolution limit of light microscopy, remain largely 
elusive to date. Muller et al. reported that ~400kb of non translated chromatin occupy roughly 
spherical volumes with about 250nm in diameter [19]. The corresponding ~2000 
nucleosomes, if present as 30nm fiber, would extend to a length of 2µm, suggesting extremely 
Introduction 
 
15 
 
tight packaging of untranscribed chromatin. It will be interesting to see if the recent 
development of subdiffraction light microscopy will reveal any internal structures in these 
compact regions. 
 
1.1.3 Remodeling chromatin 
During development and differentiation cells show remarkable transcriptional 
plasticity. Accordingly, since the interpretation of all genetic information relies on direct 
binding of regulators and the transcriptional machinery to DNA, the packing and unpacking 
of chromatin is a tightly controlled process, specific for loci harboring genes that need to be 
activated or repressed at any given time point as a response to environmental cues. Access to 
the DNA is not only modulated by packaging into higher order structures like the 30nm fiber, 
but also by the positioning of nucleosomes on the DNA. Nucleosomes occlude transcription 
factor binding sites and hinder RNA PolII while it is travelling through the gene [20], and in 
vitro transcription of a chromatinized template is severely slowed down, as compared to 
naked DNA [21]. However, while promoter regions tend to be depleted of nucleosomes in 
vivo in order to allow transcription factor and Pol II binding to DNA, most genes carry 
nucleosomes in their transcribed regions [22, 23]. The active regulation of chromatin structure 
and the ability of RNA PolII to overcome the obstacles imposed by the chromatin template 
are the result of a complex interplay between nucleosome assembly and disassembly by 
histone chaperones, ATP-dependent remodeling, replication independent incorporation of 
histone variants and post transcriptional modifications of the histones. Each of these 
mechanisms will be discussed below. An additional modification that impacts on chromatin 
structure and transcription is DNA methylation; however, since this modification plays a 
minor role in Drosophila it is beyond the scope of this brief introduction to chromatin 
biology.   
 
1.1.4 Nucleosome assembly / disassembly 
In order to prevent aggregation and potentially deleterious effects of their highly 
positive charge, histones, when not in association with DNA, are under most circumstances 
bound to histone chaperones. These proteins not only prevent unwanted interactions with 
other factors, as previously believed. Histone chaperones can act alone or as part of larger 
protein complexes to link the incorporation of histones into DNA and the removal of histones 
Introduction 
 
16 
 
off DNA to processes like replication, transcription and DNA repair [24, 25]. Many histone 
chaperones have higher affinities for certain histones and are specific for distinct processes, 
and they are often able to not only catalyze the assembly of histones into or disassembly from 
DNA but also the reverse reaction. Some histone chaperones can on their own bind and 
transfer histones, such as Asf1, while others are part of multichaperone complexes with more 
than one chaperone subunit as in the case of the CAF-1 complex. Initially, nucleosomes are 
established during S-phase in a step-wise process in which the histone chaperones CAF1 and 
Asf1 deposit H3/H4 tetramers onto the DNA. It is currently believed that Asf1 acts as a 
histone donor for CAF-1 during this process, whereas another histone chaperone, Nap1, later 
adds H2A/H2B to build the octasomes [26, 27]. Structural analysis has revealed that Asf1 
binds to the same interface in dimeric H3/H4 that also mediates interaction between two 
H3/H4 dimers, and it has been demonstrated in vitro that Asf1 is able to disrupt the H3/H4 
tetramer [28]. A role for Asf1 in nucleosome disassembly has also been supported by studies 
in S. cerevisiae, showing that Asf1 is required for efficient nucleosome eviction during 
transcription [29]. However, 95% of the H2A/H2B dimers but only 5% of H3/H4 dimers are 
exchanged during transcription, suggesting that the Pol II complex is able to transcribe 
through the H3/H4 tetramer [30]. Transcription coupled disassembly of H2A/H2B is mediated 
by FACT (facilitates chromatin transcription), a multichaperone complex consisting of Spt16 
and SSRP1, which also promotes reassembly behind the elongating Pol II. This reassembly is 
crucial as exemplified by deletion of spt6 in yeast cells. This histone chaperone also promotes 
nucleosome reassembly after Pol II passage, and loss of spt6 leads to aberrant transcription 
initiating from cryptic promoters in the transcribed regions [31]. Many histone chaperones 
also provide histone binding capacity in the context of large enzymatic complexes, such as 
actin-related protein (Arp) 7 and 9 in the SWI/SNF chromatin remodeling complex, or Arp4 
in the INO80 complex, where they can be involved in transcription regulation, DNA repair 
and other processes. In addition, histone chaperones can also link histone modifying activities 
to their substrates, as in the case of Vps75 and the H3K56 specific HAT Rtt109 in S. 
cerevisiae [32], or Arp4, which recruits the NuA4 complex to γH2AX in budding yeast [33]. 
Many other histone chaperones are involved in the propagation of epigenetic marks or in 
processes such as transcriptional memory, and the physical and functional network of histone 
chaperone interactions is under active investigation. Since the aim of this introduction is to 
provide a brief overview over the basic principles of chromatin biology, I recommend recent 
reviews for further reading on this fascinating field of research [24, 25]. 
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1.1.5 ATP dependent chromatin remodeling 
The exact positioning of nucleosomes on the DNA can have a profound impact on 
gene expression, since it can dramatically alter the accessibility of the DNA for transcription 
factors. Although preferential positioning of nucleosomes over certain DNA sequences has 
been clearly demonstrated in vitro, there is still an ongoing debate as to whether nucleosome 
positions in vivo are encoded in the genome or the result of sequence independent remodeling 
[34-36]. In any case, the ability to actively move nucleosomes over favored or unfavored 
positions on the DNA sequence is required for basically all chromatin related processes, like 
DNA replication, recombination, repair and transcription [37]. ATP dependent chromatin 
remodeling enzymes are highly conserved proteins that belong to the swi2/snf2 helicase 
superfamily of ATPases and can use energy to slide nucleosomes along the DNA. They can 
be subdivided into the SWI/SNF, ISWI, CHD and INO80 families depending on the sequence 
homology of their ATPase domains (Table 1). While all remodelers have an affinity for 
nucleosomes, a variable domain and cofactor architecture directs their activity to specific loci 
and distinct processes by interaction with modified histone tails and other chromatin related 
proteins or transcription factors. The following paragraphs give a short overview of the main 
remodeler families and present some examples of their functions.   
The SWI/SNF family of remodelers is an 8-12 subunit complex that slides and ejects 
nucleosomes in many diverse processes besides chromatin assembly. The catalytic ATPase 
contains a SANT domain followed by a bromodomain capable of binding to acetylated 
histone tails, and indeed histone acetylation increases the remodeling efficiency of SWI/SNF 
complexes and the enhanced RNA PolII elongation mediated by yeast RSC [38, 39]. 
SWI/SNF family members interact with multiple transcriptional activators (reviewed in [37]), 
and there is strong evidence for the SWI/SNF family to be involved in gene activation. 
dBrahma for instance is required for Pol II mediated expression of most genes on Drosophila 
polytene chromosomes [40], and yeast RSC lowers the nucleosome density at promoters, 
thereby promoting transcription [41].  
ISWI family remodelers usually contain one or two catalytic subunits and a varying 
set of a few specialized attendant proteins. The ATPase contains a SANT followed by a 
SLIDE domain at its C-terminus, which together bind to an unmodified histone tail and DNA 
[42]. 
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Table 1. Remodeler composition and orthologous subunits. Taken from [37]. 
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The ISWI family members ACF and CHRAC mostly optimize nucleosome spacing during 
chromatin assembly and transcriptional repression [42]. Yeast ISW2 for instance is recruited 
to many genes by the yUme6 repressor, and helps to generally repress cryptic transcription 
initiation [43, 44]. In contrast, the NURF complex can randomize spacing in support of 
transcription, emphasizing the functional diversity mediated by changes in subunit 
composition [45]. At the same time, the activity of NURF is required to maintain the 
chromatin structure of the male X chromosome in Drosophila, which undergoes selective, 
massive unfolding upon NURF inactivation [45, 46]. 
The CHD or Mi2 complex is monomeric in lower eukaryotes but can include up to 10 
subunits in vertebrates. Characteristic are two tandemly arranged chromodomains at the N-
terminus of the catalytic subunit, which in the case of human CHD can bind to the H3K4me2 
or me3 marks correlated with active chromatin [47, 48]. In S. pombe CHD has been shown to 
eject nucleosomes at promoters to stimulate transcription activation [49]. All four CHD 
members colocalize with PolII on polytene chromosomes in Drosophila [50, 51], and yeast 
Chd1 interacts with multiple elongation factors suggesting a general role of CHD remodelers 
in Pol II elongation [51]. In contrast, the vertebrate Mi2/NuRD complex contains histone 
deacetylase activities and has repressive functions (reviewed in [52]).  
Complexes of the INO80 family contain more than 10 subunits and are characterized 
by an insertion in the middle of the ATPase domain to which regulatory factors such as actin 
related proteins (ARP) can bind. INO80 can function in gene activation [53], and the related 
yeast Swr1 complex deposits the variant histone H2A.Z at gene promoters [54]. Furthermore, 
it has been shown in yeast and human that INO80 is required for the recovery of stalled 
replication forks during replicative stress in S-phase [55, 56]. In addition, INO80 has received 
a lot of attention for its role in DNA repair and recombination. INO80 and the complexes of 
the SWR1 subfamily are quickly recruited to the site of DNA double strand breaks where they 
help to create the 3′ single-stranded DNA overhang critical for the repair mechanism [57]. 
The above examples for remodeler functions are far from being complete. The central 
role that energy dependent mobilization of nucleosomes plays for virtually all chromatin 
related processes has led to a huge diversification of this group of enzymatic complexes, and 
the limited space of this introduction cannot do full justice to the topic. The reader may 
therefore refer to some recent reviews for a more comprehensive introduction into the biology 
of chromatin remodeling complexes [37, 58].  
We have seen so far how histones and DNA form chromatin in order to control 
accessibility of the DNA template, and how histone chaperones and chromatin remodeling 
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complexes together regulate the assembly of this structure. However, the resulting chromatin 
is far from being uniform.  Instead, chromatin structure is further differentiated through 
posttranslational modifications of histones, and by the incorporation of alternative histone 
proteins, the so called histone variants.  
 
1.1.6 Histone variants 
Maybe the most direct way to modulate chromatin structure is the incorporation of 
non-canonical histone variants into the core nucleosome. Variant forms have been identified 
for all histones, and their origins date back to the earliest diversifications of eukaryotic 
lineages. Other then canonical histones, histone variants can be expressed in a replication 
dependent or independent manner and are usually expressed from one gene. The incorporation 
of variant histones can specifically alter the fundamental structure and stability of the core 
nucleosome itself, as well as the recruitment of chromatin modifying enzymes and 
transcription factors. Therefore, individual histone variants have evolved to serve specific 
processes such as transcriptional activation, repression or memory, DNA damage and 
centromere formation [3]. This chapter gives a short overview over the most common 
eukaryotic histone variants and points out some examples for their functions.  
CenH3, also known as CENP-A according to the first identified mammalian example, 
functionally refers to the quickly evolving and relatively lowly conserved group of 
centromere specific H3. The histone fold domains of CenH3s show ~50-60% identity with 
canonical H3 and no conservation in the N-terminal tails. The mechanisms that maintain 
CenH3 at centromeres are not well understood, although CenH3 shows some preference for 
AT-rich DNA, which is usually enriched at centromeres [59]. The structure of CenH3 
nucleosomes is unusual and controversial. In yeast and Drosophila CenH3 nucleosomes 
induce positive supercoils into the DNA, suggesting a right-handed helix [60]. Atomic force 
measurements show that Drosophila CenH3 (CID) nucleosomes are of half the height as 
canonical nucleosomes, and they protect less than the usual ~150bp of DNA against nucleases 
[61]. Accordingly, Drosophila CID nucleosomes contain one copy each of CID, H4, H2A and 
H2B and most likely resemble half of an octameric nucleosome, or a hemisome. The situation 
is not as clear in yeast, where either a hemisome or a (CenH3–H4)2 tetrameric structure has 
been proposed for CenH3 containing nucleosomes. 
H3.3 in most animals only differs at 4 residues from canonical H3, including a change 
from Ala to Ser at position 31 in the N-terminal tail and substitutions at residues 87, 89, and 
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90 near the beginning of α2. H3.3 is incorporated and continuously exchanged in the body of 
transcribed genes during transcription elongation [62, 63], while the three substitutions in α2 
prevent replication independent incorporation of canonical H3 [64]. The turnover of H3.3 is 
generally higher as compared to H3, and this might contribute to the maintenance of active 
chromatin. Interestingly H3.3 is enriched on the male X chromosome in Drosophila, most 
likely reflecting the enhanced transcriptional activity resulting from dosage compensation 
[65]. An intriguing study using a Xenopus laevis nuclear transplantation assay furthermore 
showed that H3.3 can mediate epigenetic memory of the transcriptional state of a gene over 
12 consecutive cell divisions, depending on the presence of Lys4 of H3.3 [66]. 
H2A.Z differs from H2A around the L1–α2 and α2–L2 junctions and in the C-terminal 
contact region to H3, rendering in vitro reconstituted nucleosomes more stable [67]. Of 
particular interest with respect to the formation of higher order chromatin structures is the 
more pronounced acidic character of the negatively charged “acidic patch” in H2A.Z, which 
lies at the flat surface of the H2A/H2B dimer [10, 68]. This region of H2A/H2B has been 
shown to bind to positively charged lysine residues in the H4 N-terminal tail of neighboring 
nucleosomes [69], and incorporation of H2A.Z might therefore favor inter-nucleosomal 
interactions. Nucleosomes containing H2A.Z are found on either side of the nucleosome 
depleted regions at gene promoters, where they are highly positioned relative to the TSS.  
Although H2A.Z promotes efficient recruitment of RNA PolII in yeast and human cells [70, 
71], the roles of H2A.Z in gene regulation as well as other processes such as heterochromatin 
formation or DNA repair are contradictory, most likely due to variable posttranslational 
modifications and the effects of nucleosome remodeling complexes [72, 73]. One intriguing 
recent discovery was that H2A.Z is required for tethering of the INO1 gene to the nuclear 
membrane in yeast during the establishment of transcriptional memory [74]. 
H2A.X is characterized by a short C-terminal motif containing Ser139, which gets 
rapidly phosphorylated by ATM, ATR and DNA-PK kinases at nucleosomes surrounding 
DNA double strand breaks (DSB). The resulting phosphorylated form termed γH2A.X helps 
to recruit DNA repair, chromatin remodeling and histone modifying enzymes to the site of 
DNA damage [73, 75]. However, the exact details of how H2A.X functions in DNA repair are 
still under active investigation. Beyond DNA repair, H2A.X is also found in numerous foci 
that are independent of DSBs and whose significance is still unclear. Furthermore, γH2A.X is 
also required for sex chromosome inactivation in the male germline and for the silencing of 
unpaired meiotic chromatin [76, 77].  
Introduction 
 
22 
 
MacroH2A is an H2A variant specific to animals. It is characterized by an additional 
“macrodomain” at its C-terminus, which is able to recognize ADP-ribose metabolites. On 
reconstituted chromatin mH2A restricts transcription factor access, probably due to sterical 
hindrance by the relatively large macrodomain, and prevents gene activation by p300 [78]. In 
a human pluripotent cell line, mH2A correlates with genes that are repressed by the polycomb 
system and carry H3 Lys27 trimethylation, consistent with a role of mH2A in conditional 
gene silencing [79], and a suppressive role of mH2A is further suggested by its enrichment on 
the human inactive female X chromosome [80]. In addition to its functions in gene repression 
mH2A has recently been shown to be recruited to activated poly-ADP-ribose polymerase at 
sites of DNA damage, where it helps to reorganize the chromatin surrounding the lesion [81]. 
Taken together, histone variants allow local reprogramming of the chromatin 
environment, in order to perform spatially or temporally restricted tasks. This concept is 
dramatically extended by the introduction of posttranslational modifications that further 
differentiate the properties of histone proteins. 
 
1.1.7 Posttranslational modification of histones 
 It has been known for nearly 50 years that acetylation of histones is associated with 
active genes in vivo [82]; however, it remained unclear if acetylation was cause or merely 
consequence of transcription. With the identification of a histone acetyltransferase activity in 
a ciliate homologue of the known yeast coactivator Gcn5, a first functional link between gene 
activation and the covalent modification of histones became apparent [83]. Subsequently, 
other previously known coactivators like CBP/p300, SRC-1, and ACTR were shown to be 
associated with histone acetyltransferase activities [84-87], and simultaneously the known 
transcriptional repressor Rpd3 was identified as a histone deacetylase [88]. Since then, more 
than 60 different often reversible posttranslational modifications of histones, including 
acetylation, methylation, phosphorylation, ubiquitylation, sumoylation, ADP-ribosylation, 
deimination and proline-isomerization, have been identified, many of which can physically 
alter the chromatin structure or impact on the recruitment of chromatin modifying factors, 
thus creating a combinatorial potential of astonishing complexity (Figure 2, reviewed in [89, 
90]). As a consequence, the old inherently static model of gene activation, in which sequence 
specific transcription factors recruit the transcriptional machinery to their target genes had to 
be replaced by a much more dynamic view, where spatial and temporal combinations of 
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histone modifications could lead to specific outcomes, not predictable by mere DNA 
sequence.  
 
  
Figure 2. Posttranslational modifications on core histones. From [91]. 
The modifications include acetylation (ac), methylation (me), phosphorylation (ph) and ubiquitination 
(ub1). Most of the known histone modifications occur on the N-terminal tails of histones, with some 
exceptions including ubiquitination of the C-terminal tails of H2A and H2B and acetylation and 
methylation of the globular domain of H3 at K56 and K79, respectively. Globular domains of each 
core histone are represented as colored ovals. 
 
One way how histone modifications can exert their functions is by changing the 
physical properties of inter- and intra-nucleosomal interactions. Acetylation neutralizes the 
positive charge of lysine residues, which will impact on the electrostatic interactions between 
histones and the DNA. Indeed, hyper-acetylation of histones has been shown to reduce 
nucleosome stability [92, 93], enhances the accessibility of chromatin fibers and facilitates the 
co-transcriptional exchange of H2A/H2B dimers, leading to an increased elongation rate of 
RNA PolII [94-97]. The impact of histone acetylation on higher-order chromatin structure has 
been directly demonstrated for acetylation of H4 on Lys16. As mentioned above, the 
positively charged tail of H4 interacts with acidic residues on the surface of the H2A/H2B 
dimer of a neighboring nucleosome, leading to chromatin compaction; and accordingly 
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acetylation of Lys16 prevents the formation of a 30nm fiber in vitro [98]. In male flies, the 
majority of X chromosomal chromatin is hyper-acetylated at H4K16, leading to chromatin 
decompaction and higher accessibility for the transcription machinery. Drosophila dosage 
compensation therefore offers an instructive model system for the establishment of a global 
chromatin environment by histone modifications.  
 The second and most characterized mode of operation for histone modifications is the 
creation or occlusion of docking sites for chromatin binding proteins. A variety of adaptor 
domains has evolved to specifically recognize certain histone modifications and recruit 
chromatin modifying factors. For example the H3K9me3 mark enriched at constitutive 
telomeric and pericentric heterochromatin is recognized by a chromodomain in the HP1 
protein [99, 100], which in turn recruits further histone deacetylase and methylase activities 
that lead to chromatin compaction [101-103]. As one of the first described examples of 
crosstalk between different histone modifications, the binding of HP1 to H3K9me3 can be 
disrupted by an adjacent phosphorylation of histone H3 at S10 [104]. Importantly, HP1 
recruits Su(var)3-9, the enzyme responsible for the H3K9me3 mark itself, and it has been 
proposed that this allows the transmission of the mark onto the newly synthesized daughter 
strand during replication to implement epigenetic memory.  
Another modification associated with the repressed state of genes is H3K27me3, 
mediated by the polycomb repressive complex 2 (PRC2) [105]. Initially described as a 
suppressor of Hox gene expression in Drosophila  [106], hundreds of developmentally 
regulated genes have been identified as polycomb targets in the recent years [107]. In the fly, 
the initial recruitment of PRC2 to its target genes involves the recognition of so called 
polycomb response elements (PREs) by DNA binding factors (reviewed in [108]). Subsequent 
methylation of H3K27 then contributes to the recruitment of PRC1, which eventually leads to 
gene repression by an as yet unknown mechanism that involves monoubiquitination of H2A at 
K119. 
The coordinated recruitment of a series of chromatin modifying proteins by 
consecutively established histone marks is a common theme that allows the temporal 
coordination of multistep processes. Another prominent example for the complex interplay of 
histone marks and the chromatin modifying machinery is the regulation by Paf1 and the 
COMPASS/TRX/MLL complexes in yeast, Drosophila and mammals, respectively.  Upon 
initial recruitment to the promoter together with RNA PolII, Paf1 serves as a recruitment 
platform for COMPASS, which contains Set1, the only H3K4 methyltransferase in yeast 
[109]. At the same time, Paf1 stimulates the independently recruited rad6-Bre1 E1/E3 ligase 
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complex to monoubiquitinate H2B at K120, and only the presence of this histone mark 
triggers the full potential of Set1 to establish H3K4me3 [109, 110].  Finally, depending on the 
context, H3K4me3 can be read by PHD fingers, chromodomains, TUDOR and MBT domains 
of a variety of factors including chromatin remodelers, histone acetyltransferase complexes 
and TFIID, mostly in support of transcription [89, 111, 112]. 
Following the original observation that certain histone modifications like acetylation 
of H3 and H4 or methylation of H3K4 correlate with actively transcribed regions, while 
others such as methylated H3K9 and H3K27 are enriched in repressed chromatin, the “histone 
code hypothesis” was proposed, stating that certain combinations of histone marks will allow 
the prediction of distinct transcriptional outputs [113]. However, this simplistic view has been 
increasingly challenged in recent years, when more and more examples for a context specific, 
often antipodal read-out of histone marks were discovered. H3K9me3 for instance was found 
in the coding region of transcribed genes, where it closely follows the pattern of H3K36me3 
[114]. Similarly, certain adaptors that recognize specific histone modifications have been 
found in activating as wells as repressive complexes. As an example, yeast eaf3, which binds 
to H3K36me3 and directs the deacetylase activity of the Rpd3S complex to the body of 
transcribed genes in order to prevent cryptic initiation, is at the same time found in the NuA4 
acetyltransferase complex [115-118]. Likewise, many histone marks can recruit opposing 
activities. In addition to the above mentioned positively acting factors, H3K4me3 is also 
recognized by demethylase activities or by the PHD finger containing ING2 protein in the 
mSin3a-HDAC1 histone deacetylase complex, which shuts off transcription of proliferation 
specific genes upon DNA damage [119, 120].   
A very instructive example for the spatial and temporal orchestration of histone marks 
is a recent study of Zippo et al. that demonstrates how a cascade of histone modifications can 
lead to a particular transcriptional outcome in a context dependent manner [121]. The authors 
found previously that serum activation of the FOSL1 gene requires the PIM1 kinase, which is 
able to phosphorylate H3S10 [122]. MSK1 and MSK2 also mediate H3S10 phosphorylation 
at the FOSL1 promoter at early time points of expression [123, 124]. In their new study Zippo 
and colleagues show, that phosphorylation of H3S10 by PIM1 at the FOSL1 enhancer is 
recognized by the 14-3-3 protein, which in turn recruits the MOF histone acetyltransferase to 
the enhancer. The resulting acetylation of H4K16 at the FOSL1 promoter forms a binding site 
for Brd4, a component of the P-TEFb kinase, which phosphorylates the C-terminal domain of 
PolII to activate transcription. In contrast, earlier recruitment of 14-3-3 by H3S10p at the 
FOSL1 promoter does not lead to MOF recruitment, thereby demonstrating the importance of 
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the spatiotemporal context for the determination of downstream events. As mentioned above, 
H4K16ac is also the hallmark of the hyperactive male X chromosome in Drosophila. 
Interestingly, the H3S10 specific Jil1 kinase is colocalizing with MOF on the male X. 
However, the recruitment of Jil1 occurs later than hyper-acetylation of H4K16 [125], 
suggesting a biological function that is unrelated to the one observed at the FOSL1 gene. 
All different means of chromatin regulation introduced so far are, alone or in 
combination, effective tools to modulate local chromatin structure.  It is important to 
recognize however, that cells represent sophisticated global networks of gene expression, 
where the activity of a gene often feeds back into the regulation of other genes [126]. 
Therefore, to maintain homeostasis of the transcriptome as a whole, the regulation of 
transcription and chromatin structure has to be an integrated process that allows the concerted 
regulation of spatially distant regions of the genome. It has become increasingly clear in 
recent years that non coding RNA transcripts play a major role in orchestrating this global 
chromatin regulation, as I will explain in more detail in the next section. 
 
1.1.8 Noncoding RNAs and chromatin 
Small RNAs  Already with the discovery of the RNAi pathway in the 1990s, the role 
of RNA as a mere transmitter of information along the central dogma 'DNA makes RNA 
makes protein' was put into question [127]. Many short regulatory RNAs were subsequently 
discovered that have roles in transcriptional control and chromatin organization (reviewed in 
[128]). As a common theme for regulation by small RNAs, a double stranded RNA sequence 
is processed by the endonuclease Dicer into a ~21nt siRNA, which is then bound by a protein 
of the Argonaute family, thereby forming the RNA induced transcriptional silencing complex 
(RITS). Argonaute bound siRNAs are then often amplified by an RNA dependent RNA 
polymerase (RdRP). Together with Argonaute, the siRNAs subsequently find and inactivate 
target mRNAs by perfect base pairing, followed by degradation of the target.  
RITS complexes can also bind to nascent transcripts and recruit chromatin modifying 
enzymes. This mechanism is exemplified in S. pombe, where low levels of transcribed RNA 
from centromeric repeats are processed by Dicer, and Argonaute directed recruitment of the 
H3K9 methyltransferase Clr4 to the site of transcription then leads to heterochromatin 
formation [128]. Interestingly, RNA also plays a role in kinetochore integrity during mitosis 
in human cells [129, 130], and the formation of human neocentromers depends on Dicer 
[131], although the molecular steps involved have not been identified. In addition to silencing 
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of pericentric heterochromatin, siRNAs mediate the silencing of transposable DNA elements 
in plants by similar mechanisms [128], and have been shown to play a role for transposon 
silencing in somatic tissues of Drosophila [132-134]. In the germ line of Drosophila and 
vertebrates, transposon silencing is mediated by piRNAs that are not dependent on Dicer for 
their biogenesis and interact with the Piwi clade of Argonaute proteins (reviewed in [135]).  
In addition, a new class of small ~50 - 200bp RNAs that function independently from 
the siRNA pathway has recently been identified as part of the polycomb repression system. 
Short RNAs transcribed from the 5’ end of repressed genes in primary human CD4+ T cells 
and murine ES cells form hairpin structures that are recognized by Suz12 in the PRC2 
complex, and 5’ fusion of such a hairpin sequence repressed transcription of a reporter gene 
[136]. 
 
lincRNAs   In the recent years, the development of whole-genome tiling-arrays and 
high-throughput sequencing technologies has led to the discovery that the majority of the 
genome in  higher organisms is transcribed into RNA, including a new class of long 
intergenic noncoding RNAs (lincRNA) larger then 200bp (reviewed in [137]). Initially 
regarded as transcriptional noise [138], it rapidly became clear that lincRNAs are produced in 
a developmentally regulated fashion and under positive evolutionary selection [139-142]. In 
the meanwhile, mounting evidence suggests that this vast hidden layer of lincRNAs plays a 
major role in the epigenetic regulation of multicellular organisms.   
 lincRNAs can interact with chromatin and the associated factors in multiple ways to 
exert their functions.  One of the first described examples was the X chromosome linked Xist 
RNA, whose expression is required for somatic silencing of one female X chromosome in 
mammals during dosage compensation, a process known as X inactivation [143].  By now, a 
complex interplay of partially overlapping and antisense RNAs has been identified that also 
includes RepA and Tsix. The Xist antagonist Tsix and RepA, which also contains sequences 
from the 5’ end of Xist, compete for binding to PRC2. Upon downregulation of Tsix on the 
future inactive X chromosome (Xi), RepA can efficiently recruit PRC2 to the Xi and activate 
expression of Xist. Xist then distributes PRC2 along the Xi, leading to H3K27me3, 
H2AK119Ub and ultimately DNA methylation and compaction of the Xi into the barr body 
([144] and reviewed in [145]).  Analogous to the mammalian situation, yet with an inverse 
outcome, roX (RNA on the X) RNAs are required for the transcriptional activation of the 
single male X chromosome during Drosophila dosage compensation, which will be discussed 
in more detail below. 
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 The recruitment of chromatin remodeling activities by lincRNAs turned out to be a 
widespread and general phenomenon. Another prominent example is the process of genomic 
imprinting in marsupials and eutherian species, during which genes get permanently repressed 
in the germ line of either the male or female sex. Here it has been shown that the 108 kb Air 
RNA tethers the H3K9 specific methyltransferase G9a to the Slc22a3 promoter during male 
specific silencing of the cis-linked Slc22a3, Slc22a2, and Igf2r genes in the placenta [146]. 
Similarly, the 90.5 kb long Kcnq1ot1 RNA mediates silencing of 10 paternally imprinted 
genes in the Kcnq1 domain by recruiting G9a and PRC2 [147]. Regulation by lincRNAs can 
also function in trans, as exemplified by the 2.2 kb HOTAIR, which is transcribed from the 
HOXC locus and mediates silencing across 40kb of the HOXD locus on another chromosome. 
HOTAIR is not only bound by Suz12 and Ezh2 in the PRC2 complex, but also recruits the 
LSD1 lysine demethylase, leading to coupled histone H3 lysine 27 methylation and lysine 4 
demethylation at the HOXD locus [148]. Another example involving recruitment of PRC2 is 
the repression of p53 target genes by the lincRNA-p21 upon activation of the p53 pathway 
[149]. In the meantime, thousands of PRC2 interacting RNAs have been identified, which are 
likely to orchestrate PRC2 function across the mammalian genome [150].  
To further increase the complexity of this new layer of genomic regulation, lincRNAs 
can exert their biological functions by a variety of additional mechanisms. They can recruit 
RNA binding proteins to modulate promoter function, like in the case of the cyclin D1 
promoter, where upon DNA damage lincRNAs recruit the TLS protein to inhibit the 
acetyltransferase activity of CREB and p300 and silence cyclin D1 expression [151]. They 
can also act as cofactors to promote transcription, as in the case of the Dlx6 gene in mice, 
where the lincRNA Evf2 recruits and activates the transcription factor DLX2 at an 
ultraconserved enhancer [152]. lincRNAs can directly control promoter choice by RNA PolII, 
for instance at the dihydrofolate reductase (DHFR) locus, where a lincRNA transcribed from 
an upstream locus can form a RNA/DNA triplex in the major promoter of DHFR that prevents 
recognition by TFIID [153]. Finally, lincRNAs can directly interact with basal components of 
the transcriptional machinery to modulate PolII function. For example, Alu elements that are 
transcribed by PolIII in humans upon heat shock can bind tightly to PolII to prevent the 
formation of active preinitiation complexes [154].  
A variety of other functions has been described for lincRNAs, involving diverse 
biological processes like mRNA splicing or the organization of nuclear speckles ([155], and 
reviewed in [156]), which are outside the scope of this introduction to chromatin, but again 
emphasize the diversity and regulatory potential of this relatively new class of molecules.  
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1.1.9 Functional states of chromatin 
The combined action of all the above mentioned mechanisms not only allows for the 
regulation of individual genes in response to environmental cues and developmental 
programs. They also enable the cell to establish functional chromatin states across extended 
genomic regions or even whole chromosomal territories. These functional states can vary in 
extent and molecular composition, and the consequences for transcription can range from 
hyperactivation, like on the male X chromosome in Drosophila dosage compensation, to gene 
repression as in polycomb mediated repression of HOX gene clusters during cell 
differentiation.  
In the oldest classification of distinct chromatin domains, well before the discovery of 
DNA as the carrier of the genetic information, heterochromatin and euchromatin had been 
defined as regions inside the nucleus, according to their susceptibility to staining with basic 
dyes [157]. Remarkably, until today, this very early classification has remained a useful 
criterion for the functional distinction of chromatin states. In general, the more condensed and 
closed architecture of heterochromatin renders it relatively inaccessible for transcription 
factors, resulting in low transcriptional activity. In contrast, euchromatin correlates with an 
open chromatin architecture; and high density gene clusters are found preferentially in open, 
euchromatic fibers [158]. However, there is no strict correlation with the gene expression 
status, since inactive genes can be found in euchromatic regions and some heterochromatic 
genes show active transcription [159]. An important distinction is made between constitutive 
and facultative heterochromatin. Constitutive heterochromatin mainly contains repetitive, 
gene-poor, and late replicating DNA sequences, such as transposable elements, telomeres and 
centromeres, is enriched for H3K9me2/3 and HP1 and is always compacted. In contrast, 
facultative heterochromatin can be actively condensed or decondensed, in order to shut off or 
activate embedded genes as part of developmental programs. The establishment of facultative 
heterochromatin is regulated by the polycomb/trithorax system and correlates with 
H3K27me3 in the repressed state. One interesting feature of heterochromatin is its ability to 
spread into neighboring chromatin regions. If a reporter gene is inserted into, or in close 
proximity to heterochromatin, its transcription can frequently become shut off, a well studied 
phenomenon known as position effect variegation (PEV). PEV has proven an invaluable tool 
for the identification of Su(var) and E(var) genes that suppress or enhance the formation and 
spreading of heterochromatin, respectively [160].  
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Very recently, several studies have suggested finer classifications of chromatin states, 
based on the comprehensive genome wide analysis of transcripts, histone modifications, 
chromosomal proteins, transcription factors, and nucleosome properties across developmental 
time courses and in multiple cell lines [141, 142, 161, 162]. It is now clear that functional 
states of chromatin cannot be predicted by the simple presence of a certain histone 
modification or non-histone protein. Instead, they are the integrated result of a vast number of 
protein factors, different RNA species and histone marks, which together orchestrate the 
formation of various chromatin environments with distinct properties. This concept becomes 
especially apparent during the process of X chromosome compensation in Drosophila, as I 
will exemplify in the final part of this introduction. 
 
1.2 Dosage compensation in Drosophila 
1.2.1 Sex chromosomes and the need for dosage compensation 
Complex genomes represent sophisticated networks, in which the expression of a gene 
is the result of the activity of many other genes [126]. Loss or gain of gene copy number has 
therefore the potential to disrupt the homeostasis of this intricate system, and genomic 
deletions are generally lethal in Drosophila when they include more than ~3% of the genome 
[163]. However, reoccurring copy number variation is not always the consequence of 
deleterious processes. In many organisms, sex determination involves an unequal distribution 
of sex chromosomes, leading to chromosomal aneuploidy in the heterogametic sex. The most 
common forms are the XX/XY system and the ZZ/ZW system, with males or females being 
the heterogametic sex, respectively (reviewed in [164, 165]). In a generally accepted model, 
the initial trigger for the evolution of sex chromosomes from a previously identical set of 
autosomes is the occurrence of a male-determining gene, which is only propagated in males. 
To be effective, recombination of this gene needs to be suppressed, creating a neo-Y 
chromosome that is unable to recombine with the corresponding sister chromosome, the 
future neo-X. Lack of recombination leads to progressive degeneration of the Y chromosome, 
rendering the male sex hemizygous for the genes encoded on the remaining X chromosome. 
To prevent the deleterious effect of this loss of gene dose, flies have evolved a dosage 
compensation system that upregulates transcription from the single male X chromosome by 
twofold (Figure 3, reviewed in [166]). Interestingly, all potential solutions to this problem 
have been realized throughout evolution. In humans, one female X chromosome is completely 
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shut off to equilibrate expression between the sexes, while in C. elegans (where the male sex 
has an X0 genotype) expression from both X chromosomes in hermaphrodites is repressed by 
half [167, 168]. In mammals and C. elegans, X chromosome repression in the homogametic 
sex would lead to an imbalance between X-linked and autosomal gene expression. Therefore, 
a second mechanism is thought to be active in these organisms that upregulates X-linked 
transcription in both sexes by an as yet unknown mechanism [169, 170].  Curiously, recent 
work in several bird and lepidopteran species of the female heterogametic ZZ/ZW type 
suggested that not all organisms have the same requirement to fully compensate transcription 
from unequally distributed sex chromosomes [171].   
 
 
 
Figure 3: Dosage compensation strategies. From [172]. 
In Drosophila, transcription from the single male X chromosome is upregulated by twofold. In 
mammals, transcription from one female X chromosome is silenced during X inactivation. In C. 
elegans, transcription from both female X chromosomes is repressed by half. It is believed that in 
mammals and C. elegans, X-linked transcription is generally activated by an independent mechanism 
to match autosomal expression levels. Upregulated chromosomes are in green; chromosomes 
subject to transcriptional enhancement and repression are in yellow; the letter ‘A‘ denotes 
autosomes. 
 
1.2.2 The MSL complex 
Drosophila dosage compensation is one of the oldest model systems for the study of 
chromatin and transcription regulation. Already in 1922 it was observed that hemizygous 
males have the same levels of eye pigmentation as heterozygous females [173]; and the term 
“dosage compensation” was later introduced based on the same phenomenon [174]. These 
observations were subsequently confirmed biochemically for enzymes encoded on the X 
chromosome [175]; and enhanced incorporation of  H3 uridine into RNA produced along the 
male X chromosome finally suggested that dosage compensation is achieved at the 
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transcriptional level [176]. The development of increasingly sophisticated genetic tools 
eventually led to the identification of the factors responsible for this transcriptional activation. 
After the first mutant allele of the male specific lethal gene MLE had been extracted from a 
natural population of D. melanogaster in Kofu, Japan [177], several genetic screens aimed at 
the identification of more genes with male specific phenotypes. These efforts soon lead to the 
identification of the male specific lethal 1 (MSL1), MSL2 and MSL3 proteins [178]. All 
MSLs were subsequently found to colocalize at hundreds of sites along the male X 
chromosome, suggesting a direct involvement in the transcriptional activation of X 
chromosomal genes [179-181]. MSL binding to X-linked chromatin was shown to be 
dependent on the MSL2 protein, which is not present in females due to translational 
repression by the master sex regulator sex-lethal [181-183], thereby ensuring male specificity 
of the dosage compensation process. Consistent with the idea that MSLs can directly 
modulate chromatin structure, it was also discovered that the male X chromosome in 
Drosophila is marked by high levels of H4K16ac, and that this hyper-acetylation is dependent 
on MSL function [179, 184]. Accordingly, a fifth MSL protein, males absent on the first 
(MOF), was identified soon after and shown to be a H4K16 specific histone acetyltransferase 
[185-187]. A model had emerged in which MSLs together bind to the male X chromosome as 
part of the dosage compensation complex (DCC), leading to hyper-acetylation and thus 
transcriptional activation of X-linked genes [188]. The DCC eventually turned out to be a 
ribonucleoprotein complex, when two additional functionally redundant non-coding RNAs 
(RNA on the X, roX1 and roX2) were identified as further essential components [189-192]. 
Interestingly, MLE was revealed in the meanwhile as the homologue of human RNA helicase 
A, and its ATPase activity is required for X chromosome targeting [193, 194]. Upon treatment 
with RNAse A, MLE is specifically removed from the male X chromosome [195]; and the 
delocalization of other MSLs observed in MLE mutants is very similar to the phenotypes 
resulting from the absence of both roX RNAs [191, 194].  
 
1.2.3 Programming of the male X chromosome 
Both roX RNA genes share another very interesting feature. Not only are their gene 
products components of the DCC, both genes are also located on the X chromosome and are 
themselves high affinity targets for DCC binding [196]. One early observation during the 
study of MSLs was the fact that, while MSL1 and MSL2 are absolutely essential for X 
chromosome targeting, core MSL complexes can bind to a subset of target loci throughout the 
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X chromosome even in the absence of MLE, MSL3 or MOF [180, 185, 197].  It was then 
shown that the roX genes retain their ability to nucleate MSL binding when moved to an 
autosomal location. Based on these observations a model was proposed in which the DCC 
would assemble with roX RNAs directly at their sites of transcription and then “spread” to 
other high affinity sites (HAS) on the X chromosome, and eventually to lower affinity binding 
sites [196]. Early attempts to define the nature of HAS in more detail, or to define consensus 
DNA sequences for MSL binding, were limited by the resolution of immunostainings and by 
the lack of more appropriate genome wide methods [198]. These limitations have been 
overcome in recent years by the development of whole genome microarrays and deep 
sequencing technologies. Coupled to chromatin immunoprecipitation (ChIP), ChIP-chip and 
ChIP-Sequencing methods have allowed to determine the HAS in high resolution, and to 
define corresponding DNA sequence motifs [199, 200]. At the same time, the precise MSL 
binding patterns on dosage compensated genes could be obtained, showing that MSLs are 
preferentially bound to the transcribed regions and 3’ ends of their target genes [201-203]. In 
addition, a series of targeting cues for the recruitment of MSLs to their low affinity targets 
have been identified recently, and we now begin to understand the formation of the dosage 
compensated X chromosome as a sophisticated multistep process. Using immuno-FISH and 
confocal microscopy it was shown that HAS cluster together upon MSL binding, thereby 
forming a three dimensional X chromosomal territory [204]. roX RNAs are expressed from 
within this territory, and the immediate assembly with MSL1 and MSL2 alters the chromatin 
binding properties of these proteins [205]. In combination with the local clustering of high 
affinity MSL binding sites, this leads to the retention of MSLs, forming an environment of 
high local MSL concentration [206]. It has been known for some time that spreading of the 
DCC to target sites of lower affinity throughout the X chromosome is dependent on overall 
MSL protein levels [207]. Indeed, the high MSL concentration within the X chromosomal 
territory allows the subsequent recognition of a combination of targeting cues in the 
transcribed region of X-linked genes, most of which would not be targeted by the DCC in any 
other chromosomal context. It has been shown using X to autosome translocations that these 
signals include the transcription dependent recognition of degenerate DNA sequences in the 
3’ end of dosage compensated genes [208]. Accordingly, the dependency of MSL spreading 
on the catalytic activity of MOF might be explained by the need to expose these signals 
through H4K16ac mediated relaxation of the chromatin structure [185]. However, DNA 
sequences are clearly not the only signal for MSL recruitment into the body of X linked 
genes, since autosomal genes can get recognized and compensated by the DCC when inserted 
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into the X chromosome, provided that they are actively transcribed [209]. Accordingly, 
transcription coupled histone modifications have been identified as additional signals for MSL 
recruitment. Soon after the finding that eaf3, the yeast homologue of MSL3, can bind to 
trimethylated H3K36 via its chromodomain [116, 117], it was shown that MSL binding 
highly correlates with the pattern of H3K36me3 on the male X chromosome in Drosophila, 
and that removal of the enzyme responsible for this histone mark leads to a loss of MSL  
spreading into X-linked genes [210, 211]. In line with these results, a similar phenotype was 
observed upon deletion of the MSL3 chromobarrel domain [212]. Interestingly however, no 
direct interaction could be detected between the MSL3 chromobarrel domain and an H3 
peptide trimethylated at K36. Instead the MSL3 chromobarrel domain was found to crystallize 
together with the N-terminal tail of histone H4 monomethylated at K20, suggesting a potential 
role of this mark for MSL function [213, 214]. Clearly more work is required to reveal all 
targeting cues that help to specifically direct the MSL complex to dosage compensated genes. 
However, the recent advances in our understanding have unraveled the general principle that a 
combination of transcription coupled signals is specifically recognized when located inside 
the especially programmed environment of the male X chromosome.  
 
1.2.4 Transcriptional activation 
The final step in this chain of events is the eventual upregulation of X-linked 
transcription. As discussed before, one hallmark of the dosage compensated X chromosome is 
the MOF mediated hyper-acetylation of H4K16, the only histone mark that directly affects 
chromatin compaction through the disruption of inter-nucleosomal contacts [98, 215]. 
Furthermore, it has been shown that tethering of MOF leads to transcriptional activation of a 
reporter gene in yeast [187], and H4K16ac is correlated with high transcription in S2 and KC 
cell lines [216]. It is therefore believed that the permissive chromatin structure associated with 
H4K16ac leads to increased transcription factor accessibility, less energy consuming 
progression of PolII through the chromatin template, and consequently transcriptional 
upregulation of the male X chromosome. However, final prove that H4K16ac is the direct 
cause of the transcriptional activation is still missing. In an alternative model, the mark would 
just serve to open up chromatin for the binding of other MSLs, which would then upregulate 
transcription using an independent mechanism. Also at which step in the transcription cycle 
dosage compensation is effective is still unknown. A recent study showed higher overall 
levels of PolII on the X chromosome in S2 cells and attributed this to enhanced release into 
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the transcribed regions of X-linked genes as well as higher PolII processivity  [217]. 
However, the authors did not compare this pattern of PolII to the female situation, leaving the 
possibility that differences in PolII levels at gene promoters might exist between sexes.   
 
1.2.5 Other factors 
Besides MSL proteins themselves, a number of other factors have been found 
associated with dosage compensation in Drosophila. The Jil-1 kinase phosphorylates serine 
10 of histone H3 and is found enriched on the male X chromosome [218]. The H3S10ph mark 
is thought to stabilize active chromatin conformations, but depletion of Jil-1 has only 
moderate effects on X-linked transcription [219]. Furthermore, normal levels of the 
heterochromatin protein Su(var)3-7, a known interactor of HP1, are required to maintain X 
chromosome structure [220, 221]; and massive bloating of the male X chromosome has been 
observed when the nucleosome remodeling factor (NURF) is inactivated [45, 46]. Conversely, 
bloating of the male X chromosome has been observed upon overexpression of the DNA 
supercoiling factor (SCF), which is also required for the compensation of X-linked genes 
[222].  In addition, it has been shown that wt levels of Upstream of N-ras (UNR), a necessary 
cofactor for translational repression of MSL2 in females, are critical for X chromosome 
targeting of the DCC in males [223]. Unexpectedly, also the nuclear pore components 
Nup153 and Mtor have been found associated with the MSL complex [224]. Both factors are 
required for targeting of the MSL complex and bind to extended regions on the male X 
chromosome [216]. It has been hypothesized that tethering to the nuclear pore might facilitate 
efficient export of X-linked transcripts from the nucleus, and both nucleoporins appear 
generally associated with actively transcribed region across the Drosophila genome [216]. To 
make the picture even more complex, recent work has suggested that genomic deletions and 
duplications on all chromosomes are transcriptionally compensated in Drosophila, and that 
the twofold activation we observe on the male X chromosome is the combined result of global 
as well as X specific compensation mechanisms [225, 226]. Analogue to the use of multiple 
targeting signals for DCC recruitment, it is conceivable that the combination of multiple 
compensation systems will result in the most robust transcriptional output, while ensuring 
flexibility at the individual gene level.  
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1.2.6 Integration of MOF into the dosage compensation complex 
Interestingly, all MSL proteins besides MSL2 are also present in females, and we are 
only beginning to understand their role in transcription regulation outside the context of the 
male X chromosome. In addition to its role in dosage compensation, MOF has recently been 
found at hundreds of active promoters across the whole genome in male and female cell lines, 
where it is bound as part of the newly identified Non-Specific Lethal (NSL) complex [215, 
224, 227]. While several studies have found H4K16ac at the 5´end of genes in Drosophila 
[215, 228, 229], it has remained unclear if MOF is active as a HAT at these sites, or if it has 
indeed any chromatin related function outside the context of the male X chromosome [230]. 
Furthermore, it is not known how MOF targeting and activity are differentially regulated and 
distributed between the NSL complex and the DCC. MOF contains a zinc finger in its C-
terminal HAT domain that is characteristic for the MYST family of acetyltransferases. In the 
case of Drosophila, this region has been shown to integrate MOF into the DCC by interaction 
with the PEHE domain of MSL1 [231]. Recently, a similar PEHE domain in NSL1, a member 
of the NSL complex, has been shown to interact at the same region [232]. Disruption of the 
MOF zinc finger furthermore prevents nucleosome binding of MOF in vitro [233]. Within the 
MSL complex there are two proteins that show similarities to chromo-like domains, MSL3 
and MOF. As mentioned before, the chromobarrel domain of Drosophila MSL3 has been 
shown to interact with DNA and monomethylated H4K20 [213, 214]. Accordingly, mutations 
in the MSL3 chromobarrel domain lead to reduced male viability, most likely due to defects 
in dosage compensation [213, 214, 234]. MOF also contains a chromobarrel domain, which in 
this case lacks the aromatic cage necessary for methyl lysine binding [235]. Instead, the MOF 
chromobarrel domain is required for MOF binding to roX RNAs in vitro and in vivo [236]. 
Remarkably however, ten years after this initial observation, the function and biological 
significance of the MOF chromobarrel domain have remained elusive. In fact, no biological 
role has been described for chromobarrel domains of the MOF-type in general, which are 
conserved in histone acetyltransferases from yeast to human [237]. In the absence of both roX 
RNAs or the RNA helicase MLE, MSLs are delocalized from the X chromosome and 
ectopically targeted to autosomal sites, the chromocenter and the 4th chromosome [185, 191]. 
In line with these results, MOF is delocalized from the X chromosome upon treatment of 
permeabilized nuclei with RNAse A [236]. Furthermore, deletion of a short “roX box” in 
roX2 leads to a specific reduction of H4K16ac on the male X chromosome, while MOF 
targeting itself remains unaffected [238, 239]. However, in marked contrast to the above 
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results, an earlier report suggested that the chromobarrel domain is dispensable for MOF 
function [231]. The remaining N-terminal half of the MOF protein appears inherently 
unstructured and has no functions assigned to it. Interestingly, although MOF has orthologs 
from yeast to mammals comprising a chromobarrel domain followed by a MYST-type HAT 
domain, the presence of a long N-terminal region is specific to Drosophila species. It seems 
therefore plausible that this domain is an evolutionarily late acquirement of Drosophila and 
involved in MOF functions that are specific to flies. 
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2. Aims and Objectives 
In the study presented in chapters 3 and 4, I set out to investigate the full extent of 
MOF functions inside and outside the context of the male X chromosome. I was furthermore 
interested to recapitulate how various domains in the MOF protein differentially regulate 
these functions in order to utilize this conserved HAT for dosage compensation in Drosophila 
species. I’ve been able to show that MOF is responsible for genome wide H4K16ac in male 
and female flies. Using ChIP-Sequencing (ChIP-Seq) we find that the vast majority of all 
active genes, X-linked as well as autosomal, are MOF targets in both sexes. MOF function is 
essential in females, since loss of MOF leads to a severe reduction in female number and 
lifespan. I next show that the Drosophila specific N-terminus of MOF controls assembly of 
the DCC on the male X chromosome, and the HAT activity of MOF. Therefore, it seems 
plausible that the addition of this region to the MOF protein in Drosophila, resulting in a 
twofold increased protein size compared to mammalian MOF, has allowed to diversify MOF 
functions and to utilize it for dosage compensation. In addition, I’ve been able to demonstrate 
that the MOF chromobarrel domain serves to trigger H4K16ac after MOF binding to 
chromatin in vivo and in vitro. Disruption of the chromobarrel domain leads to a genomewide 
loss of H4K16ac and consequently compromised MSL spreading into X-linked genes. 
Multiple levels of control therefore reflect the enhanced complexity of MOF functions in flies 
and the resulting need for increased context dependent regulation of MOF activity. All 
bioinformatics analysis involved in this work was performed by Florence Cavalli at the 
European Bioinformatics Institute in Hinxton. The main findings presented in chapter 4 are 
currently under peer review for publication. The submitted manuscript, which was written by 
myself, can be found in Appendix C. 
In chapter 5, I will describe ongoing work that aims at elucidating the mechanism of 
transcriptional upregulation of male X-linked genes during dosage compensation in 
Drosophila. To this end, I generated genomewide RNA PolII ChIP-Seq profiles from 3rd 
instar larva salivary glands from male, female and male MSL2 RNAi flies. Analysis of this 
data suggests that dosage compensation operates at the level of transcription initiation.  This 
result constitutes a major advance in the field of dosage compensation and is currently being 
verified by additional control experiments. 
 In chapter 6, I present my contributions to two major publications, in which I 
investigated the role of the H3K36 specific methyltransferase HypB/Set2 for dosage 
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compensation and the role of MOF for NSL function in Drosophila. Both original 
manuscripts can be found in Appendix A and B. 
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3.1 MOF is responsible for H4K16ac on all chromosomes in male and female flies 
In this study we first wanted to evaluate whether or not MOF is responsible for global H4K16 
acetylation, since a recent report focusing on a small set of autosomal gene promoters did not 
find a decrease in H4K16ac upon disruption of the MOF gene. However, the authors were 
unable to show that these regions were actual sites of MOF binding [230]. Therefore, in order 
to provide direct evidence that MOF acts as a HAT also outside the context of the male X 
chromosome, we performed immunostainings of male and female 3rd instar larva polytene 
chromosomes from wildtype (wt) and mof2 mutant flies that carry a premature stop codon and 
lack a functional MOF protein [185], using antibodies against MOF, MSL1 and H4K16ac. 
While the male X chromosome, marked by MSL1 staining, appeared enriched for H4K16ac in 
wt flies, we also detected widespread acetylation across autosomes as well as the 
chromocenter (Figure 4A). Likewise, female samples showed widespread H4K16ac, but no 
apparent enrichment on the X chromosomes, which also lacked MSL1 staining. Strikingly, 
H4K16ac was entirely lost from all chromosomes in male and female mof2 flies, in the 
absence of MOF. In the males, this was accompanied by reduced staining of MSL1 on the X 
chromosome in a pattern most likely corresponding to the previously described high affinity 
sites (HAS), and subsequent delocalization of MSL1 staining to autosomal sites.  Importantly, 
H4K16ac was restored on all chromosomes in both sexes upon expression of an HA-tagged 
MOF full length transgene (FL-MOF) in flies of the mof2 background. We recapitulated the 
same global MOF dependency of H4K16ac by western blots using extracts prepared from 3rd 
instar larvae (Figure 4B). Female wt flies showed about half the amount of global H4K16ac 
compared to wt males, reflecting the presence of the hyper-acetylated male X chromosome. In 
the absence of endogenous MOF in the mof2 background, H4K16ac levels were drastically 
reduced in males and females, while no significant differences were observed upon probing 
with antibodies against H4. Importantly, H4K16ac could again be globally restored in both 
sexes by expression of FL-MOF. This data clearly demonstrates that MOF is responsible for 
genomewide H4K16ac in Drosophila. 
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Figure 4. MOF is the major H4K16 specific HAT in the male and female genome. 
(A) Immunostaining of polytene chromosomes from male and female third instar larva salivary 
glands, using antibodies against H4K16ac, MSL1 and HA (MOF) as indicated. DNA staining is shown in 
blue (Hoechst 322). (B) Western blot analysis of extracts prepared from wt, mof2 and FL-MOF 
expressing male and female 3rd instar larva showing the effect of MOF depletion on H4K16ac  
 
3.2 MOF is essential for female survival 
Since MOF has been identified in a screen for male specific lethality, the obvious question 
arises, what the significance of MOF mediated H4K16ac is for female flies. Although a 
developmental delay and reduced fertility have been described for females homozygous for 
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the mof2 allele, that study did not assay for defects in female viability [230]. To address this 
question we generated homozygous mof2 females. When compared to control flies, the 
number of mof2 females reaching adulthood was reduced by approximately two-fold, and 
these flies were mostly sterile (Figure 5A). More strikingly however, the average lifespan of 
mof2 mutant female flies was drastically reduced to an average of 8 days as compared to 37 
days in the control flies with the same set of balancer chromosomes (Figure 5B). Furthermore, 
this reduction in lifespan was rescued efficiently by expression of a MOF transgene. This 
result strongly suggests that MOF mediated H4K16ac is essential for female survival, 
although one cannot rule out additional MOF functions that might contribute to this 
phenotype. 
 
 
 
Figure 5. MOF is essential for female viability.  
(A) Number of eclosed mof2 adults compared to the control carrying the wt MOF allele. While males 
show full lethality female number is reduced approx. two fold. Error bars represent the standard 
deviation from three independent experiments. (B) Lifespan of control, mof2, and FL-MOF expressing 
female flies after eclosion. Error bars represent the standard error of the mean. 
 
3.3 Most active genes are targeted by MOF and H4K16ac in both sexes 
A previous microarray based study performed in our laboratory correlating genome wide 
MOF binding and H4K16ac in male and female SL-2 and Kc cell lines was limited to the 
topmost 1% of signals in order to score the most stringent target sites, and was thus likely to 
underestimate the real number of MOF targets [215]. We therefore used antibodies against 
MOF and H4K16ac in chromatin immunoprecipitations followed by ChIP-Seq to obtain 
comprehensive genome-wide profiles from male and female 3rd instar larva salivary glands 
(Table A1). To control for differences in sonication efficiency and histone occupancy, we also 
sequenced ChIP material obtained with antibodies against histone H4, as well as the 
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corresponding input samples. The resulting profiles showed a good overlap between sites of 
MOF binding and H4K16ac in both sexes (Figure 6A).  
 
 
Figure 6. MOF acetylates promoters across the male and female genome.  
(A) Genomic patterns of MOF-binding and H4K16 acetylation. Screenshots of the Integrated Genome 
Browser show the patterns (log2FC values) of MOF-binding (dark colour) and H4K16 acetylation (light 
colour) in male (blue colour shades) and female (red colour shades) salivary glands along a 20kb 
section of chromosome 3L (left) and a 25 kb section of the X chromosome (right). Genomic 
coordinates and the locations of annotated Refseq genes on the forward (+) and reverse (-) strands 
are indicated below. (B) Profiles of MOF-binding and H4K16 acetylation along genes. The plots show 
the average log2FC signal for MOF-binding (red) and H4K16ac (black) along genes in wt males (left) 
and females (right). Log2FC signals are shown for the region surrounding the TSS (-2000bp to 
+2000bp) and for the 3’-end of the gene (3’-end to -2000bp upstream of the transcription 
termination site). Average log2FC values for X-linked and autosomal genes are represented by solid 
and dashed lines, respectively.  
 
While the male X chromosome displayed the previously described global enrichment for 
MOF and H4K16ac [215, 230], MOF and H4K16ac signals on autosomes and the female X 
chromosome appeared mostly restricted to gene promoters. To confirm that these 
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observations apply generally, we computed composite MOF and H4K16ac profiles by 
averaging the log2 fold-change values across all genes (Figure 6B). These distributions 
highlight distinct sex and chromosome specific patterns for MOF binding and H4K16ac. On 
the male X chromosome, MOF binds to the entire gene body, with peaks of increased binding 
at the promoter and the 3’-end of genes. On male autosomes and generally in females, MOF 
binds only at gene promoters. The pattern of H4K16 acetylation closely follows that of MOF 
binding [215]. Interestingly, we observe a shift of the H4K16ac signal downstream of gene 
promoters, most likely reflecting acetylation of the first nucleosome downstream of the 
transcription start site (TSS). We next used the pattern of MOF-binding to classify genes into 
three categories: (i) those with no binding; (ii) those that are bound in the promoter region; 
(iii) those that are fully bound along their whole length (table A2, for details see materials and 
methods). On the male X chromosome, 898 genes were fully bound by MOF, while 1,704 
genes were fully acetylated, corresponding to 75% and 94% of all active genes, respectively. 
In contrast, only one X-linked gene was fully bound by MOF in females and just 158 were 
fully acetylated, demonstrating that MOF binding and acetylation in the transcribed region of 
X-linked genes are specific to dosage compensated genes in males. We also detected 387 
genes on the male X chromosome that were bound by MOF only at their promoters and a 
much smaller group of 44 genes that showed MOF binding only in their transcribed regions 
(Figure 7).  
 
 
Figure 7. Profiles of MOF binding along X chromosomal genes  
Average log2FC signal for MOF-binding along X chromosomal genes in wt males classified as being 
bound only at gene promoters (A), gene promoters and full bodies (B) or exclusively at gene bodies 
(C). Log2FC signals are shown for the region surrounding the TSS (-2000bp to +2000bp) and for the 
3’-end of the gene (3’-end to -2000bp upstream of the transcription termination site). 
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Interestingly, most gene promoters of this latter group also appeared devoid of NSL proteins 
in our earlier analysis [227], again demonstrating that MOF binding to gene promoters 
happens in the context of the NSL complex (data not shown). Importantly, we also detected a 
large number of MOF bound (4830) and acetylated (4690) autosomal targets, with most of the 
signals located at gene promoters. This number includes a striking 81% (MOF) and 76% 
(H4K16ac) of all active autosomal genes, signifying the role of MOF for autosomal gene 
regulation. Similar numbers were found across all chromosomes in females. Genes positive 
for MOF binding and H4K16ac included most targets previously identified by Kind et al., 
however, due to the higher sensitivity of the ChIP-Seq technique the overall number of 
positive genes was more than doubled in either case (Figure 8).  
 
 
Figure 8. The ChIP-Seq approach is more sensitive compared to ChIP-chip 
Overlap of MOF-bound and H4K16–acetylated genes detected by the ChIP-chip analyses performed 
by Kind et al. (2008) from cell lines and our ChIP-seq analysis using third instar salivary gland samples. 
Both male and female samples are presented. 
 
Further evidence that H4K16ac at gene promoters is indeed mediated by MOF was provided 
by the good correlation between MOF binding and H4K16ac at gene promoters in both sexes 
(Figure 9). On autosomes, 83% (males) and 87% (females) of MOF-bound genes were also 
acetylated. Similarly, on the X chromosome, 98% of the male and 85% of the female MOF-
bound genes were acetylated at the same time. However, on the male X chromosome, we also 
detected 735 genes that were acetylated despite lacking MOF, suggesting spreading of MOF 
mediated H4K16 acetylation into neighboring genes. This is in agreement with a model in 
which transient DCC interactions can spread H4K16ac in large domains across the male X 
chromosome, even in the absence of detectable DCC binding [196, 215, 230]. We did not 
observe the same phenomenon on the female X chromosome.  
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Figure 9. MOF correlates with H4K16ac genome wide. 
Overlap in MOF-bound (left) and H4K16-acetylated (right) autosomal (top) and X-linked genes 
(bottom) genes between males and females. (D) Overlap of MOF-bound with H4K16-acetylated 
genes in wt males and females. Autosomal (left) and X-linked (right) genes were divided into three 
categories showing full (full), promoter-only (prom) or no (not) binding by MOF. For each category, 
the stacked barplot specifies the number of genes showing full (full), promoter-only (prom) or no 
(not) H4K16 acetylation. The numbers within each block indicate the percentage of genes within this 
block relative to all genes in the category.  
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Next, we compared MOF binding and H4K16ac between males and females. At X-
linked promoters, we found a high level of correlation between MOF binding in males and 
females (ρ=0.72). However, this correlation was lost when binding was compared for gene 
bodies (ρ=0.05), where MOF binding is specific for males. Similarly, H4K16ac correlated at 
gene promoters (ρ=0.54), but not along the body of genes (ρ=0.27). When comparing 
individual genes, we found that almost all female MOF-bound genes on the X chromosome 
(99%) are also MOF targets in males (Figure 10). A similar result was observed for H4K16ac. 
However, a significant proportion of genes was MOF-bound or acetylated (31% and 47%, 
respectively) only in males, reflecting male specific action of the DCC. On the autosomes, 
correlations between the sexes were high at promoters for both MOF and H4K16ac (ρ=0.77 
and ρ=0.86 respectively). Additionally, we found large overlaps between individual target 
genes: 98% of all autosomal MOF-bound genes in females were also bound by MOF in 
males, and 87% of the acetylated genes in females were also acetylated in males. These 
results suggest that outside the context of the DCC, MOF functions very similar in male and 
female flies. 
 
 
 
 
Figure 10. MOF regulates the same genes in male and female flies. 
Overlap in MOF-bound (left) and H4K16-acetylated (right) autosomal (top) and Xlinked genes 
(bottom) genes between males and females. 
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3.4 The MOF N-terminus controls DCC function 
The above analysis underscored the dual role that MOF plays in transcription regulation and 
dosage compensation in Drosophila. The increased diversity of MOF functions in Drosophila 
species implies the necessity for tight regulation of MOF targeting and activity. We therefore 
wanted to dissect the molecular mechanisms that orchestrate these functions to utilize this 
evolutionary conserved transcriptional regulator for compensation of the male X 
chromosome. A hallmark of MOF in Drosophila species is the presence of a long N-terminal 
segment that is absent in other organisms (Figure 11).  
 
 
 
 
Figure 11. The MOF N-terminus is specific to Drosophila species 
Alignment of the MOF amino acid sequence in different animal species. Evolutionary distance 
between Drosophila melanogaster and D. virilis is approx. 55 mio years, D. melanogaster and D. 
sechellia approx. 2,5 mio years. Sequence conservation is indicated by darker greyscales. 
 
This region shows relatively little sequence conservation and is variable in length between 
different Drosophila species. In Drosophila melanogaster the first 350 amino acids of MOF 
do not contain any known protein domains and appear as largely unstructured in secondary 
structure predictions. So far no function has been assigned to this region, which comprises 
about half of the MOF protein; however the absence of this part in organisms with different 
modes of dosage compensation suggest a specific requirement of the MOF N-terminus for this 
process. To test if the N-terminus carries essential functions in vivo, we assayed the capability 
of a series of MOF mutant proteins to rescue the male lethal phenotype associated with the 
loss of endogenous MOF.  
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Figure 12. MOF transgenes analyzed in this study 
(A) Schematic representation of the domain structure of the known MOF alleles mof1 and mof2, as 
well as the MOF derivatives generated for this study. Globular domains in the MOF protein are the 
chromobarrel domain (chromo), the C-terminal HAT domain (HAT) containing a zinc finger (Zn). G691 
is located in the catalytic center of the MOF HAT domain. Y416D and W426G reside in the 
chromobarrel domain and disrupt RNA binding. 
 
To this end we introduced HA-tagged MOF transgenes by p-element mediated transformation 
into flies, including a control construct comprising full length MOF (FL-MOF) and a series of 
deletions in the N-terminal half of the MOF protein, ∆1 (∆ 176-228), ∆ 2 (∆ 241-357), ∆ 3 (∆ 
98-357) and ∆N (∆ 1-349) (Figure 12). All transgenes were expressed to wt levels upon 
induction with armadillo-Gal4, as determined by western blot (Figure 13). Full length HA-
tagged MOF completely rescued male lethality in this assay when compared to heterozygous 
mof2 females resulting from the same cross (Figure 14A).  In contrast, male viability was 
increasingly compromised up to ~90% upon progressive deletions of the N-terminal region. 
This result demonstrates that this part of the protein is essential for MOF function. Having 
confirmed the essential nature of the N-terminal domain for MOF function, we wanted to 
assay for defects in MOF targeting to X-linked genes or autosomes, DCC recruitment to the X 
chromosome, and general H4K16ac.  
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Figure 13. MOF transgenes are expressed to wt levels. 
(A-H) Western blot analysis using extracts from male adult fly heads expressing the indicated 
transgenes. Two to three independent lines were analyzed for each mutant variant. Tubulin (Tub) 
was used a loading control. 
 
We again performed immunostainings of 3rd instar larva polytene chromosomes from male 
flies that express MOF transgenes in the mof2 background. Upon immunostaining with anti-
HA antibodies, FL-MOF appeared in a wildtype pattern, showing pronounced enrichment on 
the X chromosome but also clear targeting to all autosomes (Figure 14B). This was 
accompanied by widespread H4K16ac, which appeared enriched on the X chromosome, while 
MSL1 staining remained restricted to the X, all reflecting wt DCC targeting and function. 
This data once more confirmed the functionality of the full length HA-tagged MOF protein in 
vivo. Strikingly, in the absence of the MOF N-terminus, preferential targeting of MOF to the 
male X chromosome was entirely lost. Also the staining of autosomal bands appeared 
reduced. Furthermore, we detected ectopic binding of MOF to the chromocenter.  
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Figure 14. The N-terminal domain of MOF controls DCC function 
(A) Rescue of male viability by expression of MOF transgenes in the mof2 background. Percentages 
refer to the number of mof2 males compared to the number of heterozygous mof2 females from the 
same cross. (B) Immunostaining of polytene chromosomes from mof2 male third instar larvae 
salivary glands expressing FL-MOF and ∆N MOF transgenes. Antibodies against HA (MOF), MSL1 and 
H4K16ac were used as indicated in the figure. DNA staining is shown in blue (Hoechst 322).  
 
At the same time MSL1 staining was reminiscent of the patterns that have been observed in 
the absence of both roX RNAs [191], with a nearly complete delocalization of MSLs from the 
X chromosome, accompanied by severe ectopic binding to autosomal sites and the 
chromocenter. Indeed, when we measured the levels of roX RNAs in the ∆N mutant 
background we found a severe depletion of roX2 by more than 98%, suggesting that the N-
terminus of MOF is required for proper incorporation of roXs into the DCC (Figure 15). This 
reduction was even more severe than the one observed in the absence of MOF, where core 
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MSL complexes reside together with roX RNAs at high affinity sites, suggesting that roX 
RNAs cannot be incorporated into the DCC when a truncated MOF protein is present in the 
complex. 
 
 
Figure 15. Degradation of roX RNA in the absence of the MOF N-terminus. 
roX2 levels in mof2 male larva salivary glands expressing MOF transgenes as indicated. Transcript 
levels were normalized to roX2 DNA recovered from the same sample.  
 
Surprisingly however, although general chromatin targeting of ∆N MOF appeared reduced, 
we still detected widespread H4K16ac on all chromosomes (Figure 14B bottom panel). To get 
a more detailed insight into the defects in autosomal vs. X chromosome targeting of the ∆N 
MOF protein, we performed ChIP from male 3rd instar larva to monitor MOF binding, 
H4K16ac and DCC recruitment at higher resolution. Chromatin was immunoprecipitated, 
using antibodies against MOF, H4K16ac, MSL1 and MSL3. The recovered DNA was 
measured by quantitative real-time PCR (qPCR). We assayed MOF binding and H4K16ac at 
the promoter regions of the autosomal genes cg6729, cg6884, cg31866, cg2708 and cg7638 
and at two non-targets, bt and cg3937. To monitor MOF function on the X chromosome, we 
used the known high affinity sites (HAS) at the roX2 gene and an additional HAS at the 
cytological location 15A8, which had previously been identified in an MSL3 mutant 
background [199]. We also included sites at the promoter, middle and 3’end of three X-linked 
genes, Rpl22, Klp3a and Ucp4a. The first one of these, Rpl22, previously showed some MSL 
binding in the absence of MSL3 and can thus be described as a medium affinity site, while the 
remaining two genes are low affinity MSL targets [199].  
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Figure 16. The MOF N-terminus is required for MSL targeting  
(A) ChIP using MOF (upper panel), and H4K16ac (lower panel) antibodies in wt male 3rd instar larva as 
well as mof2 larva or mof2 larva that express FL-MOF or ∆N MOF transgenes. Binding to the 
autosomal genes bt, cg3937, cg6729, cg6884, cg31866, cg2709, cg7638, the X-linked high affinity 
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sites at the roX2 gene and location 15A8, as well as the X chromosomal genes Rpl22, Klp3a, and 
Ucp4a is shown. Primers were positioned at the promoter (P), middle (M), and end (E) of genes. The 
exact position of the primers is described in the Supplemental Data. ChIP is shown as percentage 
recovery of input DNA (% Input). Error bars represent standard deviation (StDev) of three 
independent experiments. (B) FL-MOF fully restores MSL binding. ChIP using MSL1 antibodies in wt 
male 3rd instar larva as well as mof2 larva or mof2 larva that express FL-MOF or ∆N MOF transgenes. 
Binding to the X-linked high affinity sites at the roX2 gene and location 15A8, as well as the X 
chromosomal genes Rpl22, Klp3a, and Ucp4a is shown. PKA is used as a negative control. Primers 
were positioned at the promoter (P), middle (M), and end (E) of genes. (C) ChIP as in (B) using 
antibodies against MSL3. 
 
 
The pattern of FL-MOF binding in the mof2 background was indistinguishable from the one 
observed for endogenous MOF in the wt, with clear binding to autosomal promoters, to the 
promoter and transcribed region of X-linked genes and to HAS (Figure 16A). MOF binding 
was accompanied by H4K16ac at all of these loci in the wt and FL-MOF background. Upon 
removal of endogenous MOF in the mof2 background alone, MOF binding and H4K16ac 
were both lost from all sites tested. Accordingly, targeting of MSL1 and MSL3 was lost from 
the body of X-linked genes in the mof2 background, but was restored to the wt pattern upon 
expression of FL-MOF (Figure 16B, C). Interestingly, the 15A8 HAS, which had been 
identified in an MSL3 mutant background, was no longer bound by MSL1 in the absence of 
MOF, demonstrating the qualitative differences among high-affinity sites in varying genetic 
backgrounds [232]. Confirming immunostainings, binding of the truncated ∆N MOF was lost 
from the transcribed regions of low affinity target genes on the X chromosome, but also 
strongly diminished at X-linked promoters and HAS (Figure 16A). Compromised MOF 
binding was accompanied by a loss of MSL1 and MSL3 from the same target sites (Figure 
16B, C). Importantly, MSL1 was also lost from the roX2 high affinity site, most likely as a 
result of low roX RNA levels and compromised DCC assembly. Chromatin binding of ∆N 
MOF was also approximately twofold reduced at the promoters of X-linked and autosomal 
genes. We therefore asked if reduced promoter binding of ∆N MOF reflects compromised 
integration into the NSL complex. To address this question, we generated SL-2 cell lines 
stably expressing Flag-tagged FL MOF, and ∆N MOF transgenes. After immunoprecipitation 
with anti-Flag antibodies followed by western blotting, membranes were probed against Flag, 
NSL1, NSL3 and MCRS2, as well as MSL1, MSL2 and MSL3. In this assay, FL MOF was 
stably interacting with all other complex partners. Deletion of the MOF N-terminus did not 
have an apparent effect on the interactions with individual MSL proteins. Importantly 
 Results 
59 
 
however, interactions with all three members of the NSL complex were clearly diminished, 
consistent with reduced targeting of ∆N MOF to gene promoters (Figure 17). Together, these 
results suggest a dual function of the Drosophila specific N-terminus of MOF, which controls 
MOF integration into the NSL complex as well as DCC assembly on the male X 
chromosome. 
 
 
 
Figure 17. The MOF N-terminus is required for incorporation into the NSL complex, provided by 
Erinc Hallacli. 
Coimmunoprecipitations were performed from nuclear extracts obtained from SL-2 cell lines stably 
expressing FLAG-tagged wt, Y416D and ∆N MOF. Input material and immunocomplexes were 
subjected to western blot analysis using the indicated antibodies for detection.   
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3.5 The N-terminus constrains MOFs enzymatic activity 
The high levels of H4K16ac that we detected in the presence of ∆N MOF in vivo, although 
chromatin targeting of the enzyme itself was reduced, suggested a potentially altered activity 
level of ∆N MOF. We therefore wanted to directly measure the enzymatic activity of the ∆N 
MOF protein. To this end we generated baculoviruses carrying the HA-tagged FL MOF and 
∆N MOF constructs to induce expression in SF21 cells for subsequent purification of the 
recombinant proteins. We then performed in vitro HAT assays on purified endogenous 
nucleosomes, using FL MOF and ∆N MOF proteins that were copurified with MSL1 and 
MSL3 to yield enzymatically active trimeric complexes [231]. In this assay, ∆N MOF 
containing trimeric complexes showed an about five-fold increase in acetylation activity 
compared to FL MOF, while monomeric FL MOF and ∆N MOF had the same low levels of 
residual activity (Figure 18). This result suggests that an autoregulatory function in the N-
terminal domain of MOF constrains its enzymatic activity, and explains why levels of 
H4K16ac remain high in vivo although targeting of ∆N MOF to chromatin is impaired. 
Compromised DCC targeting to the X chromosome in the presence of ∆N is thus likely the 
result of defects in complex assembly and roX degradation in vivo rather than of a reduction 
in H4K16ac.  
 
 
 
Figure 18. The MOF N-terminus constrains HAT activity, provided by Herbert Holz. 
Acetylation assay on native nucleosomes. Each reaction contains 5 nM of FL or ∆N MOF proteins, 
with or without MSL1 and MSL3, respectively, and 1.5 μg of native nucleosomes purified from MCF-7 
cells. 
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3.6 The Zn finger of MOF is required for targeting to the X and autosomes 
Previous work had identified the zinc finger region in the HAT domain of MOF as required 
for interaction with MSL1 and for nucleosome binding [231, 233]. Accordingly, an 
overexpressed MOF variant with a disrupted zinc finger lost the characteristic enrichment on 
the X chromosomal territory upon immunostaining in male SL-2 cells. Recently, the same 
region of MOF has been shown to mediate interactions with the NSL complex via NSL1 
[232]. We therefore wanted to ask if the zinc finger cooperates with the N-terminal domain in 
MOF regulation, and if disruption of the zinc finger would thus lead to similar phenotypes.  
 
 
 
Figure 19. The zinc finger region is required for general chromatin targeting  
(A) Immunostaining of polytene chromosomes from mof2 male third instar larvae salivary glands 
expressing the ∆Zn MOF transgene, using antibodies against H4K16ac, MSL1 and HA (MOF) as 
indicated. DNA staining is shown in blue (Hoechst 322). (B) Immunostaining of salivary glands from 
mof2 male third instar larvae expressing the FL-MOF or ∆Zn MOF transgene, using antibodies against 
HA (MOF) and MSL1 as indicated. DNA staining is shown in blue (Hoechst 322). 
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Figure 20. The zinc finger region is required for chromatin binding of MOF 
(A) Chromatin immunoprecipitation (ChIP) using MOF (upper panel), and H4K16ac (lower panel) 
antibodies in mof2 male 3rd instar larva expressing FL-MOF (black) or ∆Zn MOF transgenes (grey). 
Binding to the autosomal genes bt, cg3937, cg6729, cg6884, cg31866, cg2709, cg7638, the X-linked 
high affinity sites at the roX2 gene and location 15A8, as well as the X chromosomal genes Rpl22, 
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Klp3a, and Ucp4a is shown. Primers were positioned at the promoter (P), middle (M), and end (E) of 
genes. The exact position of the primers is described in the Supplemental Data. ChIP is shown as 
percentage recovery of input DNA (% Input). Error bars represent standard deviation (StDev) of three 
independent experiments. (B) MSL1 recruitment to the male X chromosome is lost in the presence of 
∆Zn MOF. ChIP using MSL1 antibodies in mof2 male 3rd instar larva expressing FL-MOF (black) or ∆Zn 
MOF transgenes (grey). Binding to the X-linked high affinity sites at the roX2 gene and location 15A8, 
as well as the X chromosomal genes Rpl22, Klp3a, and Ucp4a, as well as the autosomal PKA gene is 
shown. PKA is used as a negative control. Primers were positioned at the promoter (P), middle (M), 
and end (E) of genes. (C) ChIP as in (B) using antibodies against MSL3. 
 
A construct carrying a short deletion comprising the zinc finger region, ∆Zn MOF (∆565-
587), was unable to rescue the male specific phenotype of the mof2 background, confirming 
the essential nature of this domain (Figure 13 and 14A). However, the phenotypes observed 
upon immunostaining differed markedly from the ones observed in ∆N MOF. Suggesting a 
general defect in chromatin binding, ∆Zn MOF was no longer detectable on polytene 
chromosomes (Figure 19A), while at the same time immunostaining of whole mount salivary 
glands verified the nuclear localization of the ∆Zn MOF protein (Figure 19B). Consistently, 
failure of ∆Zn MOF targeting led to a complete loss of H4K16ac staining from all 
chromosomes. As a consequence, MSL1 appeared restricted to HAS on the X chromosome 
and showed enhanced binding to autosomes, corresponding to the pattern observed in the 
mof2 background alone. This result was verified by ChIP, showing a complete loss of ∆Zn 
MOF from all target sites (Figure 20A). Disrupted chromatin binding was accompanied by a 
concomitant loss of H4K16ac, and consequently compromised spreading of MSL1 and MSL3 
into X-linked genes (Figure 20A, B, C). These data suggest that the zinc finger region is 
required for basic functionality of MOF, with respect to all chromatin related tasks. This is in 
marked contrast to the N-terminal domain, which rather controls the distribution and activity 
of MOF to carry out its diverse functions. 
 
3.7 The chromobarrel domain is required for global H4K16ac 
Two point mutations in the MOF chromobarrel domain at Tyr416 and Trp426 were 
previously shown to disrupt MOF’s interaction with roX RNA in vitro and in vivo [236], and 
the corresponding residues have been shown to be required for nucleic acid binding in Esa1, a 
closely related HAT in yeast (Figure 21A). To verify that the MOF chromobarrel domain 
directly interacts with RNA, we generated plasmids containing the chromobarrel domain of 
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MOF (amino acids 346-448) with an N-terminal 6 His-tag for bacterial expression. The 
recombinant protein was purified and used in and electromobility gel shift assay (EMSA). 
Indeed, bacterial expressed wt chromobarrel domain directly interacted with a single stranded 
RNA probe in this experiment, and this interaction was lost upon mutation of Tyr416 or 
Trp426 (Figure 21B, C).  
 
 
 
 
Figure 21. The MOF chromobarrel domain interacts with RNA, provided by Ibrahim Ilik. 
(A) Ribbon diagram of the Drosophila MOF chromo-barrel domain (left panel). Residues Tyr416 and 
Trp426 are shown as sticks. Structure of the yeast Esa1 chromodomain (residues 17-89, middle 
panel) in the same orientation as MOF. Structure of the extended chromodomain of yeast Esa1 
(residues 1-89, right panel). The N- and C- termini form a short β-sheet and a loop following Tyr56 
changes its conformation. (B-C) The MOF chromobarrel domain interacts with RNA. (B) MOF 
chromobarrel domain (amino acids 346-448, lanes 1-2) and two point mutants (Y416D, lanes 3-4 and 
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W426G, lanes  5-6) were expressed in BL21 (DE3) cells and purified over Ni-NTA. 1-2µg protein was 
loaded onto a 4-12% PAA gel and stained with GelCode Blue. (C) EMSA carried out with 25-50-100ng 
of protein and α32P-CTP labeled RNA (84nt, single-stranded) shows that wild-type chromodomain 
(lanes 2-4) interacts with RNA and forms protein-RNA complexes.  In point mutants Y416D and 
W426G this interaction seems to be completely abolished (lanes 5-10). Lane 1 contains radiolabeled 
RNA without any protein. 
 
Surprisingly, a later study claimed that the MOF chromobarrel domain had a minor 
role to play in dosage compensation [231]. However, this study only tested the capacity of 
MOF to target to the X chromosomal territory by simply overexpressing MOF variants in a 
male cell line, leaving the possibility that potential defects in MOF function have been 
masked by the presence of the endogenous protein. Since the chromobarrel domain is required 
for MOF interaction with roX RNA, we expected to find similar effects on DCC targeting in 
Y416D and W426G MOF expressing flies as the ones observed in the presence of ∆N MOF, 
where roX RNA levels are strongly diminished. Strikingly, overexpression of MOF variants 
carrying point mutations in the chromobarrel domain (Y416D and W426G) failed to rescue 
male lethality of the mof2 background (Figure 13 and 14A). This result clearly shows that the 
essential nature of the MOF chromobarrel domain had been overlooked in previous 
experimental setups. Intriguingly however, the observed phenotypes differed substantially in 
further analysis. Upon disruption of the chromobarrel domain, we only found a moderate 
reduction in roX2 levels in vivo (Figure 22).  
 
 
Figure 22. Moderate reduction of roX levels upon disruption of the chromobarrel domain. 
roX2 levels in mof2 male larva salivary glands expressing MOF transgenes as indicated. Transcript 
levels were normalized to roX2 DNA recovered from the same sample.  
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Figure 23. The chromobarrel domain is required for H4K16ac. 
Immunostaining of polytene chromosomes from mof2 male third instar larva salivary glands 
expressing W416G or Y416D MOF as indicated, using antibodies against HA (MOF), MSL1 and 
H4K16ac. DNA staining is shown in blue (Hoechst 322). 
 
Furthermore, Y416D and W426G MOF were still detected across all autosomes in 
immunostainings, and appeared enriched on the X chromosome (Figure 23). This result 
suggested that both chromobarrel domain mutants integrate into the NSL complex as well as 
the DCC. Indeed, when we immunoprecipitated stably expressed FLAG-tagged Y416D MOF 
from SL-2 cells, interactions to other MSLs appeared only slightly reduced while interactions 
to NSL complex members remained unaffected (Figure 17). To our great surprise however, 
upon immunostaining of polytene chromosomes with antibodies against H4K16ac, we saw a 
severe reduction of the histone mark across all chromosomes for both chromobarrel domain 
mutants (Figure 23). This suggested a more general role of the chromobarrel domain than 
previously anticipated, which seems to involve the activation of MOFs enzymatic capacity 
after its initial recruitment to chromatin, irrespective of the chromosomal context. Considering 
the dramatic reduction of H4K16ac upon disruption of the MOF chromobarrel domain, we 
wanted to assay for defects in chromatin targeting at higher resolution.  
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Figure 24. The chromobarrel domain is required for MSL spreading but not promoter binding. 
(A) MOF targeting is lost from the male X chromosome but retained at autosomal promoters in the 
presence of Y416D MOF, while H4K16ac is lost globally. ChIP using MOF (upper panel), and H4K16ac 
(lower panel) antibodies in mof2 male 3rd instar larva expressing FL-MOF (black) or Y416D MOF 
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transgenes (grey). Binding to the autosomal genes bt, cg3937, cg6729, cg6884, cg31866, cg2709, 
cg7638, the X-linked high affinity sites at the roX2 gene and location 15A8, as well as the X 
chromosomal genes Rpl22, Klp3a, and Ucp4a is shown. Primers were positioned at the promoter (P), 
middle (M), and end (E) of genes. The exact position of the primers is described in the Supplemental 
Data. ChIP is shown as percentage recovery of input DNA (% Input). Error bars represent standard 
deviation (StDev) of three independent experiments. (B) MSL1 recruitment is lost from the 
transcribed region of X-linked genes in the presence of Y416D MOF. ChIP using MSL1 antibodies in 
mof2 male 3rd instar larva expressing FL-MOF (black) or Y416D MOF transgenes (grey). Binding to the 
X-linked high affinity sites at the roX2 gene and location 15A8, the X chromosomal genes Rpl22, 
Klp3a, and Ucp4a, as well as the autosomal PKA gene is shown. Primers were positioned at the 
promoter (P), middle (M), and end (E) of genes. (C) ChIP as in (B) using antibodies against MSL3. 
 
To this end, we performed ChIP from Y416D MOF expressing male 3rd instar larva to 
monitor differences in MOF binding, H4K16ac and DCC recruitment. Disruption of the 
chromobarrel domain had diverse effects on MOF targeting. The Y416D mutant MOF protein 
showed no difference in binding to gene promoters and the roX2 HAS (Figure 24A). 
However, binding to the 15A8 HAS and the transcribed region of Rpl22 was twofold reduced, 
while targeting to the transcribed region of the low affinity genes Klp3a and UCP4a was 
completely lost. This data indicated a specific defect in chromatin targeting of Y416D MOF 
as part of the DCC, while DCC independent binding to gene promoters remained unaffected. 
Indeed, when we assayed X-linked target sites for MSL binding, the pattern observed in the 
presence of Y416D MOF was very similar to the one observed in the mof2 background, 
showing a loss of MSL1 and MSL3 from the 3’end of low affinity target genes (Figure 24B). 
Together, these data confirmed the observation from immunostainings that disruption of the 
chromobarrel domain impairs DCC targeting to low affinity target sites.  We next analyzed 
H4K16ac across X-linked and autosomal target sites in the presence of Y416D MOF. 
Strikingly, H4K16ac was strongly reduced across all sites, including gene promoters and 
HAS, where the Y416D MOF protein was still readily detected (Figure 24A). This result 
suggests that the chromobarrel domain serves to trigger MOFs catalytic activity after initial 
recruitment of MOF to its chromatin targets. The observed loss of H4K16ac was striking and 
surprising. We therefore performed western blots from 3rd instar larva extracts to confirm the 
global reduction in H4K16ac by an independent method. When probing with HA antibodies, 
we found that all five MOF transgenes were stably expressed to similar levels (Figure 25). 
Antibodies against tubulin and unmodified histone H4 were used as loading controls. MSL1 
levels appeared clearly diminished in the presence of ∆Zn, ∆N, Y416D and W426G MOF, 
reflecting compromised MSL complex assembly on X linked genes. MSL3 seemed less 
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destabilized in the presence of Y416D MOF, but mirrored MSL1 levels in all other mutant 
backgrounds. FL-MOF efficiently rescued the mof2-mediated loss of H4K16ac to wt levels. 
No H4K16ac was detected upon deletion of the zinc finger in ∆Zn MOF, reflecting 
compromised chromatin targeting of this mutant. Consistent with our previous analysis, 
substantial amounts of H4K16ac could be detected after deletion of the N-terminus in ∆N 
MOF. Strikingly however, global H4K16ac levels were dramatically reduced in both 
chromobarrel domain mutants, confirming the general role of this domain for genome-wide 
H4K16ac. To control for the specificity of the assay we also probed against H4K5ac as well 
as H4K8ac and H4K12ac. These histone marks are not mediated by MOF in Drosophila, and 
remained unchanged in each of the MOF mutants analyzed (Figure 25 and data not shown). 
 
 
 
  
Figure 25. The chromobarrel domain is required foer bulk H4K16ac. 
Western blot analysis of extracts from mof2 male 3rd instar larva expressing the indicated MOF 
transgenes. Membranes were probed with antibodies as indicated. 
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3.8 The chromobarrel domain triggers acetylation after nucleosome binding 
In order to recapitulate the requirement of the chromobarrel domain for MOF HAT activity in 
vitro, we again generated baculoviruses to express and purify Y416D and W426G MOF 
proteins from SF21 cells and performed HAT assays on nucleosomal substrates. Consistent 
with our in vivo observations, H4 directed acetylation activity was approximately three- to 
five-fold reduced in trimeric complexes containing Y416D and W426G MOF, as compared to 
FL MOF (Figure 26A and data not shown). This reduction was specific to nucleosomal 
substrates, since the same trimeric complexes showed comparable activities towards free 
histones, which also confirmed functionality of the MOF HAT domain itself (Figure 26B). 
The activity of ∆N MOF containing trimeric complexes towards free histones was slightly 
enhanced, although the increase was not as pronounced as on a nucleosomal substrate.  
 
 
 
 
Figure 26. The MOF chromobarrel domain triggers H4K16ac after nucleosome binding, provided by 
Herbert Holz. 
(A) Acetylation assay on native nucleosomes. Each reaction contains 5.3 nM of FL, Y416D or W426G 
MOF proteins, with or without MSL1 and MSL3, respectively, and 1.5 μg of native nucleosomes 
purified from MCF-7 cells. (B) Acetylation assay on free histone octamers. 40 ng (21.3 nM) of the 
indicated recombinant MOF-protein or trimeric complexes were incubated with C14 labeled acetyl 
coenzyme A and 1,5 µg of recombinant  (Xenopus) histone octamer. The reaction was then applied 
on a P81 filter paper, air dried, washed and counted in scintillation liquid. 
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We then wanted to ask at which step of initial substrate binding and subsequent 
acetylation the chromobarrel domain functions. To address this question we performed 
affinity purifications of trimeric complexes using biotinylated DNA or mononucleosomes 
coupled to streptavidin beads. Nucleosome binding of trimeric complexes containing the ∆N 
MOF protein was slightly weakened as compared to FL MOF (Figure 27). This result further 
highlights the enhanced enzymatic activity of ∆N MOF on the same substrate. Strikingly, 
trimeric complexes containing Y416D and W426G MOF proteins bound as efficiently to the 
nucleosomal substrate as FL MOF trimeric complexes. Initial binding to the nucleosome is 
thus independent of a functional chromobarrel domain, which is then required to activate the 
subsequent acetylation of the H4 tail. 
 
 
 
 
 
Figure 27. The chromobarrel domain is not required for nucleosome binding, provided by Herbert 
Holz.  
Nucleosome pull down experiments are shown using trimeric complexes containing FL, Y416D, 
W426G or ∆N MOF together with MSL1 and MSL3 proteins. Purified endogenous histone octamers 
from Drosophila embryos were wrapped with 147 bp biotinylated DNA to assemble 
mononucleosomes and coupled to streptavidin beads. After incubation with trimeric complexes and 
stringent washing, MOF binding was detected by western blot analysis using HA antibodies. 5% of the 
Input material, IP using empty streptavidin beads as a control (mock-IP), and nucleosome IP (nuc-IP) 
are shown. 
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4.1 MOF is the major H4K16 specific HAT in Drosophila 
Since the recent discovery that MOF resides at autosomal gene promoters as part of 
the NSL complex, the full extent of MOF function at these sites has remained elusive [215, 
227, 230]. Disruption of other NSL complex members leads to lethality in males and females 
[224]. This suggested that MOF is not strictly necessary for NSL complex function, since 
adult female flies can be recovered in the absence of MOF [186]. However, although MOF 
was identified in a screen for male specific lethality, this study did not address defects in 
female viability. We now show that MOF is indeed an essential gene in both sexes, since the 
number of females reaching adulthood, and especially female lifetime, are drastically reduced 
in the absence of MOF. Furthermore, the contribution of MOF to H4K16ac at gene promoters 
had previously remained unclear [230]. Our data demonstrates that, in addition to its role in X 
chromosome dosage compensation, MOF is targeted to the vast majority of all active gene 
promoters in male and female flies. Importantly, we also show that in the absence of MOF, 
H4K16ac is lost from all MOF target sites in the male and female genome. In fact, bulk 
H4K16ac is lost genome wide in 3rd instar larva upon disruption of MOF in both sexes, 
suggesting that MOF is the major H4K16ac specific HAT in Drosophila. However, since a 
recent study showed that ATAC2 is contributing to bulk H4K16ac during embryonic 
development [240], the possibility remains that additional enzymes might have the capacity to 
mediate H4K16ac in certain developmental stages or tissues. Interestingly, bulk H4K16ac is 
also strongly diminished in human cells upon RNAi of the close homologue hMOF [241, 
242], and it has subsequently been shown that hMOF is targeted to thousands of gene 
promoters across the human genome [243]. It is noteworthy that dosage compensation in 
mammals does not involve MSL proteins, and accordingly hMOF does not appear enriched 
on the mammalian X chromosome [243]. The most closely related MYST domain in yeast 
resides in S.cerevisiae SAS2p [237], which hyperacetylates subtelomeric regions to prevent 
Sir3p binding and spreading of telomeric heterochromatin [244, 245]. However, a better 
resemblance of the MOF domain architecture is found in the yeast homologue Esa1p, which 
like MOF contains a chromobarrel domain preceding the MYST domain. Interestingly, Esa1p 
is generally recruited to the promoters of active protein coding genes where it mediates 
acetylation of histone H4 as part of the NuA4 complex, and this complex also contains a yeast 
homologue of Drosophila MSL3, Eaf3 [246]. It is therefore highly likely that the pattern of 
MOF binding that we observe at promoters across male and female autosomes and on the 
female X chromosome in Drosophila, is indeed reflecting the most ancient mode of MOF 
function. 
Discussion 
75 
 
4.2 MOF controls dosage compensation via its N-terminal domain 
A prominent feature of MOF in all Drosophila species is the presence of a large N-
terminal region, which is absent in all other MOF homologues from yeast to human. Addition 
of this domain correlates with the evolution of the Drosophila dosage compensation system, 
involving the targeting of MSLs and H4K16ac to the male X chromosome [247]. It seems 
thus plausible that the N-terminal domain has added functions that utilize the evolutionarily 
ancient transcriptional regulator MOF for the novel task of dosage compensation. Strikingly, 
upon deletion of the MOF N-terminus, MSL targeting to the X chromosome was completely 
abolished. This also included high affinity sites (HAS), which are otherwise resistant to MOF 
depletion [185]. Deletion of the MOF N-terminus therefore has a dominant negative effect on 
DCC formation. Aberrant MSL targeting was reminiscent of the phenotypes observed in roX1 
and roX2 double mutants [191], and indeed roX levels were reduced by 98% in the absence of 
the MOF N-terminus. This result suggests that, although interactions to MSL1 and MSL3 are 
mediated by the zinc finger region of MOF, the N-terminus is required to assemble the core 
MSL subunits together with roX RNAs into a functional DCC. At the same time, the N-
terminus is also required for proper integration of MOF into the NSL complex at gene 
promoters. Importantly, despite these defects, N-terminally truncated MOF was still active as 
a HAT and able to target to chromatin (Figures 14 and 16). In marked contrast to this, 
disruption of the evolutionarily conserved zinc finger, which is a feature common to all HATs 
of the MYST type, completely disrupted MOF function (Figures 19 and 20).  
MSL protein domains required for DCC assembly and targeting, as well as their 
cognate DNA binding sequences have been shown to undergo rapid adaptive coevolution in 
Drosophila melanogaster [248, 249]. Also roX RNA sequences are highly divergent 
throughout Drosophila species [238]. Likewise, the N-terminal domain of MOF shows huge 
variation in size and amino acid sequence between Drosophila species suggesting ongoing 
selective pressure by other MSLs or roX RNA. Another striking feature of the N-terminal 
domain is its intrinsic disorder, according to secondary structure prediction. It is a recently 
emerging concept that protein function is not necessarily linked to fixed secondary and 
tertiary structures [250]. Functional disordered regions have been particularly suggested for 
domains in hub proteins that control a variety of biological processes and mediate interactions 
to multiple interaction partners [251]. The most prominent example of this type of regulation 
is p53, which interacts with hundreds of binding partners via intrinsically unstructured 
domains. The N-terminal domain of MOF has relatively few hydrophobic amino acids, 
suggesting solubility in solution. We therefore propose that the unstructured N-terminal 
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domain integrates the multiple functions of MOF in dosage compensation and for 
genomewide H4K16ac (Figure 28). 
 
 
 
Figure 28. Several layers of regulation control genomewide H4K16ac in Drosophila.  
Our data suggests that in Drosophila MOF is responsible for the majority of H4K16ac at gene 
promoters in males and females, and for hyperacetylation along the male X chromosome. MOF 
activity is tightly regulated to achieve these diverse tasks. The Nterminal region is required for 
targeting of MOF to gene promoters and for assembly the MSL complex. At the same time the N-
terminus constrains the enzymatic activity of the MOF HAT domain, which is only unleashed in the 
context of the MSL complex to achieve hyperacetylation of the male X (blue arrows). The next layer 
of regulation is imposed by the chromobarrel domain (CD). Following binding of MOF to its 
chromatin target sites, nucleic acid interactions of the chromobarrel domain are required to trigger 
acetylation of the H4 tail (red arrows), which subsequently allows MSL complex spreading along the 
transcribed regions of genes. The chromobarrel domain thus acts as an “on-off switch” for H4K16ac. 
 
A further intriguing finding was that the N-terminus constrains MOF HAT activity in 
vivo and in vitro. Again the necessity for this additional level of regulation arises from the 
dual function that MOF has adopted in Drosophila. We show that H4K16ac displays much 
higher baseline levels on the male X chromosome as in any other chromosomal context. 
Furthermore, MOF mediated H4K16ac extends beyond regions of MSL binding on the male 
X chromosome. We do not observe the same phenomenon on male autosomes or in females, 
where much lower levels of H4K16ac are restricted to sites of MOF binding at gene 
promoters. The activity level of MOF thus differs to a large degree depending on the 
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chromosomal context. It is known that MOF requires interaction with MSL1 and MSL3 to be 
active as a HAT in vitro. However, our data suggests that an additional constrain is imposed 
on MOF’s enzymatic activity by an autoinhibitory function residing in its N-terminus. 
Interestingly, our data shows that in the ∆N MOF background, H4K16ac spreads from sites of 
MOF binding into neighboring regions even in the absence of other MSLs. We therefore 
propose that in the wildtype situation, the N-terminus may control or restrict the H4K16ac 
spreading around sites of MOF binding, and this constrain is only released in the presence of a 
fully assembled DCC on the male X chromosome for more extensive acetylation (Figure 28). 
In previous experimental setups, loss of MOF mediated H4K16ac has been accompanied by 
simultaneous loss of MSLs from the transcribed regions of X-linked genes [185, 186, 215, 
230]. Therefore the possibility remained that H4K16ac could merely serve to allow MSL 
spreading along the X chromosome, and upregulation of transcription would be achieved 
subsequently by additional activities residing in other MSL proteins. Although MSLs were 
entirely lost from the body of low affinity target genes in the absence of the MOF N-terminus, 
the reduction in H4K16ac was less pronounced, most likely reflecting the presence of 
hyperactive MOF at nearby promoters. Intriguingly, about 11% of males escaped lethality in 
this background. This suggests that in these individuals, the presence of H4K16ac on X 
chromosomal genes has been sufficient to ensure dosage compensation despite the lack of 
MSL binding. This result supports the view that H4K16ac is sufficient to upregulate 
transcription of X-linked genes, and that the main function of the DCC is to direct H4K16ac 
to the male X chromosome. 
 
4.3 The MOF chromobarrel domain controls H4K16ac genomewide 
An earlier study claimed that the MOF chromobarrel domain had a minor role to play 
in dosage compensation [231]. However, this study only tested the capacity of MOF to target 
to the X chromosomal territory by simply overexpressing MOF variants in a male cell line, 
leaving the possibility that potential defects in MOF function have been masked by the 
presence of the endogenous protein. Indeed, demonstrating the advantages of the in vivo 
system, we were able to reveal the crucial role that the MOF chromobarrel domain plays for 
all aspects of MOF function. Upon disruption of its nucleic acid binding properties, MSL 
spreading to X-linked genes is compromised, leading to a defect in dosage compensation. 
This is reminiscent of the phenotype observed upon deletion of the chromobarrel domain of 
MSL3 [212]. However, the MSL3 chromobarrel domain is thought to contribute to MSL 
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targeting via its binding to the H3 tail trimethylated at K36 [210]. Also an interaction with the 
H4 tail monomethylated at K20 has been proposed [213, 214]. In contrast, the MOF 
chromobarrel domain lacks the aromatic cage required for binding to methylated lysine 
residues. We therefore believe that reduced MSL spreading in MOF chromobarrel domain 
mutants is not the result of a direct chromatin binding defect of the MOF protein, consistent 
with the fact that binding of MOF to gene promoters in vivo and to nucleosomes in vitro is 
unaffected upon disruption of the chromobarrel domain. It has been shown previously that the 
chromobarrel domain mediates MOF binding to roX RNAs, and it is possible that this 
interaction contributes to spreading of the DCC along dosage compensated genes. However, 
the most dramatic and unexpected consequence upon disruption of the chromobarrel domain 
was the dramatic loss of genomewide H4K16ac. It is clear from previous work that this 
reduction of H4K16ac alone is sufficient to disrupt MSL spreading on the X chromosome. 
Indeed, upon direct mutation of the catalytic site in the MOF enzyme, MSL binding is 
restricted to high affinity sites in a pattern similar to the one observed in chromobarrel domain 
mutants [185].  
The structure of the Drosophila MOF chromobarrel domain (aa 367-454) has been 
determined by NMR [235] (Figure 21A). While Tyr416 (Y416) is one of the putative 
aromatic cage residues and is partially buried in the core of the structure, Trp426 (W426) is 
solvent exposed on a β-sheet formed by strands α2, α3 and α4. As mentioned above, a similar 
domain is present also in the yeast Esa1p. It has been shown there that in presence of a short 
N-terminal extension, a minor conformational change occurs in the core of the Esa1p domain, 
triggering its RNA/DNA binding activity [252]. Interestingly, a similar structure of the 
chromobarrel domain of MSL3 has recently been determined in complex with dsDNA and the 
N-terminal tail of histone H4 monomethylated at H4K20 [213]. Both MOF and Esa1 possess 
equivalent highly conserved surfaces that could be involved in the interaction with nucleic 
acids (Figure 21A). Accordingly, extensive mutagenesis studies in Esa1p identified residues 
involved in nucleic acid binding, including residues corresponding to MOF Tyr413, Tyr416, 
Asn420, Arg422 and Trp426. Mutations of these residues in Esa1p were lethal or produced 
severe growth effects [252]. In the MSL3 structure, Trp66 corresponding to MOF 
chromobarrel domain Trp426 is directly involved in the interaction with DNA (Figure 29). 
Although the aromatic residues that are critical for interaction of the MSL3 chromobarrel 
domain with the methylated lysine side chain of the H4 peptide are not well conserved, it 
remains unclear whether MOF and Esa1 could bind unmodified histone tail residues. 
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Figure 29. Conservation between the MOF and MSL3 chromobarrel domains, provided by Jan 
Kadlec. 
(A) Ribbon representation of the complex of MSL3, DNA and the H4 peptide (PDB code 3OA6). The 
structure of the MOF chromobarrel domain (PDB code 2BUD) is superimposed onto the one of MSL3. 
(B) Surface representation of the MSL3 chromobarrel domain in the same orientation as in (A) 
highlighting areas of conserved residues involved in DNA and H4 binding. The conservation of the 
surface is represented from gray to red (red is 100 % conserved) according to the color scale bar. The 
aromatic cage around Phe56 includes also Tyr31, Trp59 and Trp63. (C) Surface conservation of the 
MOF chromobarrel domain based on ortholog sequences ranging from human to nematodes. The 
conserved surface corresponding to the MSL3 DNA binding region includes Asn420, Arg422, Tyr314, 
Trp426 and Arg387. Tyr416 forms a floor of a cavity surrounded by Leu419, Leu423 and His393. 
 
However, one could potentially envisage that a mode of action similar to MSL3 may 
also exist for the Esa1p and MOF chromobarrel domains, and that interaction with nucleic 
acid and the unmodified H4 tail direct the tail for acetylation by the MYST domain. It has 
been shown previously that the MOF chromobarrel domain binds to nucleic acids with a 
preference for RNA over DNA, and interacts with roX RNAs in vivo [236]. We now show 
that the nucleic acid binding properties of the MOF chromobarrel domain are necessary to 
trigger H4K16ac on a nucleosomal substrate in vitro, where the local DNA concentration is 
high due to tethering of the complex to the nucleosome via other domains. Interestingly, 
deletion of a conserved stem loop structure in roX RNAs leads to a specific loss of 
hyperacetylation from the male X chromosome in vivo, while MOF is still targeted to the X 
chromosome in this background [238, 239]. It is therefore tempting to speculate that upon 
ordered assembly of roX RNAs and MSL proteins in vivo, roX RNAs could engage in similar 
interactions with the chromobarrel domain and H4 tail to promote high acetylation levels 
throughout the body of X-linked genes. Since the chromobarrel domain is also conserved in 
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human MOF it is likely that MOF’s acetylation activity is controlled in a similar manner in 
humans.  
 
4.4 Summary 
In this study we have revealed the function of the MOF chromobarrel domain, which 
is to elicit the activity of its associated HAT enzyme on the chromatin target. The huge degree 
of sequence conservation of the MOF protein between flies and mammals suggests that a 
similar mode of operation might be present in mammalian MOF. Our findings thus have 
important implications for the study of this enzyme in humans, where it is implicated in a 
wide range of processes like transcription, DNA repair and cancer [121, 243, 252]. In 
addition, it will be exciting to test if chromodomains in other enzymatic complexes can 
directly control their associated enzyme activities in a similar way. In contrast to the 
chromobarrel domain, the N-terminal part of the MOF protein is specific to Drosophila 
species and regulates MOFs function in dosage compensation. Accordingly, our work also 
highlights how a MYST HAT has been adopted through evolution to carry out distinct tasks 
on X chromosomal and autosomal genes. We propose that the enzymatic activity of other 
MYST family HATs may be under similar regulation by associated domains for context 
specific function. 
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5.1 The mechanism of dosage compensation 
As I have pointed out before, the potentially most important question in the field of 
Drosophila dosage compensation is at what level transcriptional upregulation of male X-
linked genes is achieved. Identifying the step in the RNA PolII transcription cycle that is 
targeted by MSL mediated transcription activation is the first step towards unraveling the 
mechanism of dosage compensation. During my PhD, I developed a ChIP protocol of 
extremely high sensitivity. I used this method to generate duplicate  ChIP-Seq profiles of the 
Rpb3 subunit of RNA PolII from approximately 3000 pairs of 3rd instar larva salivary glands 
from wt male, wt female and male MSL2 RNAi animals. Table 2 shows the number of 
sequencing reads obtained for each data set. 
 
 
Table 2: ChIP-Seq samples with numbers and percentages of mapped reads.  
This table shows the total numbers of reads sequenced from each sample, the numbers and 
percentages of the reads mapped on the D. melanogaster genome by Bowtie [253], and the genome 
coverage obtained from these mapped reads. 
 
The bioinformatics analysis of this data, performed by my collaborators at the 
European Bioinformatics Institute, was still ongoing at the time of submission of this thesis, 
and experiments to support our early conclusions are currently underway. For this reason I 
will just give a short outlook into this ongoing project. Nevertheless, the data obtained so far 
already enables us to make some important conclusions. Figure 30 shows the resulting 
average plots of PolII on X-linked and autosomal genes. It is immediately evident that the 
levels of PolII are approximately two fold enriched in the transcribed region of male X-linked 
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genes, demonstrating that our method is able to accurately capture enhanced transcription by 
PolII.  
 
Figure 30: Differences in Pol II binding between dosage-compensated and non-compensated genes.  
(A) Average Pol II-binding profiles of X-linked (red) and autosomal (blue) genes are shown for males, 
females and male MSL2 RNAi. Grey lines indicated the transcription start site and 3’end of genes. An 
unscaled window was used for the promoter region and end of genes; (TSS-300bp, TSS+500bp) and 
(3'end-500bp, 3'end+300bp). The transcribed region of genes (TSS+500bp, 3'end-500bp) was scaled 
according to gene length. 
 
This result is in agreement with a recent study that showed a similar enrichment in the 
transcribed region of X-linked genes using the GRO-Seq (global run on) method, albeit with 
lower sensitivity [217].  However, one major conclusion of that study, which was limited to a 
male cell line system and did not include a female data set, was that dosage compensation 
does not affect the levels of RNA PolII at gene promoters. Strikingly, in our analysis we find 
that males show an increase in the binding of PolII to X-linked relative to autosomal 
promoters, when compared to the female situation. Importantly, increased promoter binding 
was lost upon MSL2 RNAi in males. The magnitude of the change is roughly two-fold (~0.85 
and ~0.95 in log2 scale for the comparison male vs. female and male vs. MSL2 RNAi 
respectively). Our data therefore strongly suggests that dosage compensation in Drosophila is 
at least partially mediated by enhanced transcription initiation on the male X chromosome. 
The hall mark chromatin modification of the male X chromosome, H4K16ac, is known for its 
ability to create an open and permissive chromatin structure, as I have elaborated on in the 
introduction of this thesis. It seems therefore convincing that increased access to the 
transcription machinery and associated factors leads to enhanced transcription initiation and 
thus a two fold increase in gene expression. Accordingly, MSL binding along the body of X-
linked genes might serve to spread acetylation by MOF, in order to create this permissive 
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environment. H4K16ac in the body of X-linked genes might also serve to pave the way for the 
increased amount of PolII loaded onto these genes in males. Global ChIP-Seq analysis does 
not allow the direct comparison of independent data sets. Therefore we cannot conclude at 
this point that the shift in rank order of male X-linked promoters is due to an increase of PolII 
binding at X-linked promoters or due to a decrease at autosomal promoters. To clarify this 
point by an absolute measurement of PolII binding in males females and upon MSL2 RNAi, 
and to verify enhanced initiation on the male X chromosome, I will next perform ChIP against 
Rpb3, PolII phosphorylated at Serine5 and TATA binding protein (TBP) and determine the 
binding at a set of X-linked and autosomal target genes as absolute Input recoveries. A further 
conclusion of the above mentioned study by the Kuroda lab was that autosomal genes 
generally suffer from decreased PolII processivity, manifested by a decreasing slope of PolII 
across the transcribed regions of autosomal genes [217]. We were not able to reproduce this 
result, since the slope of PolII across transcribed regions appeared similar on X-linked and 
autosomal genes in males and females, although a decrease in processivity was observed on 
all chromosomes upon MSL2 RNAi. 
Here, some fundamental limitations of the study presented by the Kuroda lab should 
be pointed out. Firstly, the conclusion that dosage compensation is not acting at the step of 
transcription initiation was based on the observation that PolII density is similar at X-linked 
and autosomal promoters in male S2 cells. However, the authors did not obtain PolII profiles 
from female flies or cell lines to investigate sex specific differences in transcription initiation. 
Secondly, a major concern regarding the Kuroda study is the use of the S2 cell line for GRO-
Seq. It has been shown previously that S2 cells show a high degree of aneuploidy, and that an 
MSL independent dosage compensation system is operating in these cells to equalize 
expression between different genomic loci despite high copy number variation (Zhang et al., 
2010), an observation that has also been confirmed in vivo [225]. Two important facts stick 
out from the work by Zhang et al., suggesting that S2 cells are generally unsuitable for the 
analysis of X chromosome compensation. First, aneuploidy is unevenly distributed between 
chromosomes, with 40% of autosomal regions showing variations in copy number but only 
18% of X-linked loci. Second, the MSL independent compensation mechanism shows less 
activity towards the male X chromosome. Any analysis aimed at determining engaged PolII in 
these cells is therefore prone to detect the signature of MSL independent compensation of 
genomic aneuploidies, with a strong autosomal bias. In contrast to this, our study is based on 
the analysis of euploid genomes, comparing the same set of genes in the male and female 
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situation. We are therefore confident that our study will provide important insights into the 
mechanism of dosage compensation in Drosophila.  
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6. Contributions to other studies 
In addition to the unpublished work presented in the first part of this thesis, I contributed 
significantly to two major publications during the course of my PhD:   
 
 “Transcription-coupled methylation of histone H3 at lysine 36 regulates dosage 
compensation by enhancing recruitment of the MSL complex in Drosophila 
melanogaster”. Mol Cell Biol 28, 3401-3409. 
In the context of this study, I showed that HypB/Set2, the enzyme responsible for 
trimethylation of H3K36 in Drosphila, is localized to active genomic regions of polytene 
chromosomes and partially colocalizes with MSL1 on the male X chromosome. I furthermore 
showed by RNAi of HypB/Set2 that removal of the H3K36me3 mark leads to defects in 
dosage compensation. I also contributed to the writing of the manuscript.  
 
 
 “The nonspecific lethal complex is a transcriptional regulator in Drosophila.”  
Mol Cell 38, 827-841. 
In the context of this study, I showed by immunostainings of polytene chromosomes that NSL 
recuitment to autosomal targets is independent of MOF. I also show that the transcriptional 
changes of autosomal genes upon removal of MOF are of less magnitude than the ones 
observed upon depletion of NSL proteins. Furthermore, I made a major contribution to the 
development of the ChIP protocoll that is used throughout this study. In addition, I partially 
contributed to the writing of the manuscript. 
 
 
Both original manuscripts can be found in the Appendix. 
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7.1 Chromatin immunoprecipitation (ChIP) 
 
7.1.1 ChIP from salivary glands 
100 Inverted 3rd instar larva were fixed in fixing solution (50 mM HEPES pH 7.6, 100 mM 
NaCl, 1 mM EDTA, 0.5 mM EGTA, 3.6% formaldehyde) for 20 min at room temperature on 
a rotating wheel. Formaldehyde was quenched with stop solution (PBS, 0.01% Triton X-100 
0.125 M glycine) for 5min. Fixed larva were washed for 5 x 2 min with buffer A (10 mM 
HEPES pH 7.6, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton X-100) and 5 x 5 min with 
buffer B (200 mM NaCl, 10 mM HEPES pH 7.6, 1 mM EDTA, 0.5 mM EGTA, 0.01% 
Triton-X 100). Salivary glands were dissected into 500 μL of RIPA buffer (25 mM HEPES 
pH 7.6, 150mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% SDS, 0.1% DOC, protease 
inhibitors) and sonicated 16 x 30 sec using a Branson 250 sonicator at 40 pulse, intensity 5, 
generating 200 bp fragments on average. The chromatin was cleared by 10 min of high speed 
centrifugation at 4°C in a table top centrifuge. The chromatin was then aliquoted in 8 samples 
and snap frozen. For immunoprecipitation, one aliquot was filled up with RIPA buffer to 
600µl and incubated with 2µl of rabbit anti-MOF, 2 µl rabbit anti-H4 (abcam ab10158), or 
5µl rabbit anti-H4K16ac (Santa Cruz sc-8662-R) antibodies O/N at 4°C. 50 µl of this material 
was then taken as Input control and 500 µl used for immunoprecipitation. For ChIP-Seq, the 
complete material from 4 x 100 salivary glands was used for Immunoprecipitation, using 3µl 
of rabbit anti-MOF, 3 µl rabbit anti-H4, 5µl rabbit anti-H4K16ac, or 6µl of rabbit anti-Rpb3 
(gift from John Lis and Karen Adelman). Immunocomplexes then isolated by adding protein 
A -Sepharose (Roche) for 3 hours, followed by six washing steps: 4x RIPA buffer, 1x DOC 
buffer (10 mM Tris at pH 8, 0.25 M LiCl, 0.5% NP-40, 0.5% DOC, 1 mM EDTA), and 1x TE 
at pH 8. The beads were resuspended in 90 μl TE and, together with the Input control, the 
crosslink was reversed at 65°C over night. After 30 min incubation at 37°C with RNaseA (0.2 
mg/ml), followed by 2 hr Proteinase K digestion (0.05 mg/ml) at 50°C, DNA was purified 
using Minelute columns (Qiagen). ChIP DNA samples were resuspended in 500 μl nuclease 
free water. We used 10 μl ChIP material for each qPCR reaction. For ChIP-Seq, the material 
from four independent IPs was pooled for each experiment (two replicates were generated for 
all Rpb3 data sets). 
 
7.1.2 ChIP from whole larva 
For whole larva ChIP, for each replicate, 100 larva were crushed to a powder in liquid 
nitrogen, dounced 30x in 20 ml NE buffer (15mM Hepes pH 7.6, 10mM KCl, 5mM MgCL2, 
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0.1mM EDTA, 0.5mM EGTA, 350mM sucrose, 0.1% Tween, 1mM DTT, protease inhibitors) 
and fixed by adding 1ml 36% formaldehyde to 1.8% final concentration for 20 min at RT. 
After quenching for 5 min at RT with 125 mM glycine, nuclei were collected by 10 min 
centrifugation at 2500g, washed 3x 5min in RIPA (25 mM HEPES pH 7.6, 150mM NaCl, 1 
mM EDTA, 1% Triton-X 100, 0.1% SDS, 0.1% DOC, protease inhibitors) sonicated 5x 30 
sec in a Branson 250 sonicator at 30 pulse, intensity 3, followed by sonication in a Covaris 
SL-2 sonicator for 6 min using the preset 200bp program. After clearing by high-speed 
centrifugation, the chromatin was split in 8 aliquots and snap frozen for subsequent 
immunoprecipitation. For immunoprecipitation, the volume was made up to 600 µl with 
RIPA. 2 µl of rabbit MSL1 or MOF, 3µl of rat MSL3, 5 µl of anti-H4K16ac (Santa Cruz sc-
8662-R) 2 µl anti-H4 (abcam ab10158), 2 µl anti-H3 (ab1791) antibodies were added and 
incubated over night at 4°C, respectively. Immunocomplexes were isolated by adding protein 
A/G-Sepharose (Roche) for 3 h, followed by six washing steps: 4x RIPA buffer, 1x DOC 
buffer (10 mM Tris at pH 8, 0.25 M LiCl, 0.5% NP-40, 0.5% DOC, 1 mM EDTA), and 1x TE 
at pH 8. The beads were resuspended in 90 μl TE and, together with the Input control, the 
crosslink was reversed at 65°C O/N. After 30 min incubation at 37°C with RNaseA (0.2 
mg/ml), followed by 2 hr Proteinase K digestion (0.05 mg/ml) at 50°C, DNA was purified 
using Minelute columns (Qiagen). ChIP DNA samples were resuspended in 500 μl nuclease 
free water. We used 10 μl ChIP material for each qPCR reaction. 
 
7.2 RNA isolation and quantitative PCR analysis  
For qRT-PCR, RNA and corresponding genomic DNA from SL-2 cells or from salivary 
glands were isolated simultaneously using the AllPrep DNA/RNA mini kit (QIAGEN), the 
RNA column was DNaseI treated, and 300 ng of total RNA was used in an RT reaction. 
qPCR was performed on an Applied Biosystems (AB) Cycler7500 with SYBR detection, and 
the amplification curves were analyzed with the corresponding AB software. Each qRT-PCR 
was repeated at least three times, values were normalized to corresponding genomic DNA 
values, and the standard deviation within each experiment was calculated. qPCR analysis of 
ChIP samples was performed using the SYBR Green PCR master mix (Applied Biosystems), 
100 ng of each forward and reverse primer, and 10 µl immunoprecipitated DNA, in an 
ABI7500 real-time PCR thermocycler (Applied Biosystems, Inc.). Recovery was determined 
as the amount of immunoprecipitated DNA relative to input DNA. Error bars represent 
standard deviation (StDev) of four independent experiments.  
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7.3 Fly stocks and crosses 
All stocks were maintained on standard medium at 25°C. To assay for female viability we 
conducted the cross y/mof2;sb/P{w+ UAS-HA-MOF}  x mof2/mof2;P{w+ UAS-HA-MOF}/tm3 
and the control cross y/w-;sb/+ x w-/w-;+/tm3 and compared the proportion of 
mof2/mof2;sb/t3 or w-/w-;sb/t3 in the respective offspring. For the complementation test, 
female flies of the genotype mof2/fm7;P{w+ UAS-HA-MOF} were crossed to 
y/fm7;P{armadillo-GAL4} males to induce transgene expression, and the ratio of male Y/mof2 
to female mof2/fm7 offspring was scored as relative male survival. 
 
For the in vivo characterization of MOF variants the following fly strains were generated: 
1. w; P{ w+ UAS-HA-MOF}/TM3 
2. w; P{ w+ UAS-HA-∆565-587-MOF}/TM6 
3. w; P{ w+ UAS-HA-∆565-587-MOF}/TM3 
4. w; P{ w+ UAS-HA-∆1-349-MOF}/Cyo 
5. w; P{ w+ UAS-HA-∆1-349-MOF}/TM3 
6. w; P{ w+ UAS-HA-∆1-349-MOF}/TM3 
7. w; P{ w+ UAS-HA-Y416D-MOF}/Cyo 
8. w; P{ w+ UAS-HA-Y416D-MOF}/Cyo  
9. w; P{ w+ UAS-HA-Y416D-MOF}/TM6 
10. w; P{ w+ UAS-HA-W426G-MOF}/TM3 
11. w; P{ w+ UAS-HA-W426G-MOF}/Cyo 
12. w; P{ w+ UAS-HA-∆176-228-MOF}/ 
13. w; P{ w+ UAS-HA-∆176-228-MOF}/ 
14. w; P{ w+ UAS-HA-∆241-357-MOF}/ 
15. w; P{ w+ UAS-HA-∆241-357-MOF}/ 
16. w; P{ w+ UAS-HA-∆98-357-MOF}/Cyo 
17. w; P{ w+ UAS-HA-∆98-357-MOF}/Cyo 
 
7.4 Immunostaining of polytene chromosomes and confocal microscopy 
Two to three pairs of salivary glands were dissected in PBS for each squash. The glands were 
transferred into a drop of 35 µl Fix solution (1.8% PFA, 45% Acetic acid, in H2O) on a glass 
slide and incubated for 10m min. A cover slip was put on top of the sample and tapped with a 
pencil to disrupt cells and nuclei, then heavily pressed with the thumb to spread the 
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chromosomes. The slide was snap frozen in liquid nitrogen, the cover slip removed with a 
razor blade and the slide transferred into PBS. The slide was then incubated in blocking 
solution (3% BSA, 0.2% NP40, 0.2% Tween20, 10% dry milk, in PBS) for 1 h. After transfer 
into a wet box, 40 µl blocking solution with primary antibody were added onto the sample 
and incubated for 1 h at RT or over night at 4°C. MOF and MSL1 antibodies were used at 
1:500, anti-K16ac Santa Cruz at 1:125 dilutions. After two times rinsing with PBS, the slide 
was washed for 15 min at RT with washing buffer (500mM NaCl, 0.2% NP40, 0.2% 
Tween20, in PBS). The slide was then incubated in the dark with 40 µl blocking solution 
containing a 1:250 dilution of fluorescently labeled secondary antibody. The slide was rinsed 
two times with PBS and washed for 15 min at RT with washing buffer. After another rinse 
with PBS, 15µl of Fluoromount were added onto the sample and the sample was covered with 
a cover slip. Images were captured with an AxioCamHR CCD camera on a Leica SP5 (Leica 
Microsystems) using an Apochromat NA 1.32 oil immersion objective. Images were arranged 
with Adobe Illustrator.  
 
7.5 Generation of protein extracts and western blotting. 
To determine protein levels in adult fly heads, flies were first anesthetized under CO2 and 
then sorted by sex. 50 flies were selected, transferred into an eppendorf tube and snap frozen 
in liquid nitrogen. Upon vigorous shaking of the tube, heads detach and can be collected into 
100µl of 2 x Laemmli buffer. Heads were sonicated for 10 sec in a Branson 250 sonicator at 
30 pulse, intensity 3. After 10 min centrifugation at full speed in a table top centrifuge, the 
supernatant was collected and boiled for 5 min at 95°C. 10µl of the sample were then used for 
PAGE. To determine protein levels in 3rd instar larva, 10 larvae were inverted in PBS, the gut, 
fat body and salivary glands were removed and the sample transferred into 100 µl 2 x 
Laemmli buffer. After sonication for 10 sec in a Branson 250 sonicator at 30 pulse, intensity 
3, the sample was boiled for 5 min at 95°C. The sonication was repeated and the sample 
subsequently cleared by 10 min high speed centrifugation. 10 µl of the sample were used for 
PAGE. After wet transfer onto a PVDF membrane (Millipore) and 1 h incubation in blocking 
solution (5% milk, 0.3% Tween-20, PBS), membranes were probed for 1 h at RT with 
blocking solution containing 1:3.000 rabbit anti-MOF; 1:3.000 rabbit anti-MSL1; 1:1.000 rat 
anti-MSL3; 1:1.000 mouse anti-HA; 1:10.000 rabbit anti-H3; 1:1.000 rabbit anti H4; 1:1.000 
rabbit anti-H4K16ac (Santa Cruz sc-8662-R); or rabbit anti-H4K5ac antibodies, respectively. 
Membranes were washed 3 x 5 min in PBS-T (0.3% Tween-20 in PBS) and incubated for 45 
min with blocking solution containing 1:15.000 anti-mouse or anti-rabbit antibodies coupled 
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to horseradish peroxidase. After another 3 x 5 min wash with PBS-T, membranes were 
incubated for 5 min with Lumi-Light western blotting substrate (Roche). The luminescence 
signal was captured on Kodak Biomax MR films.  
 
7.6 Expression and purification of Drosophila recombinant proteins with the baculovirus 
system 
The MOF variant proteins expressed in the baculovirus system were cloned as full length 
constructs in HA-pFastBac vectors. Recombinant baculoviruses were generated as described 
in the manual “Bac-to-Bac Baculovirus Expression System” (Invitrogen). Recombinant 
viruses for expression of MSL1 and FLAG-MSL3 were readily available in the lab. 
Recombinant viruses were used to infect insect cells (SF21) and these were harvested 2 days 
after infection by dissolving the cell pellets in HEMG-200 Buffer (25mM Hepes pH 7,6 ; 
1mM EDTA ; 12,5 mM MgCl2 ; 10 % Glycerol ; 200 mM KCl,  0,5% Triton X-100 reduced ; 
Complete Protease Inhibitor(Roche) ; 0,2 µM PMSF). For purification of the recombinant 
proteins, whole-cell-extracts were incubated for 2 h with HA-Agarose or Flag-Agarose-Beads 
(Sigma), followed by washes with HEMG-500 and HEMG-200. HA-and Flag-peptides 
(Sigma) were used in a concentration of 400 ng/µl to elute the recombinant proteins. All 
recombinant proteins were stored in HEMG 200 Buffer. 
 
7.7 HAT-assay on nucleosomal templates 
HAT assays were performed by Herbert Holz. In a 20 µl reaction containing 50 mM Tris pH 
8,0, 0,1 mM EDTA pH 8, 0, 1 mM DTT,  1 mM PMSF, 5% Glycerol, 10 mM Na-butyrate 
and 0,02 µCi of acetyl coenzyme A (acetyl-1-14C, 60 mCi/mmol (Perkin Elmer)) we 
incubated 5.3 nM (10 ng) of the respective recombinant MOF-protein (or trimeric complexes) 
with 1,5 µg of endogenous mono, -di- nucleosomes obtained from MCF-7 cells (human breast 
cancer cell line). For preparation of MCF-7 nucleosomes:  See Epigenome Network of 
Excellence (NoE) protocols (http://www.epigenome-
noe.net/researchtools/protocol.php?protid=22). After a 60 min incubation at 26°C the whole 
reaction volume was applied on a precast 12% BIS/Tris Novex Gel (Invitrogen) and run in 1x 
MES Buffer at 130V for 45 min and 155 V for another 45 min. Proteins were visualized by 
Coomassie R 250 Blue staining, destained, and the gel was dried on a 3 MM paper using a 
vacuum dryer (Biorad) at 80°C for 2 h. The dried gel was subsequently exposed on an 
imaging plate BAS-IP MS 2025 for 5 days. Acetylation signals were obtained by scanning the 
IP-MS plate on a FLA5000 scanner (Fujifilm). 
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7.8 Filter binding HAT-assay  
Filter binding assays were performed by Herbert Holz. In a 30 µl reaction containing 50 mM 
Tris pH 8,0, 0,1 mM EDTA pH 8, 0, 1 mM DTT, 1 mM PMSF, 5% Glycerol, 10 mM Na-
Butyrate and 0,02 µCi of acetyl coenzyme A (acetyl-1-14C, 60 mCi/mmol (Perkin Elmer)) we 
incubated 21.3 nM (40 ng) of the respective recombinant MOF-protein (or trimeric 
complexes) with 1,5 µg of recombinant (Xenopus) histone octamer. After a 60 min incubation 
at 26°C the whole reaction volume was applied on a P81 filter paper (Whatman, 1,5 x 1,5 
cm), air dried and washed 3x10 min at RT in a large volume of 50 mM Na-carbonate pH 9,2. 
After rinsing the filters in acetone, they were air dried and counted in 5 ml of scintillation 
liquid (Rotiszint eco plus, Roth). 
 
7.9 Electrophoretic mobility shift assay (EMSA) 
The EMSA assay was performed by Ibrahim Ilik. N-terminal-6-His-tagged MOF 
chromobarrel domain constructs, including the wild-type chromobarrel domain (amino acids 
346-448 of full-length MOF) and two point mutants Y416D and W426 were expressed in 
BL21 (DE3) cells and purified using Ni-NTA chromatography (Qiagen). The following 
template is used to express a 84nt radiolabeled (α32P-CTP) ssRNA using Riboprobe T7 kit 
(Promega): 
CGTAATACGACTCACTATAGGGAGAAAGAACGAATATATATACGCGCAAATTAA
GCAAATATATATGCATATATGGGAACGCGATTTTAATGAAGAGCTCTTC. The final 
RNA product of the in vitro transcription is underlined. EMSA was carried out with 25-100 
ng of protein and 1µL of RNA (20kcpm/µL) in 20µL RNA binding buffer (20mM HEPES, 
NaOH (pH 7.6), 3mM MgCl2, 10% Glycerol, 1mM DTT, 0.1mg/ml BSA). The mixture was 
incubated on ice for 30 minutes and run on a 6% native polyacrylamide gel for 90 minutes at 
120V. In order to visualize RNA-protein complexes, the gel was dried and exposed to an 
autoradiography film (Kodak XAR).  
 
7.10 Immunoprecipitation of MOF constructs from SL-2 stable cell lines 
Generation of stable cell lines and immunoprecipitations were performed by Erinc Hallacli. 
All MOF constructs used for SL-2 stable cell line generation carry N-terminal 3xFlag 6His 
tags and are under the control of an MtnA promoter.  The vector also contains a Neomycin 
cassette, allowing omitting of the co-transfection step. 1 million cells were transfected with 
0.5 µg of DNA with Qiagen Effectene reagent. The cells were selected initially with 1 mg/ml 
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Geneticin. During the amplification period, the concentration of Geneticin was gradually 
reduced to its final concentration of 0.25 mg/ml. For immunoprecipitation experiments, equal 
number of cells from different lines (FL MOF, MOF ∆N, MOF Y416D) along with WT 
MOCK cells were induced with 100 mM CuSO4 for one day and harvested. Nuclei were 
isolated and nuclear extracts were prepared by freeze-thaw cycles in HEMGT 150 buffer (25 
mM HEPES 7.6, 0.1 mM EDTA, 12.5 mM MgCl2, 10% Glycerol, 0.2% Tween-20 and 150 
mM KCl). INPUT samples were taken from the nuclear extract. Nuclear extracts were 
incubated with 30 ml bed volume of magnetic Flag Agarose beads (Sigma) for 2 hours at 4°C. 
The beads were washed four times with HEMGT 150 buffer and eluted with 3xFlag peptide 
(final 0.4 mg/ml concentration) containing HEMGT 150 buffer overnight. The elutions were 
precipitated by TCA/Acetone method and resuspended with 4 x Laemmli Buffer.  
 
7.11 ChIP-Seq data analysis 
All ChIP-Seq data analysis was performed by Florence Cavalli and Juanma Vaquerizas at the 
European Bioinformatics Institute. 
 
7.11.1 Data processing 
ChIP samples were sequenced using Illumina GAIIx machines at the EMBL GeneCore 
facility. Resulting reads were mapped to the D. melanogaster genome 
(dmel_r5.11_FB2008_08) using the Bowtie software [253] with the following parameters: -n 
2 -k 1 --solexa1.3-quals --best. With these settings, the software maps reads only to unique 
locations in the genome, choosing the best possible hit. The software takes into consideration 
the read-quality during alignment and removes all reads containing ambiguous nucleotide 
assignments (N). Reads mapping to heterochromatic regions were discarded from further 
analysis (Table S1). We divided the D. melanogaster genome into non-overlapping 25 bp 
bins, and counted the number of reads mapped to each bin.  These read-counts were then 
inputted to the DESeq BioConductor package [254]; counts were normalized between IP and 
input samples by applying a scaling factor accounting for differences in the total numbers of 
reads per sequencing run. Any bins with read counts of zero were discarded from further 
analysis. For each bin, DESeq outputted a log2 fold-change (log2FC) value between 
normalized read counts in the IP and control samples. We used input DNA as the control for 
MOF-binding and histone H4-binding as the control for the H4K16 acetylation marks. As 
DNA fragment sizes after sonication was ~200 bp, we smoothed log2FC values using a 400 
bp sliding window approach [215]. The final log2FC values represented the signal from the IP 
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samples relative to controls, with positive values corresponding to enrichments in the IP 
sample and negative values corresponding to enrichments in control sample. We calculated 
log2FC thresholds to indicate significant binding or acetylation compared with the control. 
Since negative log2FC values (i.e. enrichment in control signal) correspond to experimental 
noise, we fitted a symmetric null-distribution to the density distribution for log2FC values 
below the mode (PMID: 16732288). We then applied an FDR-adjusted p-value cut-off of 0.05 
to identify 25 bp bins containing significant binding or acetylation. All ChIP-Seq data will be 
made available at European Nucleotide Archive (ENA) (http://www.ebi.ac.uk/ena/). 
 
7.11.2 Detection of MOF-bound and H4K16-acetylated genes 
For the classification of binding patterns, gene bodies were defined as all exonic sequences 
between +500 bp downstream of the transcription start site (TSS) to the 3’-end, as annotated 
in the Ensembl database. The promoter was defined as the region between -200 bp and the 
TSS: the region was selected by identifying the mode for average MOF-binding at the 5’-end 
of all genes which falls about -100 bp upstream of the TSS in both male and female samples 
and then providing a 100 bp window either side. We excluded any genes that are <600 bp 
(1,205 loci) in length, as they were too short for this analysis. There is a clear bi-modal 
distribution dividing partially bound genes from fully bound ones. We used a threshold of 
70% (relative to the gene body length) to differentiate between the two types of binding. Next, 
we classified partially bound genes as promoter bound, if they contained at least one bin with 
significant binding in the promoter region defined above. We used a similar classification to 
identify patterns of H4K16 acetylation. In this case, the promoter was defined as the region 
between the TSS and +500bp downstream, in order to accommodate shift in acetylation 
patterns towards the interior of genes compared with MOF-binding.  
 
7.11.3 Gene expression profiling 
Gene expression was measured using Affymetrix Drosophila2 GeneChips in at least triplicate 
for wt male and female 3rd instar larva salivary glands. Data analysis was performed using 
publicly available packages in the BioConductor Software Suite [PMID: 15461798]. Raw 
.CEL files were processed using GCRMA and probe sets were mapped to genes using 
annotation available from the Ensembl database (v57) [PMID: 21045057]. Expressed genes 
were identified as those outputting MAS5.0 ‘present’ calls in all available biological 
replicates. Microarray data will be available at ArrayExpress upon acceptance of the 
manuscript [PMID: 21071405]. 
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In Drosophila melanogaster, dosage compensation relies on the targeting of the male-specific lethal (MSL)
complex to hundreds of sites along the male X chromosome. Transcription-coupled methylation of histone H3
lysine 36 is enriched toward the 3 end of active genes, similar to the MSL proteins. Here, we have studied the
link between histone H3 methylation and MSL complex targeting using RNA interference and chromatin
immunoprecipitation. We show that trimethylation of histone H3 at lysine 36 (H3K36me3) relies on the histone
methyltransferase Hypb and is localized promoter distal at dosage-compensated genes, similar to active genes
on autosomes. However, H3K36me3 has an X-specific function, as reduction specifically decreases acetylation
of histone H4 lysine 16 on the male X chromosome. This hypoacetylation is caused by compromised MSL
binding and results in a failure to increase expression twofold. Thus, H3K36me3 marks the body of all active
genes yet is utilized in a chromosome-specific manner to enhance histone acetylation at sites of dosage
compensation.
Similar to sex determination in mammals, sex determination
in flies involves an unequal distribution of sex chromosomes,
with females carrying two X chromosomes compared to one
in males. The resulting difference in gene dose requires com-
pensating mechanisms that guarantee equal expression of X-
linked genes in both sexes. In mammals, dosage compensation
involves transcriptional silencing of one of the two female
copies of the X chromosome. In flies, the opposite strategy is
realized, as transcription on the single male X chromosome is
increased twofold.
Genetic screens in flies identified five proteins and two non-
coding RNAs that are essential for the process of dosage com-
pensation and whose absence causes male-specific lethality
(MSL). The proteins MSL1, MSL2, MSL3, MLE (maleless),
and MOF (males absent on the first) form a ribonucleoprotein
complex (the MSL complex), together with the two noncoding
RNAs, roX1 and roX2 (RNA on the X), which specifically
binds to hundreds of sites on the male X chromosome and
promotes transcriptional upregulation (16, 18, 25). This tran-
scriptional upregulation is believed to involve histone hyper-
acetylation of dosage-compensated genes by the histone H4
lysine 16-specific histone acetyltransferase MOF (10).
Recent studies suggested that MSL complex binding sites
fall into two categories: high-affinity sites which are able to
bind partial MSL complexes consisting of MSL1 and MSL2 (in
mutant backgrounds of MSL3, MLE, and MOF) and low-
affinity sites which require the full complement of the MSL
complex (8, 12, 17). It has been postulated that the presence of
high-affinity sites creates high local concentrations of MSL
complex members on the X chromosome, which subsequently
allows MSL complex binding to sites of lower affinity. Chro-
matin immunoprecipitation coupled with DNA microarrays
(ChIP-chip) profiling experiments showed that the MSL com-
plex localizes primarily to the 3 end of dosage-compensated
genes (2, 9). Indeed, DNA elements in the 3 end of these
target genes have been shown to be required for MSL binding,
yet the ability to recruit the MSL complex strongly depends on
their transcriptional activity (6, 14). This suggests that recog-
nition of target DNA sequences with relatively low affinity for
MSL proteins either is dependent on high chromatin accessi-
bility or requires an additional, transcription-coupled signal.
Interestingly, trimethylation of histone H3 at lysine 36
(H3K36me3) is a histone modification that has been shown to
be enriched specifically toward the 3 end of active genes (3,
20, 22, 23). In Saccharomyces cerevisiae, H3K36me is bound by
the chromodomain protein Eaf3 and recruits the Rpd3S
HDAC complex to remove transcription-coupled hyperacety-
lation, which could otherwise unmask internal transcription
start sites (5, 11, 13). MSL3 is a Drosophila homologue of yeast
Eaf3, opening the possibility that it interacts with methylated
H3 lysine 36 to recruit the MSL complex to the 3 end of
dosage-compensated genes.
In this study, we investigated the relationship between
H3K36 methylation and MSL complex recruitment using RNA
interference (RNAi) and ChIP in male Drosophila SL2 cells.
We show that H3K36me3 is enriched promoter distal at dos-
age-compensated genes and relies on the histone methyltrans-
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ferase Hypb, similar to active autosomal genes (4). Despite
comparable regulation, decreased H3K36me3 has an X-spe-
cific effect on the acetylation of H4 lysine 16 (H4K16ac), as it
causes a reduction of that mark on dosage-compensated genes,
while on autosomal genes, levels are increased. Hypoacetyla-
tion on the male X chromosome as a consequence of Hypb loss
of function coincides with reduced binding of the MSL1 and
MOF proteins. Importantly, compromised MSL recruitment
FIG. 1. High-resolution analysis of di- and trimethylation of H3K36 on autosomal and dosage-compensated genes. ChIP analysis of Drosophila
SL2 cells using antibodies specific for H3K36me2 or H3K36me3 and quantification by real-time PCR. Shown are the average and standard
deviation of ChIP enrichments from at least three independent experiments normalized to histone H3 occupancy. The x axis reflects the base pair
position relative to the transcriptional start site. The y axis reflects enrichment (bound/input values are displayed as percent recovery of input
DNA). H3K36me2, left scale; H3K36me3, right scale. Numbers in graphs are gene identification numbers according to Flybase.
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results in a failure to adequately upregulate the expression of
a subset of X-linked genes. Thus, our data indicate that H3K36
trimethylation provides an important signal to attract MSL
complex proteins to genes and further establish that the his-
tone acetylation readout of H3K36 methylation in males is
chromosome specific.
MATERIALS AND METHODS
Tissue culture of SL2 cells. Drosophila SL2 cells were kept in Schneider
medium (Gibco) supplemented with 10% fetal calf serum.
RNAi in cultured SL2 cells. Double-stranded RNA (dsRNA) for RNAi knock-
down of Drosophila Hypb (bp 3236 to 3944) was generated according to Ambion
MEGAscript manual instructions. 1  106 SL2 cells were plated in 2 ml medium
and treated with 70 g dsRNA for 4 days. Treatment was repeated after cell
splitting for a total of 7 days before harvesting cells for subsequent analysis.
Western blot analysis and antibodies. Western blottings were performed as
previously described (4). Mouse monoclonal antibody against Hypb was used as
previously described (4). Purified, bacterially expressed protein fragments were
used to generate pMal-Hypb (amino acids [aa] 1 to 436), pMal-Hypb (aa 919 to
1135), and pMal-Hypb (aa 2040 to 2363), according to standard procedures.
Hsp70 (mouse monoclonal; StressGen), H2A (Upstate 07-146), H3 (Abcam
ab1791), H3K36me2 (Upstate 07-369), H3K36me3 (Abcam ab9050), H4K8ac
(Upstate 07-328), H4K12ac (Upstate 07-595), H4K16ac (Upstate 07-329), MOF,
and MSL1 (19) were used for the analysis.
ChIP. ChIPs of histone modifications, MOF and MSL1, were carried out as
described previously (4).
Immunostaining of polytene chromosomes. Preparation of polytene chromo-
somes and immunostaining were performed as described previously (http://www
.igh.cnrs.fr/equip/cavalli/Lab%20Protocols/Immunostaining.pdf). Hypb antibody
and preserum were used in a 1:15 dilution; all other antibodies were used in a
1:250 dilution. Images were taken with a Leica Sp5 confocal microscope (Leica
Microsystems, Mannheim) using an HCX PL APO 63.0 1.40 oil objective.
Reverse transcription and real-time PCR. Reverse transcription and quanti-
tative real-time PCR analysis were performed as described previously (14). PCR
conditions and autosomal primer sequences were as described previously (4, 28).
Additional details for primer positions and sequences are available from the
authors.
RESULTS
Distributions of H3 lysine 36 methylation states are similar
at dosage-compensated and autosomal genes. To determine
whether distribution of H3K36 methylation parallels the pat-
tern of MSL binding, we performed ChIP with antisera specific
for di- and trimethylation of this residue in male SL2 cells.
ChIP enrichments were quantified by real-time PCR to deter-
mine K36 methylation states along selected X-linked and au-
tosomal genes. On the X chromosome, both methylation states
were enriched on a set of genes known to be subject to dosage
compensation (14, 24, 26) yet displayed distinct patterns of
localization. Dimethylation was preferentially localized proxi-
mal to promoters, whereas trimethylation peaked in the middle
and in the 3 ends of dosage-compensated genes (Fig. 1),
reminiscent of MSL binding. To determine whether K36 meth-
ylation states are distinct at MSL target genes, we compared
X-linked profiles with di- and trimethylation on autosomes.
Both methylation states were enriched along the body of tran-
scriptionally active autosomal genes and assumed localizations
that generally mirrored those of dosage-compensated genes
(Fig. 1). This is in agreement with the distributions that we
obtained recently for individual autosomal genes as well as for
chromosome-wide profiles in female Kc cells (4).
These results indicate that the H3K36 methylation signature
at dosage-compensated genes on the male X chromosome is
similar to that on autosomes.
Hypb mediates transcription-dependent trimethylation of
H3 lysine 36 on autosomes and X chromosome. In Drosophila,
trimethylation of H3K36 relies on the activity of the SET-
domain-containing protein CG1716 (4, 15, 24a, 29). Based on
homology to the human histone methyltransferase HYPB (27),
we refer to CG1716 as Hypb. In female cells, Hypb is enriched
on actively transcribed genes and coincides with H3K36 tri-
FIG. 2. Hypb binds autosomes and the male X chromosome. Polytene chromosomes of male third-instar larvae were stained with antibodies
against Hypb (green) and MSL1 (red). DNA was visualized by Hoechst staining (blue). (A) Hypb localized preferentially to euchromatic interband
regions, suggesting a general role in transcription. (B) Hypb partially localizes to sites of MSL1 enrichment along the X chromosome, consistent
with a role in the trimethylation of H3K36 on dosage-compensated genes.
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methylation downstream of promoters (4). We determined the
chromosomal distributions of this enzyme in Drosophila males
by immunofluorescence staining of polytene chromosome
squashes isolated from third-instar larvae. At low resolution,
Hypb displayed binding to interbands and puffs with no appar-
ent preference for any particular chromosome (Fig. 2A). When
we performed costaining with an antibody against MSL1, we
observed partial colocalization at many sites along the X chro-
mosome (Fig. 2B). Despite an extensive overlap with MSL1
binding, we did not detect a characteristic pattern of Hypb
localization on the compensated X chromosome, suggesting
that Hypb is present at all sites of active transcription.
To define the contribution of Hypb to H3K36 trimethyla-
tion, we reduced transcript levels by RNAi in male SL2 cells.
Hypb knockdown reduced protein levels, as indicated by West-
ern blot analysis (Fig. 3A), and resulted in a specific decrease
in H3K36 trimethylation, while dimethylation was slightly in-
creased (Fig. 3B). These bulk methylation changes are similar
to the ones previously observed following RNAi knockdown in
female Kc cells (4).
Next, we examined by ChIP if the bulk effects on H3K36
methylation recapitulate changes at individual loci on auto-
somes and the X chromosome. At two autosomal genes,
knockdown of Hypb reduced the presence of trimethylation
and coincided with an increase of H3K36 dimethylation (Fig.
3C). This reflected the RNAi effects on bulk methylation and
was similar to changes detected for individual genes in female
Kc cells (4). Moreover, we show that the same chromatin
changes also occur at six dosage-compensated genes following
Hypb RNAi in male SL2 cells (Fig. 3C).
We conclude that Hypb mediates trimethylation of H3K36
on autosomes and the X chromosome in male Drosophila cells.
H3K36 trimethylation is required for hyperacetylation of
H4K16 on the dosage-compensated X chromosome. Having
established that H3K36me3 is equally regulated on all chro-
mosomes, we asked if trimethylation mediates distinct down-
stream effects at autosomal and X-linked genes. In budding
yeast, H3K36 methylation has been reported to regulate acet-
ylation of histones H3 and H4 on transcribed open reading
frames through recruitment of an HDAC-containing complex
(5, 11, 13). Reduction of H3K36 trimethylation in female Dro-
sophila cells also affected histone acetylation levels in tran-
scribed regions, yet only for H4 lysine 16 acetylation (4). We
therefore investigated if H4K16ac is subject to differential reg-
ulation in male cells. ChIP in male SL2 cells revealed that
H4K16ac peaks at promoters of active autosomal genes and is
less abundant along gene bodies (see the supplemental data at
http://www.fmi.ch/groups/schubeler.d/web/data.html) (J. Kind
J. M. Vaquerizas, and A. Akhtar, unpublished data), similar to
female Kc cells. In contrast, we detected highly elevated levels
of H4K16ac along the gene body of dosage-compensated
genes, which is in agreement with previous reports (9, 24). On
these genes, H4K16ac was especially abundant in the 3 end,
reminiscent of the localization of H3K36me3 (see the supple-
mental data at http://www.fmi.ch/groups/schubeler.d/web/data
.html).
Western blot analysis of Hypb knockdown showed that a
reduction of trimethylation coincided with decreased levels of
bulk acetylation at H4K16 (Fig. 4A). This was different from
female cells where global acetylation increases in response to
Hypb knockdown (4). Interestingly, when tested at specific loci
by ChIP, we observed that levels of acetylation increased at
autosomal genes yet at the same time decreased at dosage-
compensated genes (Fig. 4B). We reasoned that this X-specific
decrease is likely to account for the global reduction, since
dosage-compensated genes show very high levels of H4K16
hyperacetylation compared to autosomal genes (see the sup-
plemental data at http://www.fmi.ch/groups/schubeler.d/web
/data.html) (24).
We conclude that while the presence of H3K36me3 reduces
H4K16ac on autosomes, similar to female Kc cells, it has an
additional male-specific function in enhancing H4K16ac on the
dosage-compensated X chromosome. One possibility is that it
contributes to MSL recruitment, which has previously been
shown to be required for H4K16 hyperacetylation by MOF.
H3K36 trimethylation enhances recruitment of MSL pro-
teins at dosage-compensated genes. The effect on H4K16ac
suggests a reduction in MOF levels at target sites, indicating a
function of H3K36me3 in MSL complex recruitment. To ad-
dress this question, we reduced Hypb-dependent trimethyla-
tion and examined the levels of MSL recruitment in the same
set of X-linked genes. We determined the binding pattern of
two selected MSL complex members by ChIP using specific
antibodies directed against MSL1 and MOF. Both proteins
were bound along gene bodies, with the strongest enrichment
found in the 3 ends, reminiscent of H3K36me3 (Fig. 5A) and
in agreement with previous studies (2, 9). The addition of
Hypb dsRNA and the subsequent reduction of H3K36me3
strongly diminished the presence of MOF at the four target
genes assayed (Fig. 5A), which was consistent with the reduc-
tion in H4K16ac at these genes. Interestingly, while MSL1
abundance was also reduced at Par-6, CG8173, and Ucp4A, it
remained mostly unaffected at sites of the roX2 gene. The roX2
gene presents 1 of 30 to 40 high-affinity sites, which contain
sequence elements that are able to attract MSL1 to the X
chromosome even in the absence of complete dosage compen-
sation complexes (12) or transcription (14). The fact that
MSL1 binding at the roX2 locus is mostly insensitive to Hypb
RNAi indicates that strong sequence affinity can mediate
robust recruitment independent of H3K36me3. However,
this MSL1 interaction appears to be insufficient to recruit a
fully functional MSL complex, as reflected by reduced MOF
FIG. 3. RNAi knockdown of Hypb has similar effects at autosomal and X-linked loci. (A) Western blot analysis using antibody specific for Hypb
reveals efficient reduction of Hypb in male Drosophila SL2 cells. Hsp70 and MOF remain unaffected by RNAi knockdown and serve as loading
controls. (B) Reduction of Hypb results in a reduction of H3K36me3 and a coinciding increase of H3K36me2. H2A serves as a loading control.
(C) Levels of H3K36 methylation states in RNAi and control cells were compared by ChIP followed by real-time PCR analysis. Shown is the ratio
of H3K36me enrichments (change [n-fold], y axis) of RNAi over control cells relative to the position from the transcription start site (x axis). Effects
on H3K36 methylation states at individual loci reflect bulk changes upon Hypb knockdown.
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binding and H4K16ac at the roX2 gene under these condi-
tions (Fig. 4B).
Hence, our results suggest that H3K36me3 is an important
signal for stable association of a fully functional MSL complex
with high-affinity sites and crucial for the binding of MSL
proteins to low-affinity target genes. In the absence of tri-
methylation, MSL binding is diminished, resulting in lower
levels of H4K16 hyperacetylation.
K36 methylation is required for transcriptional regulation
at MSL target genes. Acetylation of H4K16 can relieve chro-
matin-mediated repression of transcription in vitro (1) and
thus directly contribute to transcriptional upregulation of dos-
age-compensated genes. To address whether H3K36-depen-
dent changes in acetylation affect transcription at target genes,
we measured mRNA expression in untreated and Hypb knock-
down cells by reverse transcription and quantitative real-time
FIG. 4. H3K36 trimethylation is required for H4K16 hyperacetylation of the dosage-compensated X chromosome. (A) Hypb RNAi results in
a reduction of bulk H4K16ac in male SL2 cells as indicated by Western blot analysis. (B) Comparison of changes in H4K16ac along autosomal
and dosage-compensated X-linked genes upon RNAi by ChIP and real-time PCR. At autosomal genes, H4K16ac levels increase upon reduction
of Hypb, whereas levels at dosage-compensated genes decrease.
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PCR. Indeed, expression of all tested dosage-compensated
genes was significantly reduced upon decline of H3K36me3
(Fig. 5B). This effect was similar to the approximately twofold
decrease of target gene mRNA levels after MSL2 knockdown
(26), indicating that trimethylation is important for adequate
transcriptional upregulation of X-linked genes. However, ex-
pression was not similarly decreased at all genes tested, since
an X-linked gene, which is not subject to dosage compensation,
and an autosomal gene remained unaffected. These results
emphasize the critical role of H3K36me3 as a chromatin sig-
nature to allow recruitment of MSL proteins to sites of tran-
scriptional compensation.
DISCUSSION
In this study, we report that trimethylation of histone H3
lysine 36 is required for high levels of H4K16ac at dosage-
compensated genes on the male X chromosome. This function
does not reflect an X-specific methylation signature, since both
H3K36 methylation states have similar localization patterns at
autosomal genes: dimethylation peaks promoter-proximal, and
trimethylation shows a 3 bias (Fig. 1). Furthermore, the reg-
ulation of H3K36me3 depends on the activity of Hypb, which
is equally targeted to autosomal and X-linked loci, indicating a
common mode of regulation (Fig. 2 and 3).
Nevertheless, downregulation of H3K36me3 in Drosophila
SL2 cells resulted in reduced levels of H4K16 hyperacetylation
at X-linked genes but simultaneously increased levels at auto-
somal genes in the same cells (Fig. 4). This differential effect on
acetylation suggests a context-dependent readout of lysine 36
methylation. In Saccharomyces cerevisiae, H3K36me signals
binding of the chromodomain-containing protein Eaf3, which
in turn recruits an Rpd3 complex to deacetylate the 3 end of
FIG. 5. H3K36 trimethylation enhances binding of the MSL complex and transcriptional upregulation at dosage-compensated genes. (A) MOF
and MSL1 enrichments at dosage-compensated genes were compared with untreated and Hypb RNAi cells by ChIP and real-time PCR analysis.
In control cells, both proteins displayed a similar pattern, localizing preferentially in the 3 end of genes. Hypb knockdown led to diminished levels
of MOF and MSL1 at all positions along Par-6, CG8173, and Ucp4A. MOF was also depleted from high-affinity sites along the roX2 gene, while
the level of MSL1 remained largely unaffected. (B) Relative mRNA expression from dosage-compensated and noncompensated genes after Hypb
knockdown. Displayed are average mRNA levels of five independent experiments, normalized to a mitochondrial RNA, comparing untreated and
Hypb knockdown cells by quantitative real-time PCR (14). Upon Hypb RNAi, mRNA expression levels of 11 dosage-compensated genes are
reduced approximately twofold. Expression levels of noncompensated X-linked runt as well as autosomal spt4 remain unchanged.
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transcribed genes (5, 11, 13). We provide evidence that the
X-specific reduction of histone acetylation in Hypb-depleted
Drosophila SL2 cells reflects compromised recruitment of
MSL1 and MOF at dosage-compensated genes (Fig. 5A). This
is in full agreement with reduced binding of MSL3 upon Hypb
knockdown, which was recently reported by Larschan and col-
leagues (15). MSL3 is one of the Drosophila homologues of
yeast Eaf3 (7) and localizes together with MOF and MSL1 to
the 3 end of dosage-compensated genes (2, 9). Thus, in anal-
ogy to yeast, MSL3 is likely to associate with H3K36me3 at the
3 end of X-linked genes, leading to robust complex binding
and enhanced H4K16 hyperacetylation. This is supported by
evidence showing that MSL3 preferentially interacts with Set2-
methylated nucleosomes in vitro (15). Moreover, our observa-
tion of Hypb localizing to active sites on polytene chromo-
somes provides further evidence for a direct role of H3K36me3
in MSL recruitment (Fig. 2B). However, not all sites enriched
for Hypb were also bound by MSL1, suggesting that
H3K36me3 is necessary but not sufficient for MSL complex
recruitment.
Whereas proper binding of the MSL complex to Par-6,
CG8173, and Ucp4A relies on the presence of H3K36me3,
Hypb knockdown did not significantly decrease MSL1 recruit-
ment at the roX2 gene (Fig. 5A) (15). This is similar to the
binding of MSL1 and MSL2 to high-affinity sites in msl3 or mof
mutant flies (10, 12, 17), suggesting that strong sequence af-
finity can target partial MSL complexes independent of
H3K36me3. Importantly, despite its presence at the roX2 locus
in Hypb knockdown cells, MSL1 was insufficient for adequate
MOF recruitment and transcriptional upregulation (Fig. 5A
and B). Thus, our data indicate that H3K36me3 is necessary at
high-affinity sites to facilitate robust MOF interaction and the
subsequent hyperacetylation needed to double transcription
(Fig. 6).
Interestingly, roX2 transcription was unaffected by Hypb
RNAi when expressed from a plasmid model system (29).
Since the consequence of reduced H3K36me3 on H4K16ac on
the roX2 plasmid was not determined in this study, it is possible
that a less pronounced reduction in acetylation might account
for this effect.
In contrast to the roX2 gene, H3K36me3 was required for
MSL1 binding to lower-affinity genes. At these genes, tran-
scription-dependent methylation might facilitate DNA acces-
sibility in the 3 end by enhancing the recruitment of MOF and
the hyperacetylation of H4K16 (Fig. 6).
At autosomal genes, reduced trimethylation caused the op-
posite effect on H4 lysine 16 acetylation. Thus, one modifica-
tion may signal two different outcomes in the same cell in a
FIG. 6. Model for MSL complex targeting to sites of dosage compensation in Drosophila. Genes along the X chromosome have various affinities
for MSL complex binding. High-affinity sites (red) can attract partially assembled MSL complexes independent of transcription-coupled chromatin
modifications. However, H3K36me3 is still necessary to facilitate robust interaction with MOF and MSL3. In comparison, the majority of target
genes contain promoter-distal sequence elements, which have relatively weak affinity for MSL recruitment (low-affinity sites [yellow]). At these
genes, transcription-dependent H3K36me3 (blue arch represents concentration of H3K36me3) enhances recognition and stable binding of fully
assembled MSL complexes. Thus, robust recruitment of the MSL proteins to the dosage-compensated X chromosome relies on combined
contributions of degenerate sequence elements and transcription-coupled histone modifications.
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chromosome-specific fashion. It is conceivable that such dif-
ferential readouts involve interaction with either distinct
methyl-binding proteins or alternative subunit compositions.
The presence of antagonistic activities in the same nucleus,
which are targeted to the same modification, requires spatial
restriction of individual protein complexes to avoid deregula-
tion by improper acetylation or deacetylation. Thus, the pref-
erential interaction of MSL proteins with H3K36me3 on the X
chromosome might be favored by locally accumulating MSL
proteins at high-affinity sites. MSL interactions with nuclear
pore proteins (19) suggest a possible role of nuclear organiza-
tion in X chromosome dosage compensation, which may fur-
ther contribute to a preferential binding of MSL proteins to
H3K36me3. Conversely, while this confines histone acetyl-
transferase activity to dosage-compensated genes on the X
chromosome, it might also ensure that the same activity is not
mistargeted to autosomal genes.
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Here, we report the biochemical characterization of
the nonspecific lethal (NSL) complex (NSL1, NSL2,
NSL3, MCRS2, MBD-R2, and WDS) that associates
with the histone acetyltransferase MOF in both
Drosophila and mammals. Chromatin immunopre-
cipitation-Seq analysis revealed association of
NSL1 and MCRS2 with the promoter regions of
more than 4000 target genes, 70% of these being
actively transcribed. This binding is functional, as
depletion of MCRS2, MBD-R2, and NSL3 severely
affects gene expression genome wide. The NSL
complex members bind to their target promoters
independently of MOF. However, depletion of
MCRS2 affects MOF recruitment to promoters. NSL
complex stability is interdependent and relies mainly
on the presence of NSL1 and MCRS2. Tethering of
NSL3 to a heterologous promoter leads to robust
transcription activation and is sensitive to the levels
of NSL1, MCRS2, and MOF. Taken together, we
conclude that the NSL complex acts as a major tran-
scriptional regulator in Drosophila.
INTRODUCTION
Eukaryotic genes that encode messenger RNAs are subject to
primary regulation at the level of transcription. A series of distinct
phases occur at the onset of transcription of these RNAs, begin-
ning with the binding of activators upstream of the core
promoter, followed by the recruitment of adaptor complexes
such as SAGA or mediator. In turn those adaptor complexes
facilitate the binding of general transcription factors (GTFs) and
RNA polymerase II and initiate transcription (Thomas and
Chiang, 2006). To better understand themechanism of transcrip-
tion initiation, characterization of yet-unidentified promoter-
bound proteins is essential.
Transcription initiation in eukaryotes involves dynamic
changes in chromatin structure that permit assembly of theMtranscription machinery at a gene promoter (Lemon and Tjian,
2000; Orphanides and Reinberg, 2000). The fundamental
structural unit of chromatin is the nucleosome, which contains
146 bp of DNA wrapped around a histone octamer composed
of two copies each of histones H2A, H2B, H3, and H4. Histones
in a nucleosomal context are subject to a variety of posttransla-
tional modifications, such as acetylation,methylation, phosphor-
ylation, ribosylation, ubiquitinylation, etc. A number of well-
conserved enzymes carry out these modifications (for review,
see Kouzarides, 2007).
Males absent on first (MOF) is a histone H4 lysine 16 specific
acetyltransferase in both Drosophila and mammals (Hilfiker
et al., 1997; Mendjan et al., 2006; Smith et al., 2000; Taipale
et al., 2005). In Drosophila, MOF is well known for its role in
dosage compensation of the male X chromosome in the context
of the male specific lethal (MSL) complex (Akhtar and Becker,
2000; Hilfiker et al., 1997; Kind et al., 2008; Smith et al., 2000,
2001). Genome-wide high-resolution binding profiles of MOF
along with MSL1 and MSL3 have shown that MSLs are enriched
primarily toward the 30 end of X-linked genes. In contrast, MOF
also binds to promoter proximal regions of the same genes as
well as to a large number of autosomal promoters, independently
of the other MSL complex members (Alekseyenko et al., 2006,
2008; Gilfillan et al., 2006; Kind et al., 2008; Legube et al.,
2006). However, it remained unclear whether MOF binds to
promoters alone or whether it is associated with additional
proteins.
Our previous studies have shown thatMOFassociates not only
with the MSL complex members, but also with a number of
uncharacterized proteins such as CG4699 (NSL1), CG18041
(NSL2), CG8233 (NSL3), CG1135 (MCRS2), and CG10042
(MBD-R2). These proteins were named as nonspecific lethal
(NSL) proteins since disruption of the respective genes by
P-element insertions in Drosophila is early larval lethal in both
sexes (Mendjan et al., 2006). However, it remained unknown
whether there was any functional link between these proteins
and MOF.
To gain further insight, in the present study, we performed
the purification and functional characterization of TAP-tagged
MCRS2 and TAP-HA-FLAG-tagged NSL1. We find NSL1,
NSL2, NSL3, MCRS2, MBD-R2, WDS, and MOF consistently
purified as a complex, which we name the NSL complex.olecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc. 827
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The NSL ComplexInterestingly, members of the NSL complex bind to MOF target
promoters on the X chromosome and autosomes in both sexes.
Chromatin immunoprecipitation (ChIP)-Seq profiling for NSL1
and MCRS2 reveals that these proteins together bind to the
promoters of more than 4000 target genes. The NSL complex
members bind to their target promoters independently of MOF.
However, MOF targeting to promoters is NSL complex depen-
dent, showing a hierarchy of recruitment. Furthermore, upon
depletion of NSL1, NSL3, or MCRS2, the stability of the NSL
complex is compromised. MCRS2, MBD-R2, and NSL3 are
important regulators of gene expression, as their depletion
severely affects themRNA levels of most of the NSL target genes
in a genome-wide manner. Our data suggest that reduction in
transcript levels is the result of impaired transcription initiation,
since it correlates with reduced levels of RNA polymerase II at
gene promoters. In addition, we show that tethering NSL3 to
a heterologous promoter activates transcription, and that the
NSL complex members as well as MOF modulate this activity.
These results suggest a cooperative interaction between the
NSL complex members and MOF. Taken together, we identify
the NSL complex as an evolutionarily conserved complex, which
acts as a major transcriptional regulator in Drosophila.
RESULTS
Biochemical Purification of the NSL Complex
Our previous copurification of MOF interacting proteins identi-
fied a set of proteins of unknown function (Mendjan et al.,
2006). To gain further insight into the nature of these interactions,
we generated stable Schneider (SL-2) cell lines expressing two
of the uncharacterized proteins—TAP-tagged MCRS2 and
TAP-HA-FLAG-tagged NSL1. Nuclear extracts were prepared
from cell lines that express tagged proteins as well as from
wild-type cells for mock purification. The quality of the affinity-
purified material was analyzed by SDS-PAGE followed by silver
staining (Figure 1A). Matrix-assisted laser desorption/ionization
time of flight, nanoelectrospray, liquid chromatography-tandem
mass spectrometry, as well as western blot analysis identified
the following proteins consistently purifying with either NSL1 or
MCRS2: NSL1, NSL2, NSL3, MCRS2, MBD-R2, WDS, and
MOF in addition to a number of other proteins (Figure 1A; Table
S1, available online).Figure 1. Purification of the NSL1 and MCRS2 Complexes
(A) Silver staining of copurified proteins from Schneider SL-2 cells stably expre
WT indicates corresponding mock purifications from wild-type SL-2 cells. From
was used, and 50% of the purified elutedmaterial was loaded on a gel; the rest of
indicates an additional area on the gel where NSL1 and MOF peptides were iden
(B) Western blot analysis of the TAP-FLAG-HA-NSL1 (TFH-NSL1) purification for
were detected in the final eluate, but not MSL1 andMSL3. Tubulin and lamin serve
is shown for detection of NSL1 in input lanes.
(C) Immunoprecipitation from Drosophila embryo nuclear extract with a-MCRS2
Asterisks represent the IgG band.
(D) Same as in (C), except immunoprecipitations were performed with a-MBDR2
(E) Reconstitution of NSL interactions using baculovirus-expressed proteins. Inte
incubation of protein extracts. Purification of HA-tagged NSL1 alone (lane 2). Afte
the gel stained with Coomassie blue.
(F) Fractions 1 to 10 of the hNSL1 (aa 883–1105)/hMOF (aa 174–458) (top) and hMO
on a SDS-PAGE and the gel stained with Coomassie blue.
(G) Superdex 200 gel filtration elution profiles of hNSL1 (aa 883–1105)/hMOF (aa
MThe nsl1 gene is located on chromosome 3R and encodes a
protein of 1550 aa which contains a MOF interacting PEHE
domain at its C terminus. The nsl2 gene is located on chromo-
some 3R and encodes a protein of 484 aa that contains two
C/H-rich domains. The nsl3 gene is located on chromosome
2R and encodes three splice variant proteins of 1001 aa, 1066
aa, and 934 aa, all containing a a/b hydrolase domain. The
mcrs2 gene is located on chromosome 3L and encodes a protein
of 578 aa containing a ForkHead-Associated domain (FHA) at its
C terminus. Thembd-r2 gene is located on chromosome 3R and
encodes two splice variants: one variant of 1169 aa containing
a Tudor, MBD, ZnF and a PHD finger domain and a second
variant of 1081 aa without the Tudor domain (Hendrich and
Tweedie, 2003).
None of these proteins were found in the control mock purifi-
cation from the wild-type SL-2 cell line, thus validating the
purification assay. The interactions were further confirmed by
western blot analysis of the eluted fractions (Figure 1B). Interest-
ingly, apart from MOF, none of the other MSL complex proteins
copurified with MCRS2 or NSL1. These results, as well as coim-
munoprecipitation experiments with WDS, MBD-R2, MCRS2,
and MSL1-specific antibodies revealed that the interaction
between these proteins and MOF was specific and distinct
from the previously characterized MSL complex (Figures 1C
and 1D). Among the proteins tested in coimmunoprecipitation
experiments only MBD-R2 revealed a substoichiometric interac-
tion with MSL1. We termed this copurified complex containing
NSL1, NSL2, NSL3, MCRS2, MBD-R2, WDS, and MOF as the
NSL complex. NSL complex elutions were also tested for histone
acetyltransferase (HAT) activity. Indeed, we detect an enrich-
ment of histone H4 directed HAT activity in these fractions
(Figures S1A and S1B).
NSL1 Directly Interacts with MCRS2 and MOF
In order to dissect the interactions between the NSL proteins,
expression constructs with tagged (FLAG or HA) as well as
untagged NSL1, MCRS2, and MOF were expressed in the
baculovirus expression system (Figure 1E; data not shown).
Copurification of these proteins revealed a stable interaction of
NSL1withMCRS2 andMOF (Figure 1E, lanes 1–3). These results
showed that the interaction between NSL1-MCRS2 and NSL1-
MOF is direct and can occur in the absence of other NSLssing TAP-FLAG-HA-NSL1 (lanes 1 and 2) and TAP-MCRS2 (lanes 3 and 4).
each cell line 1.5 ml of nuclear extract with a protein concentration of 6mg/ml
the material was used for subsequent mass spectrometry analysis. The bracket
tified upon band excision by mass spectrometry analysis.
NSL proteins. NSL1, NSL2, MCRS2, MBD-R2, WDS, Z4, Chromator, and MOF
d as negative controls. The open arrow indicates the NSL1 bait. Long exposure
or a-MSL1 antisera. The blot was probed with various antibodies as indicated.
or a-WDS antibodies.
raction of NSL1 with MCRS2 (lane 1) and DrosophilaMOF (dMOF, lane 3) upon
r purification via the corresponding tag, proteins were run on a SDS-PAGE and
F (aa 174–458) (bottom) Superdex 200 gel filtration profiles. Fractions were run
174–458) in blue and of hMOF (174-458) in red.
olecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc. 829
Figure 2. MCRS2, MBD-R2, NSL1, and MOF Colocalize Globally on Wild-Type Male and Female Drosophila Third Instar Larval Polytene
Chromosomes
Coimmonufluroscence staining ofMCRS2 (green) withMBD-R2, NSL1,MOF, andMSL1 (red); DNA counterstained byHoechst. As a control of binding specificity,
coimmunostaining of MCRS2 and MSL1 is shown. White boxes indicate the zoomed area in the right panels showing the extent of colocalization.
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The NSL Complexcomplex members. We further characterized the interaction for
the mammalian orthologs hMOF and hNSL1 and could observe
that the HAT domain of hMOF (aa 174–458) and the C-terminal
domain of hNSL1 (aa 883–1105) were sufficient for interaction.
Furthermore, gel filtration as well as multiangle laser light scat-
tering (MALLS) analyses revealed that this interaction was based
on a stoichiometry of 1:1 between the two proteins (Figures 1F
and 1G; Figure S1C). These results further demonstrate the
high degree of evolutionary conservation between NSL1 and
MOF interaction across species.
The NSL Complex Members Are Localized
on MOF Target Promoters
The biochemical association of NSL proteins with MOF promp-
ted us to address whether these proteins are chromatin bound830 Molecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc.in vivo. We therefore performed immunofluoresence staining
of Drosophila third instar larval male and female polytene chro-
mosomes using antibodies against MCRS2, NSL1, MBD-R2,
and MOF. All four proteins showed extensive genome-wide
colocalization with each other as well as with MOF on interbands
of the polytene chromosome squash preparations in both sexes
(Figure 2; Figure S2A, available online).
To gain more detailed insight as to where chromatin binding
was occurring, ChIP assay was performed on wild-type male
salivary glands using antibodies against MCRS2, MBD-R2,
NSL1, and MOF; corresponding preimmune sera were used as
negative controls. ChIP samples were analyzed using quantita-
tive real-time PCR (qPCR). Seven genes, which were recently
identified as MOF target genes either on X chromosomal
(CG6506, CG4406, Dspt6, and Rb) or autosomal (Sec5,
Figure 3. NSL1, MCRS2, and MBD-R2 Bind to the Promoters of X Chromosomal and Autosomal Genes
ChIP analysis from larval male salivary glands using antibodies against MOF, NSL1, MCRS2, and MBD-R2. Respective preimmune sera were used as negative
controls. Immunoprecipitated DNA was amplified by qPCR with primer sets indicated in the Supplemental Experimental Procedures. Six X-linked genes
(CG6506, CG4406, Dspt6, Rb, CG6398, and OdsH) and three autosomal genes (Sec5, CG9536, and Gprk2) were evaluated using primers positioned at the
promoter (P1), middle (P2), and end (P3) of the coding sequence. Percentage input is determined as the amount of immunoprecipitated DNA relative to input
DNA. Error bars represent standard deviation (StDev) of five independent experiments.
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The NSL ComplexCG9536, andGprk2) locations (Kind et al., 2008), were tested for
NSL binding. Two MOF nontarget genes (CG6398 and OdsH)
were used as negative controls. Distribution on each gene was
analyzed using primers located toward the promoter (P1), middle
(P2), and the end of the coding region (P3) as indicated in Figure 3
(also see Experimental Procedures). Consistent with previous
studies (Kind et al., 2008), MOF showed binding to the promoter
regions of autosomal genes, whereas on X chromosomal
targets, binding is also distributed along the transcribed regions
(compare Figure 3, X targets versus autosomal targets). Interest-Mingly, we found that NSL1, MCRS2, and MBD-R2 are enriched
on promoter proximal regions of X chromosomal as well as auto-
somal MOF target genes (Figure 3). To further address whether
this binding pattern is specific to male salivary glands, we
performed ChIP from female salivary glands, SL-2 cells, as well
as from whole larvae, which showed the same results (Fig-
ures S2B–S2D). Furthermore, to get a global perspective, ChIP
followed by Solexa deep sequencing analysis revealed that clus-
ters ofMCRS2 andNSL1 highly coincide on promoters, suggest-
ing that these proteins act in a complex also in the chromatinolecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc. 831
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The NSL Complexcontext (Figures 4A, 4B, and 4D; Figure S3A, available online).
Over 4000 promoters were bound by NSL1 and MCRS2,
70% of these corresponding to active genes (p < 2.2e-16;
Fisher’s exact test; Figure 4C). Correlation with the 50 end of
primary transcripts confirmed that NSL1 and MCRS2 binding
peaks near transcription start sites. The most frequent distance
to the nearest cluster of NSL1 and MCRS2 binding is 45 bp
upstream and +2 bp downstream from the transcription start
sites, respectively (Figures S3B and S3C). Furthermore,
H4K16Ac and MOF binding are enriched at promoters of
NSL-bound genes when compared with promoters of genes
not bound by MCRS2 and NSL1 (Figure 4E). This happens for
both SL-2 and Kc cells (p < 2.2e-16 for all cases; t test). In
contrast, H3K27me3, a mark enriched on inactive genes
(Schwartz et al., 2006), is depleted on promoters bound by
MCRS2 andNSL1 (p < 2.2e-16; t test). Taken together, the above
results reveal the NSL complex as a promoter-bound complex in
Drosophila.
NSL1 and MCRS2 Are Required for the Stability
of the NSL Complex
P-element insertions in MBD-R2, MCRS2, and NSL3 lead to
early larval lethality in both sexes (see Supplemental Experi-
mental Procedures available online). Therefore, to analyze the
functional significance of the NSL complex, we performed
tissue-specific RNAi-mediated knockdown in Drosophila using
the Gal4-upstream activating sequence (UAS) system (Brand
and Perrimon, 1993). RNAi-mediated knockdown of MBD-R2,
MCRS2, and NSL3 in eye imaginal discs using an eyeless-Gal4
driver resulted in a reduced, rough eye phenotype signifying
that these proteins are important for development (Figure S4,
available online).
To further examine the fate of the NSL complex components
upon depletion of individual proteins of the complex, we chose
to knockdown MCRS2, MBD-R2, and NSL3 in the salivary
glands using patched-Gal4,UAS-EGFP/+;UAS-RNAi/+, where
EGFP positively marks the knockdown cells. Upon depletion of
these proteins, the development of salivary glands is impaired,
as observed by reduced gland size (data not shown). Interest-
ingly, depletion of MCRS2 led to a severe reduction of nuclear
NSL3 staining, and to a slight reduction in the nuclear staining
of MBD-R2 and NSL1 compared to the control glands
(Figure S5, available online). Depletion of NSL3 protein resulted
in a slight reduction in MCRS2 levels, while the staining of
NSL1 and MBD-R2 remained unaffected. In contrast, we did
not observe any changes in NSL complex members distribution
in MBD-R2 and Z4 depleted glands (Figure S5).
The reduction in staining could be a result of impaired stability
of the complex caused by degradation of proteins, changes inFigure 4. ChIP-Seq Analysis Reveals that NSL1 and MCRS2 Bind to Pr
(A) Snapshot of a chromosome 2R region obtained using Genomatix ElDorad
(yellow blocks) and transcripts (gray blocks) are highlighted.
(B) Flybase genes located in the selected region.
(C) Overlap between MCRS2-bound, NSL1-bound, and actively expressed gene
(D) Chromosomal maps of genes bound byMCRS2 (red) and NSL1 (green). The ex
(top) and  strand (bottom) are shown in gray.
(E) Distribution of fold enrichments for MOF binding, H4K16ac, and H3K27me3 in
NSL1 (p < 2.2e-16 in all cases; see Supplemental Experimental Procedures).
Mthe transcript levels, and/or changes in nuclear and cytoplasmic
distribution of the proteins. In order to address this issue, we
used Schneider (SL-2) cells to prepare nuclear and cytoplasmic
extracts. The efficiency of nuclear and cytoplasmic extract
preparations was measured by detecting tubulin levels, which
is enriched in the cytoplasm (Figure 5). The effect of the depletion
of MCRS2, MBD-R2, and NSL3 could be reproduced in SL-2
cells using the same RNAi sequences as in the flies (Figures 5A
and 5B). Western blot analysis for the components of the NSL
complex revealed that in MCRS2 depleted cells, NSL3 and
NSL2 protein levels were severely reduced, while MBD-R2 and
NSL1 protein levels were slightly affected. These effects were
specific to the NSL complex members, as MOF andMSL3 levels
remained unchanged (Figure 5A). We observed similar results
with NSL1 and NSL3 depletion, where depletion of NSL1
severely affected NSL2 while NSL3 depletion affected the levels
of NSL3, NSL1, NSL2, andMBDR2. Levels of other NSL proteins
were also moderately compromised in these experiments with
the exception of MOF or Tubulin. In contrast, depletion of MOF
protein did not affect NSL complex protein levels (Figure 5B).
Furthermore, we found that the NSL complex members are
bound to their own genes (Figure S6, available online), suggest-
ing autoregulation by the complex. Consistent with these obser-
vations we also noticed a reduction in mRNA levels of NSL2 and
NSL3 in MCRS2 depleted cells (Figure S7A, available online).
Taken together, these results suggest that the integrity of the
NSL complex is interdependent.
Depletion of MCRS2, MBD-R2, and NSL3 Affects
the Expression of Target Genes
Polytene chromosome staining as well as the ChIP-Seq
approach revealed genome-wide association of NSLs to the
promoter regions of a large number of target genes. One of
the most obvious questions that arise is whether binding of the
NSL complex to target genes is implicated in the regulation of
gene expression. P-element insertion mutants of MCRS2,
MBD-R2, and NSL3 are early larval lethal. So, to measure the
effect on transcriptional activity, total RNA was isolated from
third instar larval MCRS2, NSL3, and MBD-R2 depleted salivary
glands and processed for quantitative reverse transcription
(qRT)-PCR analysis (see Experimental Procedures). We chose
a set of MCRS2 and NSL1 target genes on both the X chromo-
some and autosomes to test for a change in transcript levels
upon MCRS2, NSL3, and MBD-R2 knockdown. Binding of
NSL1, MCRS2, MBD-R2, and MOF to the promoters of these
genes was confirmed by ChIP (Figure 3; Figures S2B–S2D).
Strikingly, we found a severe reduction in transcript levels for
most of the tested NSL complex target genes upon depletion
of MCRS2, NSL3, or MBD-R2, respectively (Figures 6B–6D).omoters Genome Wide
o; tracks show read counts for NSL1 and MCRS2 (red). Gene promoters
s in salivary glands.
tent of overlap is shown in yellow. For each chromosome genes on the + strand
SL-2 and Kc cells for genes bound (red) and unbound (black) by MCRS2 and
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Figure 5. The Stability of the NSL Complex Is Compromised upon Depletion of NSL1, NSL3, and MCRS2
(A) Western blot analysis of the NSL complex members in MCRS2-RNAi, EGFP-RNAi, and MBD-R2-RNAi treated SL-2 cells.
(B) Western blot analysis of the NSL complex members in EGFP-RNAi, MOF-RNAi, NSL1-RNAi, and NSL3-RNAi treated SL-2 cells. C and N are the lanes
loaded with cytoplasmic and nuclear extract, respectively. Percentage of extract loaded is also shown. Asterisks indicates the position of a cross-reacting
band recognized by MCRS2 in the cytoplasmic fraction. Schematic representation of the NSL protein levels is shown on top of each RNAi condition, where
gray color indicates reduced protein levels for the respective protein.
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MCRS2 (Figure S7B).
To address whether these effects were also observed on a
genome-wide scale we performed gene expression profiling of
RNA isolated from MCRS2, MBD-R2, and NSL3 depleted sali-
vary glands using Affymetrix arrays (Figure 6A). We observed
that RNAi depletion of any of these proteins results in a very
similar pattern of gene expression changes (Figure 6A; Pearson
correlation > 0.86 for all comparisons). A total of 5045 genes
were differentially expressed in the MCRS2 depleted glands,
3996 genes in the MBD-R2 depleted glands and 4213 genes in
the NSL3 depleted glands. In all cases, there was a significant
enrichment of differentially expressed genes among the bound
ones (p < 2.2e-16 for all three RNAi experiments; Fisher’s exact
test). Moreover, correlation of genome-wide promoter binding
with the expressed genes in the salivary glands revealed 3347
out of 6092 active gene promoters to be bound by both NSL1
and MCRS2 (Figure 4C).
We found similar numbers of up- and downregulated genes
among NSL targets, indicating that the loss of the complex is
associated with both gene activation and repression. These
results were confirmed by qRT-PCR (Figure 6B). A notable834 Molecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc.exception was MCRS2: The qRT-PCR validation strongly sug-
gested a major activating role. Such a role is difficult to observe
using standard array procedures that usually assume a moder-
ated and balanced change on gene expression upon the studied
perturbation. To account for this, we performed linear regression
between the qRT-PCR and the microarray-generated data (see
Supplemental Experimental Procedures). The results indicated
a global downregulation upon MCRS2 RNAi depletion that was
not observed for any of the other RNAi treatments (data not
shown).
Gene expression analysis was also done using salivary glands
of male larva that carry the mof 2 mutation, where a premature
stop codon prevents formation of a functional MOF protein (Hil-
fiker et al., 1997). The effect of NSL depletion on gene expression
was generally more severe in its magnitude than the one
observed in the absence of MOF (compare Figure 6 with Fig-
ure S7C). Furthermore, MCRS2, NSL3, and MBD-R2 depletion
did not show a bias for X chromosomal genes, with genes on
all chromosomes being similarly affected. Interestingly, binding
of the NSL complex members MCRS2, MBD-R2, and NSL1 to
chromatin was unaffected in mof 2 mutant salivary glands as
shown by polytene chromosome staining (Figure S8, available
Figure 6. Depletion of MCRS2, MBD-R2, and NSL3 Affects Gene Expression on X Chromosomes and Autosomes
(A) Heatmap displaying gene expression changes upon RNAi depletion of MCRS2, MBDR2, and NSL3 (columns) for genes bound by MCRS2 and NSL1 (rows).
Downregulated genes are shown in red. Upregulated genes are shown in blue. Trace lines (yellow) centered in themiddle of each column represent themagnitude
of the change according to the scale. Both rows and columns were clustered using hierarchical clustering.
(B–D) Quantitative RT-PCR analysis of Sec5, CG9536, Eyg, CG5098, CG15011, NSL1, NSL2, NSL3,MCRS2,MBD-R2, and CG6695 located on autosomes and
Peb, CG3573, CG4406, CG6506, Ucp4a, Rpb1, Rpl22, Mof, and Klp3A located on the X chromosome. Wild-type control Ptc-GAL4 salivary gland expression
(black bars) and RNAi depleted salivary gland expression (gray bars). Ptc-Gal4;UAS-MCRS2-RNAi (B), Ptc-Gal4;UAS-MBD-R2-RNAi (C), and Ptc-Gal4;UAS-
NSL3-RNAi (D). Error bars represent standard deviation (StDev) of three independent experiments. Expression levels were normalized against the respective
genomic DNA.
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regulation upstream of MOF function. We therefore propose
the evolutionarily conserved NSL complex as an important
transcriptional regulator in Drosophila.
Depletion of MCRS2 Affects the Integrity
of the NSL Complex at Promoters
To further assess whether MCRS2 is required to stably maintain
the integrity of the NSL complex on chromatin, we performed
ChIP for NSL1, MBD-R2, and MOF on NSL1 and MCRS2 target
genes upon MCRS2 depletion. We chose RNAi-mediated
knockdown in SL-2 cells, since salivary glands are greatly
reduced in size upon MCRS2 knockdown, thus limiting the
amount of sample available for ChIP. As expected, depletion
of MCRS2 led to reduced levels of MCRS2 at target promoters
(Figure 7A) and up to 90% of knockdown efficiency (Figure 5A).
Interestingly, depletion of MCRS2 resulted in a severe reduction
in the binding of NSL1 and MBD-R2 to these target genesM(Figure 7A), while their overall protein levels were only moder-
ately affected (Figure 5). These results demonstrate that
MCRS2 is required to stably maintain the integrity of the NSL
complex at target promoters.
Furthermore, although the protein level of MOF was unaf-
fected upon depletion of MCRS2 (Figure 5A), MOF binding to
target promoters was substantially reduced (Figure 7A). Similar
results were obtained by performing ChIP on whole larvae using
an MCRS2 mutant (Figures S9A–S9C, available online). We also
tested the effects of MCRS2 depletion on the levels of H4K16Ac
and H3K4me3, as both marks are associated with active genes.
ChIP using antibody against histone H4 was used as control. We
observed no significant reduction in H3K4me3 levels at these
promoters, however, acetylation at H4K16 was moderately
reduced upon depletion of MCRS2 (Figure 7A). Moderate reduc-
tion of H4K16Ac may be explained by the dynamic nature of
MOF interaction at these sites or a low H4K16Ac turnover.
However, another very likely possibility could be that since theseolecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc. 835
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The NSL ComplexChIPs were performed in SL-2 cells, presence of the MSL
complex may still be responsible for overall acetylation levels.
Indeed, when comparing MOF levels at the 50 versus 30 end of
X-linked genes, we observed a more significant reduction at
the promoters versus the 30 end upon MCRS2 depletion (Fig-
ure S9D). Consistent with these observations, whenwe repeated
theChIP in Kc cells depleted ofMCRS2, where theMSL complex
is not assembled, NSL1, MBD-R2, and MOF as well as H4K16
levels were severely affected (Figure S10A, available online).
As mentioned earlier, upon depletion of MCRS2, MBD-R2,
and NSL3, the mRNA levels of most of the tested target genes
were reduced. We were next interested to know whether the
reduction in expression of these target genes is a result of
defects in the recruitment of RNA polymerase II to their
promoters. Depletion of MCRS2 led to a severe loss of NSL1,
NSL2, NSL3, and MBD-R2 from gene promoters. We therefore
chose to assay the binding of RPB3—a subunit of the core
RNA polymerase II (Adelman et al., 2005) on the target genes
in MCRS2 depleted cells. Interestingly, the levels of RPB3 on
target promoters were significantly reduced in MCRS2 depleted
cells (Figure 7A). However, overall nuclear RNA polymerase II
levels remain unaffected as shownbywestern blot (Figure S10B).
These results suggest that the reduction in expression upon loss
of the NSL complex from its target genes might be a conse-
quence of altered recruitment of RNA polymerase II to the
promoters, suggesting a function of NSLs in early transcriptional
regulation.
NSL3-Driven Transcription Activation Is Modulated
by NSL1, MCRS2, and MOF
Next, we were interested in studying whether the NSL complex
has the potential to activate transcription. We therefore
expressed two components of the NSL complex, NSL3 and
MCRS2, fused to the Gal4 DNA-binding domain in SL-2 or Kc
cells cotransfected with a UAS-driven luciferase reporter. Inter-
estingly, expression of Gal4-NSL3 resulted in potent activation
of the reporter (Figure 7B). In contrast, transfection of Gal4 alone
or Gal4-MCRS2 did not show activation of the reporter gene. We
next tested whether activation by Gal4-NSL3 is sensitive to the
endogenous levels of NSL complex members. For this purpose
we depleted NSL1 and MCRS2 as well as MOF in cells trans-Figure 7. Depletion of MCRS2 Affects the Integrity of the NSL Comple
(A) ChIP using antibodies against MCRS2, NSL1, MBD-R2, MOF, Rpb3 (Pol II), H
CG4406) and three autosomal genes (Sec5,CG15011, and CG5098) in EGFP-RN
were positioned at the promoters of thementioned genes. Exact positions of the p
as the amount of immunoprecipitated DNA relative to input DNA. Error bars repr
(B) Tethering NSL3 via the GAL4 DNA-binding domain activates transcription of
(bottom). Transient transfection of either empty vector (–), vector expressing the
Error bars represent standard deviation (StDev) of three independent experimen
(C) NSL3-mediated transcription activation is affected by depletion of MCRS2, NS
ing GAL4 DNA-binding domain (Gal4), or GAL4NSL3 in cells treated with EGFP
compared to vector control. Error bars represent standard deviation (StDev) of t
(D) Summary model: MOF protein is present in two distinct complexes. The classic
30 end of X-linked genes and the NSL complex that is a promoter-bound complex
two PEHE domain-containing proteins. The stability of the NSL complex is interde
the complex. Tethering NSL3 via Gal4 DNA-binding domain to a UAS containing h
activation is modulated by the presence of NSL1, MCRS2, or MOF. We propos
at promoters might promote transcription initiation, while interaction of MOF with
elongation.
Mfected with Gal4-NSL3 or Gal4-DBD as a control. Reduction in
levels of NSL1 or MCRS2 severely affected the transcription
activation mediated by NSL3. Similarly, depletion of MOF sub-
stantially reduced reporter activation (Figure 7C). These results
strongly suggest that the NSL complex members and MOF
work synergistically to activate transcription.
DISCUSSION
Here we report the biochemical purification and functional
analysis of the NSL complex. The members of this complex
are evolutionarily conserved between fruit flies and humans
(Mendjan et al., 2006). Intriguingly, we find that 55% of all active
genes are bound by the NSL complex in Drosophila. We show
that loss of binding of these factors severely affects expression
of target genes. Interestingly, loss of NSL proteins affects MOF
binding as well as RNA pol II recruitment to promoters. Further-
more, we show that the NSL complex and MOF work synergisti-
cally to activate transcription. Taken together, these results
identify the NSL complex as a transcriptional regulator in the
Drosophila genome.
Genome-wide Colocalization of the NSL Complex
Members on Gene Promoters
We present several lines of evidence that the NSL complex
resides at gene promoters. First, immunostaining of polytene
chromosomes with antibodies against NSL complex members
and MOF highly colocalizes in both sexes (Figure 2; Figure S2A).
Second, NSL1, MCRS2, MBD-R2, and MOF colocalize at the
promoters of the tested MOF target genes in salivary glands as
shown byChIP experiments (Figure 3). TheNSL complex binding
at promoters is not restricted to salivary glands, as we found
essentially the same results using chromatin from SL-2 cells
and whole larvae (Figures S2B–S2D). Finally, using ChIP and
Solexa sequencing, we show that NSL1 and MCRS2 signals
highly overlap at the promoters of 4000 genes in salivary
glands (Figure 4). There is a striking correlation between
promoter-bound NSL complex members and MOF as over
70% of previously identified MOF-bound promoters in SL-2
and Kc cells (Kind et al., 2008) overlap with promoter-bound
NSL1 and MCRS2 in male salivary glands (Figure 4E).x at Target Promoters
istone H4, and H4K16Ac on four X-linked genes (OdsH, Ucp4A, CG6506, and
Ai treated (black bars) and MCRS2-RNAi treated (gray bars) SL-2 cells. Primers
rimers are described in the Supplemental Data. Percentage input is determined
esent standard deviation (StDev) of four independent experiments.
the luciferase reporter under the UAS promoter in SL-2 cells (top) and Kc cells
GAL4 DNA-binding domain (Gal4), GAL4NSL1, GAL4NSL3, or GAL4MCRS2.
ts.
L1, and MOF. Transient transfection of either empty vector (–), vector express-
RNAi, MCRS2 RNAi, MOF RNAi, or NSL1 RNAi. y axis shows fold enrichment
hree independent experiments.
al MSL complex (or the dosage compensation complex) that is enriched on the
. Within these two complexes MOF directly interacts with either MSL1 or NSL1,
pendent, MCRS2, NSL1, and NSL3 playing amajor role in the overall stability of
eterologous reporter activates transcription in both SL-2 and Kc cells and this
e a working model that synergistic interaction of the NSL complex with MOF
the MSL complex at the 30 end of X-linked genes may facilitate transcription
olecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc. 837
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of MOF from the 30 end of X-linked target genes in males, but,
surprisingly, MOF binding at the promoters of the same genes
was unaffected (Kind et al., 2008). The results shown in the
present study unravel that MOF binds to the promoters in an
association with the NSL complex and that this association is
not restricted to the male X chromosome, but is genome wide
in both sexes. The observation that MOF binding at promoters
is reduced upon depletion of MCSR2 clearly suggests that the
NSL complex contributes to the recruitment of MOF to target
gene promoters (Figure 7). However, chromatin binding of the
NSL complex members is not affected in the absence of MOF,
implicating NSLs in transcription regulation upstream of MOF.
These data reveal a hierarchy of recruitment at these target
promoters. Furthermore, it is noteworthy that NSL mutants are
early larval lethal in both sexes, whereas, Mof mutants are
male lethal due to dosage compensation defects, but females
are viable to the adult stage albeit being sterile (Gelbart et al.,
2009). These observations suggest that NSL1, NSL2, NSL3,
MCRS2, and MBD-R2 are important regulators during fly devel-
opment and play additional functions very likely independent
of MOF.
MCRS2 Is Required to Stably Maintain the NSL Complex
on Promoters
We find that the integrity of the NSL complex is interdependent,
very likely operating at both transcriptional and posttranscrip-
tional levels. Our study identifies NSL1 and MCRS2 among the
key players in maintaining the integrity of the NSL complex.
Depletion of MCRS2 not only affected protein levels of NSL2
and NSL3, but ChIP analysis also revealed that in the absence
of MCRS2, the rest of the complex is unable to achieve efficient
chromatin targeting. There is an interesting resemblance of the
above observations with that of the MSL complex where the
MSL2 protein is required for complex stability (Beckmann
et al., 2005; Gebauer et al., 2003; Grskovic et al., 2003; Kelley
et al., 1997).
MCRS2 contains a FHA domain at its C terminus. The FHA
domain is a phosphopeptide recognition domain found in
many regulatory proteins. It displays specificity for phospho-
threonine-containing epitopes but also recognizes phosphotyro-
sine with relatively high affinity (Durocher and Jackson, 2002). It
is provocative to speculate that MCRS2 could recognize the
phosphorylated forms of the members of the NSL complex
through the FHA domain to stabilize and recruit the complex to
its target promoters.
The NSL Complex Regulates Transcription at Promoters
Depletion of NSL components resulted in expression changes of
many of the NSL-bound genes on autosomes as well as on the X
chromosome. Importantly, magnitude and extent of the expres-
sion effect was more severe than the one observed in the
absence of MOF, suggesting a MOF-independent mechanism
for NSL function. However, it remains possible that the role of
MOF at target promoters is to fine tune gene expression by
modulating NSL function. This is further supported by our obser-
vations that NSL3-mediated transcription activation is sensitive
to endogenous MOF levels. The broad polytene chromosome838 Molecular Cell 38, 827–841, June 25, 2010 ª2010 Elsevier Inc.staining as well as ChIP-Seq analysis of the NSLs shows that
many chromatin regions are occupied by the NSL complex,
which is likely to be involved in the regulation of a wide spectrum
of genes (Figure 7D).
The observation that RNA polymerase II recruitment to target
genes is affected upon depletion of MCRS2 suggests that the
NSL complex is involved in early steps of transcription. Taking
into account that over 4000 promoters are bound by both
NSL1 and MCRS2, correlating with 55% of the active genes,
and that the expression of most of the NSL target genes tested
in this study is compromised upon the loss of NSL complex
members in salivary glands, several fundamental questions
emerge: How is the NSL complex targeted to responsive
promoters? Which step of transcription initiation requires the
presence of the NSL complex?
The NSL complex could possibly recognize specific DNA
sequences at promoter regions or is brought to promoters
through the interactions with components of the transcription
machinery or regulatory proteins present on the promoters.
These interactions would most probably be transient, and reflect
an inherent instability, as no such proteins were found purifying
with the NSL complex members.
Another very likely possibility is that the complex recognizes
histone marks. The NSL proteins harbor a rich composition of
chromatin-binding domains. For example, WDS is a protein
with the potential of binding to histone H3. It belongs to the
WD family and consists of seven WD40 repeats (Hollmann
et al., 2002). It is known that these repeats are involved in
protein-protein interaction and are present in many chromatin-
associated complexes (Cao et al., 2002). The mammalian ortho-
log of this protein, WDR5, binds specifically to the N-terminal tail
of histone H3 and thereby helps to recruit the MLL containing
H3K4-specific methyltransferase complex to its target pro-
moters (Wysocka et al., 2005). Methylated H3K4 is coupled to
transcription activation (Zhang and Reinberg, 2001). We show
that H3K4me3 is unaffected in the absence ofMCRS2, indicating
that the NSL complex recruitment could be downstream of this
activation mark. WDS could potentially have analogous func-
tions in recruiting the NSL complex to target promoters in order
to regulate the transcription of target genes. Another member of
the complex is MBD-R2, which has a Tudor and methyl binding
(MBD) domains (Taipale et al., 2005). Tudor domains share simi-
larity to chromodomains, which also bind methylated residues
(Lachner et al., 2001). In yeast, Tudor domains have been shown
to bind methylated H3K79 (Huyen et al., 2004). MBD domains
bind to methylated DNA and are involved in transcriptional
repression in mammals (Bird, 2002). However, DNA methylation
happens much more seldom in Drosophila than in mammals and
its function remains unclear (Lyko et al., 2000). MBD-R2 is there-
fore another candidate that could recognize modified histones
and target the NSL complex to promoters in Drosophila.
It is important to emphasize that we have shown earlier that the
mammalian orthologs of the Drosophila NSL complex members
were found copurifying with human MOF (Mendjan et al., 2006).
These observations have been further confirmed recently (Cai
et al., 2010). The mammalian NSL complex was shown to have
amore relaxed substrate specificity acetylating histone H4 lysine
5, 8, and 16, in comparison to the MSL complex where MOF
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The NSL Complexpreferentially acetylates histone H4 lysine 16 (Cai et al., 2010;
Mendjan et al., 2006). Similar to the Drosophila MOF protein
which can acetylate nonhistone substrates (Buscaino et al.,
2003; Morales et al., 2004), mammalian MOF alone or in associ-
ation with MSL1v1 (NSL1) has recently been shown to acetylate
other nonhistone substrates such as TIP5 or p53, respectively
(Li et al., 2009; Zhou et al., 2009). It therefore remains to be
seen in the future whether the mammalian NSL complex could
also play a more global role in transcriptional regulation. Besides
transcription, NSL components have also recently been impli-
cated in other cellular processes (Dobbelaere et al., 2008;
Nybakken et al., 2005). In summary, the biochemical purification
and functional characterization of NSL proteins described in
this study reveals an important evolutionarily conserved
genome-wide promoter-bound complex that acts as a major
transcriptional regulator in Drosophila.
EXPERIMENTAL PROCEDURES
Biochemical Purifications
Biochemical purifications from SL-2 cells expressing tagged proteins
(TAP-MCRS2 or HA/FLAG NSL1) were always accompanied with control
purifications from wild-type SL-2 nuclear extract to be able to compare
specific enrichment.
TAP purifications were done essentially as described (Rigaut et al., 1999)
with the following changes in the protocol: All buffers contained 25mMHEPES
(pH 7.6) instead of Tris-HCL, KCl instead of NaCl, 1/100 volume of RNasin
(Promega), 0.2% Tween-20, and 20% glycerol. For details on HA/FLAG
purifications see Supplemental Experimental Procedures.
Silver Staining and Mass Spectrometry
Silver staining and mass spectrometry were performed as previously
described (Shevchenko et al., 1996). Purified protein samples were prepared
for mass spectrometry in two ways. Either individual silver-stained protein
bands were digested in gel with trypsin (Figure 1A) or complex elutions were
electrophoresed for a few minutes, nonseparated proteins stained with Coo-
massie blue, total band excised, and trypsin digested (Table S1). The samples
were separated for 45 min on a nano-flow 1D-plus Eksigent (Eksigent, Dublin,
CA) HPLC system coupled to a qStar Pulsar i quadrupole time-of-flight mass
spectrometer (Applied Biosystems, Darmstadt, Germany). Analysis was
performed as described (Fraterman et al., 2007). Taxonomy parameter was
restricted to Drosophila, and peptides below a score of 18 were excluded.
All proteins were identified with a summed peptide MASCOT score above
45 in at least two independent experiments.
Biochemical Interaction Assays
Recombinant full-length NSL1, MCRS2, and MOF were either singularly or
coexpressed using the baculovirus coexpression system. Details of the purifi-
cation are available upon request.
For the hMOF/NSL1 interaction, a His-tag fusion of the C-terminal fragment
of hNSL1 (883–1105) and untagged MOF HAT domain (174–458) were coex-
pressed in E. coli BL21Star(DE3) (Invitrogen) from pProEXHTb (Invitrogen)
and pRSFDuet-1 (Novagen) expression vectors, respectively. The complex
was first purified by affinity chromatography using Ni2+ resin. In parallel,
a His-tag version of hMOF(174–458) was expressed from pProEXHTb. The
His tag was removed by TEV protease following the Ni2+ affinity chromatog-
raphy. The gel-filtration profiles were obtained using Superdex 200 column
(GE Healthcare).
RNAi in SL-2 Cells, Nuclear, and Cytoplasmic Fractions
RNAi of SL-2 and Kc cells was performed as described in Worby et al. (2001)
with the following modifications. All knockdown cells were transfected with
50 mg dsRNA using Lipofectamine (Invitrogen). The cells were harvested after
6 days for MCRS2 RNAi. EGFP control RNAi experiments were performed inMparallel. Nuclear and cytoplasmic extracts were done from 2 3 106 cells.
The cell pellet was dissolved in HEMG 40 (HEMG buffer contains 25 mM
HEPES pH 7.6, 0.5 mM EDTA, 5 mM MgCl2, and 20% glycerol; so HEMG
40 is HEMG with 40 mM KCl), and placed for 10 min on ice for swelling.
NP40 was added to 1% final concentration, vortexed for 7 s, and centrifuged
at 3000 rpm for 5 min. The supernatant containing cytoplasmic extract was
carefully removed to a new eppendorf tube and 43 Laemmli buffer was added.
The nuclei pellet was washed extensively with HEMG 150 and lysed in
23 Laemmli buffer.
RNAi Knockdown in Larval Salivary Glands
The homozygous transgenic RNAi fly strains carrying UAS-MCRS2-RNAi,
UAS-NSL3-RNAi, UAS-MBD-R2-RNAi, and UAS-Z4-RNAi were indepen-
dently crossed to Ptc-Gal4, UAS-eGFP, and raised at 25C to obtain efficient
knockdown. Salivary glands from third instar larvaewere dissected in PBS and
processed for either immunofluroscence antibody staining or for RNA isolation
and qRT-PCR analysis. Antibodies against NSL1, NSL3, MCRS2, MBD-R2,
MOF, H4K16Ac, MSL1, and Z4 for IF were used at 1:100 dilution.
RNA Isolation and Quantitative PCR Analysis
For qRT-PCR, RNA and corresponding genomic DNA from SL-2 cells or from
salivary glands were isolated simultaneously using the AllPrep DNA/RNA mini
kit (QIAGEN), the RNA column was DNaseI treated, and 300 ng of total RNA
was used in a RT reaction. qRT-PCR was performed on a Applied Biosystems
(AP) Cycler7500 with SYBR detection, and the amplification curves were
analyzed with the corresponding AP software. Each qRT-PCR was repeated
at least three times, values were normalized to corresponding genomic DNA
values, and the standard deviation within each experiment was calculated.
qPCR analysis of the ChIP samples was performed using the SYBR Green
PCR master mix (Applied Biosystem), 100 ng of each forward and reverse
primer, and 1 ml immunoprecipitated DNA, in an ABI7500 real-time
PCR thermocycler (Applied Biosystems, Inc.). The formula [%ChIP/input] =
[E(Ctinput  CtChIP) 3 100%] (E represents primer annealing efficiency) was
used to calculate the percentage of DNA recovery after ChIP, as compared
to the amount of input material. The primers designed for the promoter (P1),
middle (P2) and the end (P3) of the gene were used for the binding analysis.
Immunofluorescence and Confocal Microscopy
Preparation of polytene chromosomes was performed as described (http://
www.igh.cnrs.fr/equip/cavalli/Lab%20Protocols/Immunostaining.pdf). MOF
and MSL1 antibodies were used at 1:500 dilution, MBD-R2 at 1:300, and
MCRS2 and NSL1 at 1:50. Immunofluorescence stainings of whole-mount
salivary glands were essentially done as described (Beuchle et al., 2001).
Images were captured with AxioCamHR CCD camera on a Leica SP5 (Leica
Microsystems) using an Apochromat NA 1.32 oil immersion objective. Images
were arranged with Adobe Illustrator.
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Abstract 
A hallmark of dosage compensation in Drosophila melanogaster is MOF-mediated 
hyperacetylation of the single male X chromosome at lysine 16 of histone H4 
(H4K16ac). MOF is recruited to X-linked target genes as part of the male specific 
lethal (MSL) complex, but has recently also been found at autosomal gene 
promoters. While chromodomains are known as recognition modules for methylated 
lysine residues, the MOF chromo-like “chromobarrel” domain interacts with nucleic 
acids. In this study, we reveal that the MOF chromobarrel domain is essential for 
H4K16 acetylation in the Drosophila genome. Furthermore, spreading of the MSL 
complex on the male X chromosome is abolished in chromobarrel domain mutants. 
The MOF chromobarrel domain therefore has an unprecedented function to 
potentiate MOF’s enzymatic in vivo, making it the first example of a chromo-like 
domain directly controlling acetylation activity. Interestingly, while the chromobarrel 
domain is conserved in human MOF, we also find that the Drosophila specific N-
terminal region of the MOF protein has evolved to perform sex specific functions. It 
modulates MOF’s HAT activity and controls assembly of the MSL complex, thus 
regulating MOF function in dosage compensation. We propose that the MOF protein 
has been especially tailored to achieve tight regulation of its enzymatic activity to 
enable its dual role on X and autosomes. 
 
 
 
 
 
 
 
 3 
Introduction 
Covalent modifications of histone tails modify chromatin structure to control 
transcription in response to environmental cues and developmental programs. 
Acetylation of lysine 16 on histone H4 (H4K16ac) has the potential to create or 
obscure binding platforms for chromatin modifying enzymes and transcriptional 
activators (Kim et al., 2010; Zippo et al., 2009). Furthermore, H4K16ac is the only 
histone mark that can directly impact on higher order chromatin structure by 
physically preventing formation of the 30nm chromatin fiber, thus creating an open, 
highly accessible chromatin environment (Bell et al., 2010a; Shogren-Knaak et al., 
2006; Zippo et al., 2009). Indeed, H4K16ac is involved in a variety of chromatin 
related processes, such as replication timing and transcription (Akhtar and Becker, 
2000; Bell et al., 2010b). Accordingly, the distribution of this histone mark needs to be 
tightly controlled throughout the genome, and loss of H4K16ac is often associated 
with human cancer (Fraga et al., 2005).  
Global H4K16ac is also hallmark of the dosage compensated male X chromosome in 
Drosophila, where the resulting permissive chromatin structure facilitates spreading 
of the dosage compensation complex (DCC), also known as the Male Specific Lethal 
(MSL) complex, and contributes to the twofold transcriptional activation of X-linked 
genes (Straub and Becker, 2007). Hyperacetylation of the X chromosome is 
mediated by Drosophila MOF, a close homologue of hMOF, which resides in the MSL 
complex together with at least four other proteins, male specific lethal 1-3 (MSL1-3) 
and maleless (MLE), as well as two non-coding RNAs on the X (roX1/2) (reviewed in 
(Hallacli and Akhtar, 2009; Ilik and Akhtar, 2009)). In addition to its role in dosage 
compensation, MOF has recently been found at hundreds of active promoters across 
the whole genome in male and female cell lines, where it is bound as part of the 
newly identified Non-Specific Lethal (NSL) complex (Kind et al., 2008; Mendjan et al., 
2006; Raja et al., 2010). While several studies have found H4K16ac at the 5´end of 
genes in Drosophila (Bell et al., 2007; Kind et al., 2008; Schwaiger et al., 2009), it 
has remained unclear if MOF is acting as a histone acetyltransferase (HAT) at these 
sites, or if it has indeed any chromatin related function outside the context of the male 
X chromosome (Gelbart et al., 2009). Furthermore, it is not known how MOF 
targeting and activity are differentially regulated and distributed between the NSL 
complex and the MSL complex. 
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In addition to DNA binding domains, many components of the transcriptional 
machinery and other chromatin modifying factors contain specialized adapter 
modules that recognize specific histone modifications. Chromodomains are well 
known targeting modules that bind to methylated lysine residues. For instance, the 
chromodomain of HP1 has been shown to bind methylated lysine 9 of histone H3 
(H3K9me3) (Lachner et al., 2001). Within the MSL complex there are two proteins 
that show similarities to chromodomains, MSL3 and MOF. The chromodomain of 
Drosophila MSL3 has been shown to interact with DNA and monomethylated H4K20 
(Kim et al., 2010; Moore et al., 2010). Accordingly, mutations in the MSL3 
chromodomain lead to reduced male viability, most likely due to defects in dosage 
compensation (Buscaino et al., 2006; Kim et al., 2010; Moore et al., 2010). A 
common feature of enzymes from the MYST family of HATs, such as Drosophila and 
human MOF, is the presence of a chromo-like domain, also known as the 
chromobarrel domain, adjacent to the enzymatic part of the protein (Sanjuan and 
Marin, 2001). However, in this case it lacks the aromatic cage necessary for methyl 
lysine binding (Nielsen et al., 2005). Instead, the MOF chromobarrel domain is 
required for MOF binding to roX RNAs in vitro and in vivo (Akhtar et al., 2000). In the 
absence of both roX RNAs or the RNA helicase MLE, MSLs including H4K16ac, are 
delocalized from the X chromosome and ectopically targeted to autosomal sites, the 
chromocenter and the 4th chromosome (Gu et al., 1998; Meller and Rattner, 2002). In 
line with these results, MOF is delocalized from the X chromosome upon treatment of 
permeabilized nuclei with RNAse A (Akhtar et al., 2000). Remarkably however, ten 
years after the initial observation that chromobarrel domains are nucleic acid binding 
modules, their function and biological significance has remained elusive. Indeed, 
while nucleic acid binding of the chromobarrel domain has also been shown for yeast 
Esa1, no biological function has been described for chromobarrel domains of the 
MOF-type in general, despite their conservation from yeast to human (Sanjuan and 
Marin, 2001). 
In this study, we show that Drosophila MOF is the major H4K16ac specific HAT 
across the male and female genome. Strikingly, disruption of the MOF chromobarrel 
domain leads to a genomewide loss of H4K16ac and consequently compromised 
MSL targeting to X-linked genes. Accordingly, we show that the chromobarrel domain 
serves to trigger H4K16ac after MOF binding to chromatin in vivo and in vitro. We 
thus reveal the biological role of the chromobarrel domain, which acts as an 
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accessory module to elicit the enzymatic capacity of its associated HAT enzyme. 
Furthermore, we also discovered that the N-terminal region of the MOF protein, 
which is absent in other organisms with different dosage compensation systems, 
controls assembly of the MSL complex on the male X chromosome and modulates 
MOF’s HAT activity. Multiple levels of control therefore reflect the enhanced 
complexity of MOF functions in flies and the resulting need for increased context 
dependent regulation of MOF activity. 
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Results 
MOF is required for genomewide H4K16ac and survival in both sexes 
In this study, we set out to investigate the function of MOF in male and female files. 
We were especially interested in determining the extent and biological significance of 
MOF activity inside and outside the context of the male X chromosome. In order to be 
able to manipulate MOF function in its in vivo context during downstream 
experiments, and to avoid the inherent limitations of cell line based approaches, we 
first wanted to obtain comprehensive genome-wide profiles from wildtype male and 
female flies. To this end, we first used antibodies against MOF and H4K16ac in 
chromatin immunoprecipitations, followed by ChIP-Seq from 3rd instar larva salivary 
glands (Table S1). The resulting profiles showed a very good overlap between sites 
of MOF binding and H4K16ac in both sexes (Figure S1A). On the male X 
chromosome, MOF binds to the entire gene body, with peaks of increased binding at 
the promoter and the 3’-end of genes. On male autosomes and generally in females, 
MOF binds only at gene promoters, as shown by composite MOF and H4K16ac 
profiles of average log2 fold-change values across all genes (Figure S1B). The 
pattern of H4K16 acetylation closely follows that of MOF binding. Interestingly, we 
observe a shift of the H4K16ac signal downstream of gene promoters, most likely 
reflecting acetylation of the first nucleosome downstream of the transcription start site 
(TSS). Strikingly, more than three quarters of all active genes were revealed as MOF 
targets on X and autosomes in both sexes (Table S2), signifying the role of MOF for 
genomewide gene regulation. Furthermore, there was a good correlation between 
MOF binding and H4K16ac, since most MOF bound genes were acetylated at the 
same time in both sexes (Figure S1D). However, on the male X chromosome, we 
also detected 735 genes that were acetylated despite lacking MOF, suggesting that 
transient the MSL complex interactions can spread H4K16ac in large domains across 
the male X chromosome, even in the absence of detectable MSL complex binding. 
Finally, we found an extremely high overlap of MOF target genes between males and 
females, especially on autosomes, suggesting that outside the context of the MSL 
complex MOF functions very similar in male and female flies (Figure S1C). These 
results confirmed our previous analysis but, due to the increased depth and 
sensitivity of the ChIP-sequencing method, also revealed that we had substantially 
underestimated the number of MOF targets (Figure S1E) (Kind et al., 2008).  
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We were next interested to test if MOF is active as a HAT also outside the context of 
the male X chromosome. For this purpose, we performed immunostainings of male 
and female 3rd instar larva polytene chromosomes from wildtype (wt) and mof2 
mutant flies that carry a premature stop codon and lack a functional MOF protein (Gu 
et al., 1998), using antibodies against MOF, MSL1 and H4K16ac. While the male X 
chromosome, marked by MSL1 staining, appeared enriched for H4K16ac in wt flies, 
we also detected widespread acetylation across autosomes as well as the 
chromocenter (Figure 1A). Likewise, female samples showed widespread H4K16ac, 
but no apparent enrichment on the X chromosomes, which also lacked MSL1 
staining. Strikingly, H4K16ac was entirely lost from all chromosomes in male and 
female mof2 flies, in the absence of MOF. In the males, this was accompanied by 
reduced staining of MSL1 on the X chromosome in a pattern most likely 
corresponding to the previously described high affinity sites (HAS), and subsequent 
delocalization of MSL1 staining to autosomal sites. Importantly, H4K16ac was 
restored on all chromosomes in both sexes upon expression of an HA-tagged MOF 
full length transgene (FL-MOF) in flies of the mof2 background. We recapitulated the 
same global MOF dependency of H4K16ac by western blots using extracts prepared 
from 3rd instar larvae (Figure 1B). Female wt flies showed about half the amount of 
global H4K16ac compared to wt males, reflecting the presence of the 
hyperacetylated male X chromosome. In the absence of endogenous MOF in the 
mof2 background, H4K16ac levels were drastically reduced in males and females, 
while no significant differences were observed upon probing with antibodies against 
H4. Importantly, H4K16ac could again be globally restored in both sexes by 
expression of FL-MOF. This data clearly demonstrates that MOF is responsible for 
genomewide H4K16ac in Drosophila.  
Since MOF has been identified in a screen for male specific lethality, the obvious 
question arises, what the significance of MOF mediated H4K16ac is for female flies. 
To address this question we generated homozygous mof2 females. When compared 
to control flies, the number of mof2 females reaching adulthood was reduced by 
approximately two-fold, and these flies were mostly sterile (Figure 1C). More 
strikingly however, the average lifespan of mof2 mutant female flies was drastically 
reduced to an average of 8 days as compared to 37 days in the control flies with the 
same set of balancer chromosomes (Figure 1D). Furthermore, this reduction in 
lifespan was rescued efficiently by expression of a MOF transgene. This result 
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strongly suggests that MOF mediated H4K16ac is essential for female survival, 
although it remains possible that additional MOF functions contribute to this 
phenotype.  
 
The MOF chromobarrel domain and N-terminus are required for male viability 
Having established the general requirement of MOF for genome wide H4K16ac in 
male and female flies, we set out to investigate how the MOF chromobarrel domain 
contributes to this activity. Two point mutations in the MOF chromobarrel domain at 
Tyr416 (Y416) and Trp426 (W426) were previously shown to disrupt MOF’s 
interaction with roX RNA (Akhtar et al., 2000), and the corresponding residues have 
subsequently been shown to be also required for nucleic acid binding in Esa1, a 
closely related HAT in yeast (Figure S2). Indeed, bacterial expressed wt 
chromobarrel domain directly interacted with a single stranded RNA probe in an 
electromobility gel shift assay (EMSA), and this interaction was lost upon mutation of 
Tyr416 or Trp426 (data not shown). To test if the chromobarrel domain carries 
essential functions in vivo, we assayed the capability of a series of MOF mutant 
proteins to rescue the male lethal phenotype associated with the loss of endogenous 
MOF. To this end, we introduced HA-tagged MOF transgenes by p-element mediated 
transformation into flies, including a control construct comprising full length MOF (FL-
MOF); a deletion of the zinc finger region, which has been previously shown to be 
required for MOF binding to chromatin (ΔZn MOF (Δ565-587)); a series of deletions 
in the N-terminal half of the MOF protein (Δ1 (Δ 176-228), (Δ 2 (Δ 241-357), Δ 3 (Δ 
98-357) and ΔN (Δ 1-349)); as well as two point mutations in the MOF chromobarrel 
domain (Y416D and W416G) (Figure S3). All transgenes were expressed to wt levels 
upon induction with armadillo-Gal4, as determined by western blot analysis (Figure 
S3 B-I). Full length HA-tagged MOF completely rescued male lethality (99.7% 
survival) in this assay when compared to heterozygous mof2 females resulting from 
the same cross (Figure 2A), while males lacking the MOF zinc finger did not survive 
the 3rd instar larva stage. Male viability was also increasingly compromised by up to 
~90% upon progressive deletions of the Drosophila specific N-terminal region of the 
MOF protein, suggesting that vital functions reside in this region. Strikingly however, 
disruption of the chromobarrel domain in Y416D and W426G MOF led to complete 
male lethality in this assay. This result clearly reveals the essential nature of the MOF 
chromobarrel domain that had been unprecedented.  
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The MOF N-terminus is required for the MSL complex assembly on the X 
chromosome 
Having confirmed the essential nature of the MOF chromobarrel domain and the 
importance of the N-terminal region for MOF function, we were next curious to assay 
for defects in MOF targeting to X-linked genes or autosomes, and in the MSL 
complex recruitment to the X chromosome. We performed immunostainings of 3rd 
instar larva polytene chromosomes from male flies that express MOF transgenes in 
the mof2 background. Upon immunostaining with anti-HA antibodies, FL-MOF 
appeared in a wildtype pattern, showing pronounced enrichment on the X 
chromosome but also clear targeting to all autosomes (Figure 2B). At the same time, 
MSL1 staining remained restricted to the X, all together reflecting wildtype MSL 
complex targeting and function. This data provided an important control and 
confirmed the functionality of the full length HA-tagged MOF protein in vivo. As 
expected, ΔZn MOF was no longer detectable on polytene chromosomes, while at 
the same time immunostaining of whole mount salivary glands verified the nuclear 
localization of the ΔZn MOF protein, suggesting a general defect in chromatin binding 
(Figures 2C and S4) (Kadlec et al., 2011). Interestingly, upon disruption of the 
chromobarrel domain, Y416D and W426G MOF were still detected across all 
autosomes in immunostainings, however, MSL spreading on the X chromosome 
appeared reduced compared to FL-MOF (Figure 2D and see below). Strikingly 
however, in the absence of the MOF N-terminus, preferential targeting of MOF to the 
male X chromosome was entirely lost. Also MOF staining at autosomal bands 
appeared reduced (Figure 2E). Furthermore, we detected ectopic binding of MOF to 
the chromocenter. At the same time MSL1 staining was reminiscent of the patterns 
that have been observed in the absence of both roX RNAs (Meller and Rattner, 
2002), with a nearly complete delocalization of MSLs from the X chromosome, 
accompanied by severe ectopic binding to autosomal sites and the chromocenter. 
Indeed, when we measured the levels of roX RNAs in the ΔN mutant background we 
found a severe depletion of roX2 by more than 98%, suggesting that the N-terminus 
of MOF is required for proper incorporation of roXs into the MSL complex (Figure 
S5A). This phenotype was surprising and suggested that the N-terminus of the MOF 
protein in Drosophila species, which is not present in human MOF, is required for X 
chromosome and the MSL complex specific MOF functions. Consistent with MSL 
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binding at X chromosomal sites, we did not observe the same reduction in roX levels 
upon disruption of the chromobarrel domain (Figure S5A).  
 
The chromobarrel domain is required for MSL spreading on the X chromosome 
It has been observed previously that the resolution provided by polytene 
chromosome stainings is not sufficient to detect defects in MSL spreading onto 
dosage compensated genes (Sural et al., 2008). It seemed therefore plausible that 
the lethality observed in chromobarrel domain mutants was caused by targeting 
defects on the individual gene level. Therefore, to get a more detailed insight into the 
MSL binding pattern upon disruption of the chromobarrel domain, we performed ChIP 
from male 3rd instar larva to monitor defects in MSL recruitment at higher resolution. 
Chromatin was immunoprecipitated, using antibodies against MSL1 and MSL3. The 
recovered DNA was measured by quantitative real-time PCR (qPCR). To monitor 
MSL recruitment to the X chromosome, we used the known high affinity sites (HAS) 
at the roX2 gene and an additional HAS at the cytological location 15A8, which had 
previously been identified in an MSL3 mutant background (Alekseyenko et al., 2008). 
We also included sites at the promoter, middle and 3’end of three X-linked genes, 
Rpl22, Klp3a and Ucp4a. The first one of these, Rpl22, previously showed some MSL 
binding in the absence of MSL3 and can thus be described as a medium affinity site, 
while the remaining two genes are low affinity MSL targets (Alekseyenko et al., 
2008). As expected, MSL1 binding was retained on roX2 high affinity sites but was 
lost from the body of X-linked genes in the mof2 background.  These defects were 
restored back to the wt pattern upon expression of FL MOF (Figure 3A). Interestingly, 
the 15A8 HAS, which had been identified as a high affinity site in an MSL3 mutant 
background, was no longer bound by MSL1 in mof2, demonstrating the qualitative 
differences among high-affinity sites in varying genetic backgrounds (Kadlec et al., 
2011). ΔZn MOF was unable to rescue the mof2 phenotype (Figure S6A). 
Furthermore, MSL1 and MSL3 binding was lost from dosage compensated genes in 
the presence of ΔN MOF, confirming immunostainings (Figure 3A). However, in 
contrast to the mof2 background, where residual MSL1 and MSL2 containing 
complexes can bind to HAS, MSL1 binding was also lost from the roX2 HAS in ΔN 
MOF, most likely as a result of compromised MSL complex assembly.  
Surprisingly, upon disruption of the chromobarrel domain in Y416D MOF, we found a 
dramatic reduction of MSL3 binding from X-linked target sites, particularly in the 
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transcribed region of genes (Figure 3B). At the same time, MSL1 binding was 
restricted to HAS and gene promoters, reminiscent of the pattern observed in the 
mof2 background when MOF is absent. This result was striking and suggested a 
crucial role of the MOF chromobarrel domain for MSL targeting into the transcribed 
region of dosage compensated genes on the male X chromosome, consistent with 
the male lethality associated with disruption of this domain.  
 
The chromobarrel domain is required for genomewide H4K16ac 
In addition to the consequences for MSL spreading on the X chromosome, we next 
wanted to more specifically address the role of the MOF chromobarrel domain and N-
terminus for MOF function itself. We therefore performed immunostainings of 
polytene chromosomes using anti-H4K16ac antibodies. The pattern of H4K16ac in 
the presence of FL-MOF corresponded to the one observed in the wt, showing 
widespread acetylation on autosomes and enriched signal on the male X 
chromosome (Figure 2B). Acetylation was lost genomewide upon deletion of the zinc 
finger region in the MOF HAT domain, reflecting defective chromatin targeting of this 
mutant MOF protein (Figure 2C). To our great surprise however, we also saw a 
dramatic loss of the H4K16ac mark across all chromosomes in the presence of both 
chromobarrel domain mutants (Figure 2D). This was particularly striking since MOF 
binding to chromatin seemed to be much less affected. This data suggested a much 
more general role of the chromobarrel domain as we had anticipated, which seems to 
involve the activation of MOFs enzymatic capacity after its recruitment to chromatin, 
irrespective of the chromosomal context. In contrast, although autosomal chromatin 
targeting of ΔN MOF appeared reduced in immunostainings, we detected widespread 
H4K16ac on all chromosomes in the presence of the ΔN MOF protein, which contains 
a functional chromobarrel domain (Figure 2E).  
Considering the dramatic reduction of H4K16ac upon disruption of the MOF 
chromobarrel domain, we wanted to assay for defects in chromatin targeting at higher 
resolution. To this end, we performed ChIP from Y416D MOF expressing male 3rd 
instar larva to monitor differences in MOF binding and H4K16ac. In addition to X-
linked target sites we also assayed the promoter regions of the autosomal genes 
cg6729, cg6884, cg31866, cg2708 and cg7638 and at two non-targets, bt and 
cg3937. The pattern of FL-MOF binding in the mof2 background was 
indistinguishable from the one observed for endogenous MOF in the wt, with clear 
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binding to autosomal promoters, to the promoter and transcribed region of X-linked 
genes and to HAS (Figure 4A). MOF binding was accompanied by H4K16ac at all of 
these loci in the wt and FL-MOF background. Upon removal of endogenous MOF in 
the mof2 background alone, MOF binding and H4K16ac were both lost from all sites 
tested. Consistent with immunostainings, ΔZn MOF was unable to rescue this 
phenotype (Figure S6C). The binding pattern of ΔN MOF suggested a general defect 
in chromatin targeting, showing a pronounced loss from X-linked target sites and a 
substantial reduction in promoter binding (Figure 4A). At the same time however, 
H4K16ac appeared much less affected on the same target sites (Figure 4B). At target 
promoters where ΔN MOF binding was about twofold reduced, H4K16ac remained 
nearly at the levels observed in the presence of FL-MOF, suggesting a potentially 
enhanced acetylation activity of the truncated enzyme.  
Disruption of the chromobarrel domain had diverse and contrasting effects on MOF 
targeting. The Y416D mutant MOF protein showed no difference in binding to gene 
promoters and the roX2 HAS (Figure 4C). However, binding to the 15A8 HAS and the 
transcribed region of Rpl22 was twofold reduced, while targeting to the transcribed 
region of the low affinity genes Klp3a and UCP4a was completely lost. This data 
indicated a specific defect in chromatin targeting of Y416D MOF as part of the MSL 
complex, while the MSL complex independent binding to gene promoters appeared 
unaffected. We next analyzed H4K16ac across X-linked and autosomal target sites in 
the presence of Y416D MOF. Strikingly, H4K16ac was strongly reduced across all 
sites, including gene promoters and HAS, where the Y416D MOF protein was still 
readily detected (Figure 4D). This result suggests that the chromobarrel domain 
serves to trigger MOFs catalytic activity after initial recruitment of MOF to its 
chromatin targets.  
MOF at gene promoters is part of the NSL complex (Raja et al., 2010). We therefore 
asked if reduced promoter binding of ΔN MOF reflects compromised integration into 
the NSL complex. To address this question, we generated SL-2 cell lines stably 
expressing Flag-tagged FL MOF, ΔN MOF and Y416D transgenes. After 
immunoprecipitation with anti-Flag antibodies followed by western blotting, 
membranes were probed against Flag, NSL1, NSL3 and MCRS2, as well as MSL1, 
MSL2 and MSL3. In this assay, FL MOF was stably interacting with all other complex 
partners (Figure S7). Also the binding of Y416D MOF to other MSLs appeared only 
slightly reduced, while interactions to NSL complex members remained unaffected. 
 13
Similarly, deletion of the MOF N-terminus did not have an apparent effect on the 
interactions with individual MSL proteins. Importantly however, interactions with all 
three members of the NSL complex were clearly diminished, consistent with reduced 
targeting of ΔN MOF to gene promoters. 
 
The chromobarrel domain triggers H4K16ac after nucleosome binding 
The observed loss of H4K16ac in chromobarrel domain mutants was striking and 
surprising. We therefore performed western blots from 3rd instar larva extracts to 
confirm the global reduction in H4K16ac by an independent method. When probing 
with HA antibodies, we found that all five MOF transgenes were stably expressed to 
similar levels (Figure 5A). Antibodies against tubulin and unmodified histone H4 were 
used as loading controls. MSL1 levels appeared clearly diminished in the presence of 
ΔZn,  ΔN, Y416D and W426G MOF, reflecting compromised MSL complex assembly 
on X linked genes. MSL3 seemed less destabilized in the presence of Y416D MOF, 
but mirrored MSL1 levels in all other mutant backgrounds. FL-MOF efficiently 
rescued the mof2-mediated loss of H4K16ac to wt levels. No H4K16ac was detected 
upon deletion of the zinc finger in ΔZn MOF, reflecting compromised chromatin 
targeting of this mutant. Consistent with our previous analysis, substantial amounts of 
H4K16ac could be detected after deletion of the N-terminus in ΔN MOF. Strikingly 
however, global H4K16ac levels were dramatically reduced in both chromobarrel 
domain mutants, confirming the general role of this domain for genome-wide 
H4K16ac. To control for the specificity of the assay we also probed against H4K5ac 
as well as H4K8ac and H4K12ac. These histone marks are not mediated by MOF in 
Drosophila, and remained unchanged in each of the MOF mutants analyzed (Figure 
5A and data not shown). 
We next wanted to recapitulate the requirement of the chromobarrel domain for MOF 
HAT activity in vitro. To this end we performed in vitro HAT assays on purified 
endogenous nucleosomes, using baculovirus expressed FL MOF, Y416D, W426G 
and ΔN MOF that were copurified with MSL1 and MSL3 to yield enzymatically active 
trimeric complexes (Morales et al., 2004). Consistent with our in vivo observations, 
H4 directed acetylation activity was approximately three to five-fold reduced in 
trimeric complexes containing Y416D and W426G MOF, as compared to FL MOF 
(Figure 5B and data not shown). We also observed that ΔN MOF containing trimeric 
complexes showed an about five-fold increase in acetylation activity compared to FL 
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MOF, while monomeric ΔN MOF showed the same low levels of residual activity 
(Figure 5C). This result suggests that an autoregulatory function in the N-terminal 
domain of MOF constrains its enzymatic activity, and explains why levels of H4K16ac 
remain high in vivo although targeting of ΔN MOF to chromatin is impaired.  
The reduced acetylation activity of chromobarrel domain mutant MOF was specific to 
nucleosomal substrates, since the same trimeric complexes showed comparable 
activities towards free histones, which also confirmed functionality of the MOF HAT 
domain itself (Figure 5D). The activity of ΔN MOF containing trimeric complexes 
towards free histones was slightly enhanced, although the increase was not as 
pronounced as on a nucleosomal substrate. We then wanted to ask at which step of 
initial substrate binding and subsequent acetylation the chromobarrel domain 
functions. To address this question we performed affinity purifications of trimeric 
complexes using biotinylated DNA or mononucleosomes coupled to streptavidin 
beads. Nucleosome binding of trimeric complexes containing the ΔN MOF protein 
was slightly weakened as compared to FL MOF (Figure 5E). This result further 
highlights the enhanced enzymatic activity of ΔN MOF on the same substrate. 
Strikingly, trimeric complexes containing Y416D and W426G MOF proteins bound as 
efficiently to the nucleosomal substrate as FL MOF trimeric complexes. Initial binding 
to the nucleosome is thus independent of a functional chromobarrel domain, which is 
then required to activate the subsequent acetylation of the H4 tail, the extent of which 
is controlled by the MOF N-terminus.  
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Discussion 
In this study we reveal a striking and unexpected role of the MOF chromobarrel 
domain for the control of genomewide H4K16ac and dosage compensation in 
Drosophila.  We show that upon MOF recruitment to its target sites H4K16ac can 
only be triggered in the presence of a functional chromobarrel domain in vivo and in 
vitro. To our knowledge, this is the first example in which a chromodomain directly 
controls the activity of its associated HAT enzyme. At the same time the Drosophila 
specific N-terminus modulates overall acetylation levels and controls MSL complex 
assembly, thereby coordinating the dual role of MOF in flies. 
 
MOF is the major H4K16 specific HAT in Drosophila 
Since the recent discovery that MOF resides at autosomal gene promoters as part of 
the NSL complex, the full extent of MOF function at these sites has remained elusive 
(Gelbart et al., 2009; Kind et al., 2008; Raja et al., 2010). Disruption of other NSL 
complex members leads to lethality in males and females (Mendjan et al., 2006). This 
suggested that MOF is not strictly necessary for NSL complex function, since adult 
female flies can be recovered in the absence of MOF (Hilfiker et al., 1997). However, 
although MOF was identified in a screen for male specific lethality, this study did not 
address defects in female viability. We now show that MOF is indeed an essential 
gene in both sexes, since the number of females reaching adulthood, and especially 
female lifetime, are drastically reduced in the absence of MOF. Furthermore, our data 
demonstrates that, in addition to its role in X chromosome dosage compensation, 
MOF is targeted to the vast majority of all active gene promoters in male and female 
flies. Importantly, we also show that in the absence of MOF, H4K16ac is lost from all 
MOF target sites in the male and female genome. In fact, bulk H4K16ac is lost 
genome wide in 3rd instar larva upon disruption of MOF in both sexes, suggesting 
that MOF is the major H4K16ac specific HAT in Drosophila. However, since a recent 
study showed that ATAC2 is contributing to bulk H4K16ac during embryonic 
development (Suganuma et al., 2008), the possibility remains that additional 
enzymes might have the capacity to mediate H4K16ac in certain developmental 
stages or tissues. Interestingly, bulk H4K16ac is also strongly diminished in human 
cells upon RNAi and mutants of the close homologue hMOF (Gupta et al., 2008; 
Smith et al., 2005; Taipale et al., 2005; Thomas et al., 2008), and it has subsequently 
been shown that hMOF is targeted to thousands of gene promoters across the 
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human genome (Wang et al., 2009). It is noteworthy that dosage compensation in 
mammals does not involve MSL proteins, and accordingly hMOF does not appear 
enriched on the inactive X chromosome (Wang et al., 2009). The most closely related 
MYST domain in yeast resides in S.cerevisiae SAS2p (Sanjuan and Marin, 2001), 
which hyperacetylates subtelomeric regions to prevent Sir3p binding and spreading 
of telomeric heterochromatin (Kimura et al., 2002; Suka et al., 2002). However, a 
better resemblance of the MOF domain architecture is found in the yeast homologue 
Esa1p, which like MOF contains a chromobarrel domain preceding the MYST 
domain. Interestingly, Esa1p is generally recruited to the promoters of active protein 
coding genes where it mediates acetylation of histone H4 as part of the NuA4 
complex, and this complex also contains a yeast homologue of Drosophila MSL3, 
Eaf3 (Robert et al., 2004). It is therefore highly likely that the pattern of MOF binding 
that we observe at promoters across male and female autosomes and on the female 
X chromosome in Drosophila, is indeed reflecting the most ancient mode of MOF 
function. 
 
The MOF chromobarrel domain controls H4K16ac genomewide 
An earlier study claimed that the MOF chromobarrel domain had a minor role to play 
in dosage compensation (Morales et al., 2004). However, this study only tested the 
capacity of MOF to target to the X chromosomal territory by simply overexpressing 
MOF variants in a male cell line, leaving the possibility that potential defects in MOF 
function have been masked by the presence of the endogenous protein. Indeed, 
demonstrating the advantages of the in vivo system, we were able to reveal the 
crucial role that the MOF chromobarrel domain plays for all aspects of MOF function. 
Upon disruption of its nucleic acid binding properties, MSL spreading to X-linked 
genes is compromised leading to a defect in dosage compensation. This is 
reminiscent of the phenotype observed upon deletion of the chromobarrel domain of 
MSL3 (Sural et al., 2008). However, the MSL3 chromobarrel domain is thought to 
contribute to MSL targeting via its binding to the H3 tail trimethylated at K36 
(Larschan et al., 2007). Also an interaction with the H4 tail monomethylated at K20 
has been proposed (Kim et al., 2010; Moore et al., 2010). In contrast, the MOF 
chromobarrel domain lacks the aromatic cage required for binding to methylated 
lysine residues. We therefore believe that reduced MSL spreading in MOF 
chromobarrel domain mutants is not the result of a direct chromatin binding defect of 
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the MOF protein, consistent with the fact that binding of MOF to gene promoters in 
vivo and to nucleosomes in vitro is unaffected upon disruption of the chromobarrel 
domain. It has been shown previously that the chromobarrel domain mediates MOF 
binding to roX RNAs, and it is possible that this interaction contributes to spreading of 
the MSL complex along dosage compensated genes. However, the most dramatic 
and unexpected consequence upon disruption of the chromobarrel domain was the 
dramatic loss of genomewide H4K16ac. It is clear from previous work that this 
reduction of H4K16ac alone is sufficient to disrupt MSL spreading on the X 
chromosome. Indeed, upon direct mutation of the catalytic site in the MOF enzyme, 
MSL binding is restricted to high affinity sites in a pattern similar to the one observed 
in chromobarrel domain mutants (Gu et al., 1998).  
The structure of the Drosophila MOF chromobarrel domain (aa 367-454) has been 
determined by NMR (Nielsen et al., 2005) (Figure S2). While Tyr416 (Y416) is one of 
the putative aromatic cage residues and is partially buried in the core of the structure, 
Trp426 (W426) is solvent exposed on a β-sheet formed by strands α2, α3 and α4. As 
mentioned above, a similar domain is present also in the yeast Esa1p. It has been 
shown there that in presence of a short N-terminal extension, a minor conformational 
change occurs in the core of the Esa1p domain, triggering its RNA/DNA binding 
activity (Shimojo et al., 2008). Interestingly, a similar structure of the chromobarrel 
domain of MSL3 has recently been determined in complex with dsDNA and the N-
terminal tail of histone H4 monomethylated at H4K20 (Kim et al., 2010). Both MOF 
and Esa1 possess equivalent highly conserved surfaces that could be involved in the 
interaction with nucleic acids (Figure S2D-F). Accordingly, extensive mutagenesis 
studies in Esa1p identified residues involved in nucleic acid binding, including 
residues corresponding to MOF Tyr413, Tyr416, Asn420, Arg422 and Trp426. 
Mutations of these residues in Esa1p were lethal or produced severe growth effects 
(Shimojo et al., 2008). In the MSL3 structure, Trp66 corresponding to MOF 
chromobarrel domain Trp426 is directly involved in the interaction with DNA (Figure 
S2E). Although the aromatic residues that are critical for interaction of the MSL3 
chromobarrel domain with the methylated lysine side chain of the H4 peptide are not 
well conserved, it remains unclear whether MOF and Esa1 could bind unmodified 
histone tail residues. However, one could potentially envisage that a mode of action 
similar to MSL3 may also exist for the Esa1p and MOF chromobarrel domains, and 
that interaction with nucleic acid and the unmodified H4 tail direct the tail for 
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acetylation by the MYST domain. It has been shown previously that the MOF 
chromobarrel domain binds to nucleic acids with a preference for RNA over DNA, 
and interacts with roX RNAs in vivo (Akhtar et al., 2000). We now show that the 
nucleic acid binding properties of the MOF chromobarrel domain are necessary to 
trigger H4K16ac on a nucleosomal substrate in vitro, where the local DNA 
concentration is high due to tethering of the complex to the nucleosome via other 
domains. Interestingly, deletion of a conserved stem loop structure in roX RNAs 
leads to a specific loss of hyperacetylation from the male X chromosome in vivo, 
while MOF is still targeted to the X chromosome in this background (Park et al., 2007; 
Park et al., 2008). It is therefore tempting to speculate that upon ordered assembly of 
roX RNAs and MSL proteins in vivo, roX RNAs could engage in similar interactions 
with the chromobarrel domain and H4 tail to promote high acetylation levels 
throughout the body of X-linked genes. Since the chromobarrel domain is also 
conserved in human MOF it is likely that MOF’s acetylation activity is controlled in a 
similar manner in humans.  
 
MOF controls dosage compensation via its N-terminal domain 
Another striking observation during this study was that the N-terminal part of the MOF 
protein is required for the MSL complex assembly, and in addition modulates the 
acetylation activity of MOF. The presence of a large MOF N-terminal region is a 
prominent feature of Drosophila species, and absent in all other MOF homologues 
from yeast to human (Figure S5B). Addition of this domain correlates with the 
evolution of the Drosophila dosage compensation system, involving the targeting of 
MSLs and H4K16ac to the male X chromosome (Bone and Kuroda, 1996). It seems 
thus plausible that the N-terminal domain has added functions that utilize the 
evolutionarily ancient transcriptional regulator MOF for the novel task of dosage 
compensation. Strikingly, upon deletion of the MOF N-terminus, MSL targeting to the 
X chromosome was completely abolished. This also included high affinity sites 
(HAS), which are otherwise resistant to MOF depletion (Gu et al., 1998). Deletion of 
the MOF N-terminus therefore has a dominant negative effect on MSL complex 
formation. Aberrant MSL targeting was reminiscent of the phenotypes observed in 
roX1 and roX2 double mutants (Meller and Rattner, 2002), and indeed roX levels 
were reduced by 98% in the absence of the MOF N-terminus. This result suggests 
that, although interaction with MSL1 and MSL3 is mediated by the zinc finger region 
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of MOF (Morales et al., 2004), the N-terminus is required to assemble the core MSL 
subunits together with roX RNAs into a functional MSL complex. At the same time, 
the N-terminus is also required for proper integration of MOF into the NSL complex at 
gene promoters. Importantly, despite these defects, N-terminally truncated MOF was 
still active as a HAT and able to target to chromatin (Figures 2, 4).  
MSL protein domains required for the MSL complex assembly and targeting, as well 
as their cognate DNA binding sequences have been shown to undergo rapid 
adaptive coevolution in Drosophila melanogaster (Bachtrog, 2008; Rodriguez et al., 
2007). Also roX RNA sequences are highly divergent throughout Drosophila species 
(Park et al., 2007). Likewise, the N-terminal domain of MOF shows huge variation in 
size and amino acid sequence between Drosophila species suggesting ongoing 
selective pressure by other MSLs or roX RNA. Another striking feature of the N-
terminal domain is its intrinsic disorder, according to secondary structure prediction. It 
is a recently emerging concept that protein function is not necessarily linked to fixed 
secondary and tertiary structures (Chouard, 2011). Functional disordered regions 
have been particularly suggested for domains in hub proteins that control a variety of 
biological processes and mediate interactions to multiple interaction partners 
(Oldfield et al., 2008). The most prominent example of this type of regulation is p53, 
which interacts with hundreds of binding partners via intrinsically unstructured 
domains. The N-terminal domain of MOF has relatively few hydrophobic amino acids, 
suggesting solubility in solution. We therefore propose that the unstructured N-
terminal domain integrates the multiple functions of MOF in dosage compensation 
and for genomewide H4K16ac (Figure 6). 
A further intriguing finding was that the N-terminus constrains MOF HAT activity in 
vivo and in vitro. Again the necessity for this additional level of regulation arises from 
the dual function that MOF has adopted in Drosophila. We show that H4K16ac 
displays much higher baseline levels on the male X chromosome as in any other 
chromosomal context. Furthermore, MOF mediated H4K16ac extends beyond 
regions of MSL binding on the male X chromosome. We do not observe the same 
phenomenon on male autosomes or in females, where much lower levels of 
H4K16ac are restricted to sites of MOF binding at gene promoters (Figure S1). The 
activity level of MOF thus differs to a large degree depending on the chromosomal 
context. It is known that MOF requires interaction with MSL1 and MSL3 to be active 
as a HAT in vitro. However, our data suggests that an additional constrain is imposed 
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on MOF’s enzymatic activity by an autoinhibitory function residing in its N-terminus. 
Interestingly, our data shows that in the ΔN MOF background, H4K16ac spreads from 
sites of MOF binding into neighboring regions even in the absence of other MSLs. 
We therefore propose that in the wildtype situation, the N-terminus may control or 
restrict the H4K16ac spreading around sites of MOF binding, and this constrain is 
only released in the presence of a fully assembled MSL complex on the male X 
chromosome for more extensive acetylation. 
In previous experimental setups, loss of MOF mediated H4K16ac has been 
accompanied by simultaneous loss of MSLs from the transcribed regions of X-linked 
genes (Gelbart et al., 2009; Gu et al., 1998; Hilfiker et al., 1997; Kind et al., 2008). 
Therefore the possibility remained that H4K16ac could merely serve to allow MSL 
spreading along the X chromosome, and upregulation of transcription would be 
achieved subsequently by additional activities residing in other MSL proteins. 
Although MSLs were entirely lost from the body of low affinity target genes in the 
absence of the MOF N-terminus, the reduction in H4K16ac was less pronounced, 
most likely reflecting the presence of hyperactive MOF at nearby promoters. 
Intriguingly, about 11% of males escaped lethality in this background. This suggests 
that in these individuals the presence of H4K16ac on X chromosomal genes has 
been sufficient to ensure dosage compensation despite the lack of MSL binding. This 
result supports the view that H4K16ac is sufficient to upregulate transcription of X-
linked genes, and that the main function of the MSL complex is to direct H4K16ac to 
the male X chromosome. 
 
Summary 
In this study we have revealed the function of the MOF chromobarrel domain, which 
is to elicit the activity of its associated HAT enzyme on the chromatin target. The 
huge degree of sequence conservation of the MOF protein between flies and 
mammals suggests that a similar mode of operation might be present in mammalian 
MOF. Our findings thus have important implications for the study of this enzyme in 
humans, where it is implicated in a wide range of processes like transcription, DNA 
repair and cancer (Rea et al., 2007; Wang et al., 2009; Zippo et al., 2009). In 
addition, it will be exciting to test if chromodomains in other enzymatic complexes can 
directly control their associated enzyme activities in a similar way. In contrast to the 
chromobarrel domain, the N-terminal part of the MOF protein is specific to Drosophila 
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species. Accordingly, our work also highlights how a MYST HAT has been adopted 
through evolution to carry out distinct functions on X chromosomal and autosomal 
genes. We propose that the enzymatic activity of other MYST family HATs may be 
under similar regulation by associated domains for context specific function. 
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Materials and Methods 
 
ChIP from salivary glands 
100 Inverted 3rd instar larva were fixed in fixing solution (50 mM HEPES pH 7.6, 100 
mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 3.6% formaldehyde) for 20 min at room 
temperature on a rotating wheel. Formaldehyde was quenched with stop solution 
(PBS, 0.01% Triton X-100 0.125 M glycine) for 5min. Fixed larva were washed for 5 x 
2 min with buffer A (10 mM HEPES pH 7.6, 10 mM EDTA, 0.5 mM EGTA, 0.25% 
Triton X-100) and 5 x 5 min with buffer B (200 mM NaCl, 10 mM HEPES pH 7.6, 1 
mM EDTA, 0.5 mM EGTA, 0.01% Triton-X 100). Salivary glands were dissected into 
500 μL of RIPA buffer (25 mM HEPES pH 7.6, 150mM NaCl, 1 mM EDTA, 1% Triton-
X 100, 0.1% SDS, 0.1% DOC, protease inhibitors) and sonicated 16 x 30 sec using a 
Branson 250 sonicator at 40 pulse, intensity 5, generating 200 bp fragments on 
average. The chromatin was cleared by 10 min of high speed centrifugation at 4°C in 
a table top centrifuge. The chromatin was then aliquoted in 8 samples and snap 
frozen. For immunoprecipitation, one aliquot was filled up with RIPA buffer to 600µl 
and incubated with 2µl of rabbit anti-MOF, 2 µl rabbit anti-H4 (abcam ab10158), or 
5µl rabbit anti-H4K16ac (Santa Cruz sc-8662-R) antibodies O/N at 4°C. 50 µl of this 
material was then taken as Input control and 500 µl used for immunoprecipitation. 
For ChIP-Seq, the complete material from 4 x 100 salivary glands was used for 
Immunoprecipitation, using 3µl of rabbit anti-MOF, 3 µl rabbit anti-H4, 5µl rabbit anti-
H4K16ac, or 6µl of rabbit anti-Rpb3 (gift from John Lis and Karen Adelman). 
Immunocomplexes then isolated by adding protein A -Sepharose (Roche) for 3 
hours, followed by six washing steps: 4x RIPA buffer, 1x DOC buffer (10 mM Tris at 
pH 8, 0.25 M LiCl, 0.5% NP-40, 0.5% DOC, 1 mM EDTA), and 1x TE at pH 8. The 
beads were resuspended in 90 μl TE and, together with the Input control, the 
crosslink was reversed at 65°C over night. After 30 min incubation at 37°C with 
RNaseA (0.2 mg/ml), followed by 2 hr Proteinase K digestion (0.05 mg/ml) at 50°C, 
DNA was purified using Minelute columns (Qiagen). ChIP DNA samples were 
resuspended in 500 μl nuclease free water. We used 10 μl ChIP material for each 
qPCR reaction. For ChIP-Seq, the material from four independent IPs was pooled for 
each experiment (two replicates were generated for all Rpb3 data sets). 
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ChIP from whole larva 
For whole larva ChIP, for each replicate, 100 larva were crushed to a powder in liquid 
nitrogen, dounced 30x in 20 ml NE buffer (15mM Hepes pH 7.6, 10mM KCl, 5mM 
MgCL2, 0.1mM EDTA, 0.5mM EGTA, 350mM sucrose, 0.1% Tween, 1mM DTT, 
protease inhibitors) and fixed by adding 1ml 36% formaldehyde to 1.8% final 
concentration for 20 min at RT. After quenching for 5 min at RT with 125 mM glycine, 
nuclei were collected by 10 min centrifugation at 2500g, washed 3x 5min in RIPA (25 
mM HEPES pH 7.6, 150mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% SDS, 0.1% 
DOC, protease inhibitors) sonicated 5x 30 sec in a Branson 250 sonicator at 30 
pulse, intensity 3, followed by sonication in a Covaris SL-2 sonicator for 6 min using 
the preset 200bp program. After clearing by high-speed centrifugation, the chromatin 
was split in 8 aliquots and snap frozen for subsequent immunoprecipitation. For 
immunoprecipitation, the volume was made up to 600 µl with RIPA. 2 µl of rabbit 
MSL1 or MOF, 3µl of rat MSL3, 5 µl of anti-H4K16ac (Santa Cruz sc-8662-R) 2 µl 
anti-H4 (abcam ab10158), 2 µl anti-H3 (ab1791) antibodies were added and 
incubated over night at 4°C, respectively. Immunocomplexes were isolated by adding 
protein A/G-Sepharose (Roche) for 3 h, followed by six washing steps: 4x RIPA 
buffer, 1x DOC buffer (10 mM Tris at pH 8, 0.25 M LiCl, 0.5% NP-40, 0.5% DOC, 1 
mM EDTA), and 1x TE at pH 8. The beads were resuspended in 90 μl TE and, 
together with the Input control, the crosslink was reversed at 65°C O/N. After 30 min 
incubation at 37°C with RNaseA (0.2 mg/ml), followed by 2 hr Proteinase K digestion 
(0.05 mg/ml) at 50°C, DNA was purified using Minelute columns (Qiagen). ChIP DNA 
samples were resuspended in 500 μl nuclease free water. We used 10 μl ChIP 
material for each qPCR reaction. 
 
RNA isolation and quantitative PCR analysis  
For qRT-PCR, RNA and corresponding genomic DNA from SL-2 cells or from 
salivary glands were isolated simultaneously using the AllPrep DNA/RNA mini kit 
(QIAGEN), the RNA column was DNaseI treated, and 300 ng of total RNA was used 
in an RT reaction. qPCR was performed on an Applied Biosystems (AB) Cycler7500 
with SYBR detection, and the amplification curves were analyzed with the 
corresponding AB software. Each qRT-PCR was repeated at least three times, 
values were normalized to corresponding genomic DNA values, and the standard 
deviation within each experiment was calculated. qPCR analysis of ChIP samples 
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was performed using the SYBR Green PCR master mix (Applied Biosystems), 100 
ng of each forward and reverse primer, and 10 µl immunoprecipitated DNA, in an 
ABI7500 real-time PCR thermocycler (Applied Biosystems, Inc.). Recovery was 
determined as the amount of immunoprecipitated DNA relative to input DNA. Error 
bars represent standard deviation (StDev) of four independent experiments.  
 
Fly stocks and crosses 
All stocks were maintained on standard medium at 25°C. To assay for female viability 
we conducted the cross y/mof2;sb/P{w+ UAS-HA-MOF}c  x mof2/mof2;P{w+ UAS-HA-
MOF}/tm3 and the control cross y/w-;sb/+ x w-/w-;+/tm3 and compared the proportion 
of mof2/mof2;sb/t3 or w-/w-;sb/t3 in the respective offspring. For the complementation 
test, female flies of the genotype mof2/fm7;P{w+ UAS-HA-MOF} were crossed to 
y/fm7;P{armadillo-GAL4} males to induce transgene expression, and the ratio of male 
Y/mof2 to female mof2/fm7 offspring was scored as relative male survival. 
 
For the in vivo characterization of MOF variants the following fly strains were 
generated: 
1. w; P{ w+ UAS-HA-MOF}/TM3 
2. w; P{ w+ UAS-HA- 565-587-MOF}/TM6 
3. w; P{ w+ UAS-HA- 565-587-MOF}/TM3 
4. w; P{ w+ UAS-HA- 1-349-MOF}/Cyo 
5. w; P{ w+ UAS-HA- 1-349-MOF}/TM3 
6. w; P{ w+ UAS-HA- 1-349-MOF}/TM3 
7. w; P{ w+ UAS-HA-Y416D-MOF}/Cyo 
8. w; P{ w+ UAS-HA-Y416D-MOF}/Cyo  
9. w; P{ w+ UAS-HA-Y416D-MOF}/TM6 
10. w; P{ w+ UAS-HA-W426G-MOF}/TM3 
11. w; P{ w+ UAS-HA-W426G-MOF}/Cyo 
12. w; P{ w+ UAS-HA- 176-228-MOF}/ 
13. w; P{ w+ UAS-HA- 176-228-MOF}/ 
14. w; P{ w+ UAS-HA- 241-357-MOF}/ 
15. w; P{ w+ UAS-HA- 241-357-MOF}/ 
16. w; P{ w+ UAS-HA- 98-357-MOF}/Cyo 
17. w; P{ w+ UAS-HA- 98-357-MOF}/Cyo 
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Immunostaining of polytene chromosomes and confocal microscopy 
Two to three pairs of salivary glands were dissected in PBS for each squash. The 
glands were transferred into a drop of 35 µl Fix solution (1.8% PFA, 45% Acetic acid, 
in H2O) on a glass slide and incubated for 10m min. A cover slip was put on top of 
the sample and tapped with a pencil to disrupt cells and nuclei, then heavily pressed 
with the thumb to spread the chromosomes. The slide was snap frozen in liquid 
nitrogen, the cover slip removed with a razor blade and the slide transferred into 
PBS. The slide was then incubated in blocking solution (3% BSA, 0.2% NP40, 0.2% 
Tween20, 10% dry milk, in PBS) for 1 h. After transfer into a wet box, 40 µl blocking 
solution with primary antibody were added onto the sample and incubated for 1 h at 
RT or over night at 4°C. MOF and MSL1 antibodies were used at 1:500, anti-K16ac 
Santa Cruz at 1:125 dilutions. After two times rinsing with PBS, the slide was washed 
for 15 min at RT with washing buffer (500mM NaCl, 0.2% NP40, 0.2% Tween20, in 
PBS). The slide was then incubated in the dark with 40 µl blocking solution 
containing a 1:250 dilution of fluorescently labeled secondary antibody. The slide was 
rinsed two times with PBS and washed for 15 min at RT with washing buffer. After 
another rinse with PBS, 15µl of Fluoromount were added onto the sample and the 
sample was covered with a cover slip. Images were captured with an AxioCamHR 
CCD camera on a Leica SP5 (Leica Microsystems) using an Apochromat NA 1.32 oil 
immersion objective. Images were arranged with Adobe Illustrator.  
 
Generation of protein extracts and western blotting. 
To determine protein levels in adult fly heads, flies were first anesthetized under CO2 
and then sorted by sex. 50 flies were selected, transferred into an eppendorf tube 
and snap frozen in liquid nitrogen. Upon vigorous shaking of the tube, heads detach 
and can be collected into 100µl of 2 x Laemmli buffer. Heads were sonicated for 10 
sec in a Branson 250 sonicator at 30 pulse, intensity 3. After 10 min centrifugation at 
full speed in a table top centrifuge, the supernatant was collected and boiled for 5 
min at 95°C. 10µl of the sample were then used for PAGE. To determine protein 
levels in 3rd instar larva, 10 larvae were inverted in PBS, the gut, fat body and 
salivary glands were removed and the sample transferred into 100 µl 2 x Laemmli 
buffer. After sonication for 10 sec in a Branson 250 sonicator at 30 pulse, intensity 3, 
the sample was boiled for 5 min at 95°C. The sonication was repeated and the 
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sample subsequently cleared by 10 min high speed centrifugation. 10 µl of the 
sample were used for PAGE. After wet transfer onto a PVDF membrane (Millipore) 
and 1 h incubation in blocking solution (5% milk, 0.3% Tween-20, PBS), membranes 
were probed for 1 h at RT with blocking solution containing 1:3.000 rabbit anti-MOF; 
1:3.000 rabbit anti-MSL1; 1:1.000 rat anti-MSL3; 1:1.000 mouse anti-HA; 1:10.000 
rabbit anti-H3; 1:1.000 rabbit anti H4; 1:1.000 rabbit anti-H4K16ac (Santa Cruz sc-
8662-R); or rabbit anti-H4K5ac antibodies, respectively. Membranes were washed 3 
x 5 min in PBS-T (0.3% Tween-20 in PBS) and incubated for 45 min with blocking 
solution containing 1:15.000 anti-mouse or anti-rabbit antibodies coupled to 
horseradish peroxidase. After another 3 x 5 min wash with PBS-T, membranes were 
incubated for 5 min with Lumi-Light western blotting substrate (Roche). The 
luminescence signal was captured on Kodak Biomax MR films.  
 
Expression and purification of Drosophila recombinant proteins with the 
baculovirus system 
The MOF variant proteins expressed in the baculovirus system were cloned as full 
length constructs in HA-pFastBac vectors. Recombinant baculoviruses were 
generated as described in the manual “Bac-to-Bac Baculovirus Expression System” 
(Invitrogen). Recombinant viruses for expression of MSL1 and FLAG-MSL3 were 
readily available in the lab. Recombinant viruses were used to infect insect cells 
(SF21) and these were harvested 2 days after infection by dissolving the cell pellets 
in HEMG-200 Buffer (25mM Hepes pH 7,6 ; 1mM EDTA ; 12,5 mM MgCl2 ; 10 % 
Glycerol ; 200 mM KCl,  0,5% Triton X-100 reduced ; Complete Protease 
Inhibitor(Roche) ; 0,2 µM PMSF). For purification of the recombinant proteins, whole-
cell-extracts were incubated for 2 h with HA-Agarose or Flag-Agarose-Beads 
(Sigma), followed by washes with HEMG-500 and HEMG-200. HA-and Flag-peptides 
(Sigma) were used in a concentration of 400 ng/µl to elute the recombinant proteins. 
All recombinant proteins were stored in HEMG 200 Buffer. 
 
HAT-assay on nucleosomal templates 
In a 20 µl reaction containing 50 mM Tris pH 8,0, 0,1 mM EDTA pH 8, 0, 1 mM DTT,  
1 mM PMSF, 5% Glycerol, 10 mM Na-butyrate and 0,02 µCi of acetyl coenzyme A 
(acetyl-1-14C, 60 mCi/mmol (Perkin Elmer)) we incubated 5.3 nM (10 ng) of the 
respective recombinant MOF-protein (or trimeric complexes) with 1,5 µg of 
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endogenous mono, -di- nucleosomes obtained from MCF-7 cells (human breast 
cancer cell line). For preparation of MCF-7 nucleosomes:  See Epigenome Network 
of Excellence (NoE) protocols (http://www.epigenome-
noe.net/researchtools/protocol.php?protid=22). After a 60 min incubation at 26°C the 
whole reaction volume was applied on a precast 12% BIS/Tris Novex Gel (Invitrogen) 
and run in 1x MES Buffer at 130V for 45 min and 155 V for another 45 min. Proteins 
were visualized by Coomassie R 250 Blue staining, destained, and the gel was dried 
on a 3 MM paper using a vacuum dryer (Biorad) at 80°C for 2 h. The dried gel was 
subsequently exposed on an imaging plate BAS-IP MS 2025 for 5 days. Acetylation 
signals were obtained by scanning the IP-MS plate on a FLA5000 scanner (Fujifilm). 
 
Filter binding HAT-assay  
In a 30 µl reaction containing 50 mM Tris pH 8,0, 0,1 mM EDTA pH 8, 0, 1 mM DTT, 
1 mM PMSF, 5% Glycerol, 10 mM Na-Butyrate and 0,02 µCi of acetyl coenzyme A 
(acetyl-1-14C, 60 mCi/mmol (Perkin Elmer)) we incubated 21.3 nM (40 ng) of the 
respective recombinant MOF-protein (or trimeric complexes) with 1,5 µg of 
recombinant (Xenopus) histone octamer. After a 60 min incubation at 26°C the whole 
reaction volume was applied on a P81 filter paper (Whatman, 1,5 x 1,5 cm), air dried 
and washed 3x10 min at RT in a large volume of 50 mM Na-carbonate pH 9,2. After 
rinsing the filters in acetone, they were air dried and counted in 5 ml of scintillation 
liquid (Rotiszint eco plus, Roth). 
 
Immunoprecipitation of MOF constructs from SL-2 stable cell lines 
All MOF constructs used for SL-2 stable cell line generation carry N-terminal 3xFlag 
6His tags and are under the control of an MtnA promoter.  The vector also contains a 
Neomycin cassette, allowing omitting of the co-transfection step. 1 million cells were 
transfected with 0.5 µg of DNA with Qiagen Effectene reagent. The cells were 
selected initially with 1 mg/ml Geneticin. During the amplification period, the 
concentration of Geneticin was gradually reduced to its final concentration of 0.25 
mg/ml. For immunoprecipitation experiments, equal number of cells from different 
lines (FL MOF, MOF N, MOF Y416D) along with WT MOCK cells were induced with 
100 mM CuSO4 for one day and harvested. Nuclei were isolated and nuclear extracts 
were prepared by freeze-thaw cycles in HEMGT 150 buffer (25 mM HEPES 7.6, 0.1 
mM EDTA, 12.5 mM MgCl2, 10% Glycerol, 0.2% Tween-20 and 150 mM KCl). INPUT 
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samples were taken from the nuclear extract. Nuclear extracts were incubated with 
30 ml bed volume of magnetic Flag Agarose beads (Sigma) for 2 hours at 4°C. The 
beads were washed four times with HEMGT 150 buffer and eluted with 3xFlag 
peptide (final 0.4 mg/ml concentration) containing HEMGT 150 buffer overnight. The 
elutions were precipitated by TCA/Acetone method and resuspended with 4 x 
Laemmli Buffer.  
 
ChIP-Seq Data processing 
ChIP samples were sequenced using Illumina GAIIx machines at the EMBL 
GeneCore facility. Resulting reads were mapped to the D. melanogaster genome 
(dmel_r5.11_FB2008_08) using the Bowtie software (Langmead et al., 2009) with the 
following parameters: -n 2 -k 1 --solexa1.3-quals --best. With these settings, the 
software maps reads only to unique locations in the genome, choosing the best 
possible hit. The software takes into consideration the read-quality during alignment 
and removes all reads containing ambiguous nucleotide assignments (N). Reads 
mapping to heterochromatic regions were discarded from further analysis (Table S1). 
We divided the D. melanogaster genome into non-overlapping 25 bp bins, and 
counted the number of reads mapped to each bin.  These read-counts were then 
inputted to the DESeq BioConductor package (Anders and Huber, 2010); counts 
were normalized between IP and input samples by applying a scaling factor 
accounting for differences in the total numbers of reads per sequencing run. Any bins 
with read counts of zero were discarded from further analysis. For each bin, DESeq 
outputted a log2 fold-change (log2FC) value between normalized read counts in the 
IP and control samples. We used input DNA as the control for MOF-binding and 
histone H4-binding as the control for the H4K16 acetylation marks. As DNA fragment 
sizes after sonication was ~200 bp, we smoothed log2FC values using a 400 bp 
sliding window approach (Kind et al., 2008). The final log2FC values represented the 
signal from the IP samples relative to controls, with positive values corresponding to 
enrichments in the IP sample and negative values corresponding to enrichments in 
control sample. We calculated log2FC thresholds to indicate significant binding or 
acetylation compared with the control. Since negative log2FC values (i.e. enrichment 
in control signal) correspond to experimental noise, we fitted a symmetric null-
distribution to the density distribution for log2FC values below the mode (PMID: 
16732288). We then applied an FDR-adjusted p-value cut-off of 0.05 to identify 25 bp 
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bins containing significant binding or acetylation. All ChIP-Seq data will be made 
available at European Nucleotide Archive (ENA) (http://www.ebi.ac.uk/ena/). 
 
Detection of MOF-bound and H4K16-acetylated genes 
For the classification of binding patterns, gene bodies were defined as all exonic 
sequences between +500 bp downstream of the transcription start site (TSS) to the 
3’-end, as annotated in the Ensembl database. The promoter was defined as the 
region between -200 bp and the TSS: the region was selected by identifying the 
mode for average MOF-binding at the 5’-end of all genes which falls about -100 bp 
upstream of the TSS in both male and female samples and then providing a 100 bp 
window either side. We excluded any genes that are <600 bp (1,205 loci) in length, 
as they were too short for this analysis. There is a clear bi-modal distribution dividing 
partially bound genes from fully bound ones. We used a threshold of 70% (relative to 
the gene body length) to differentiate between the two types of binding. Next, we 
classified partially bound genes as promoter bound, if they contained at least one bin 
with significant binding in the promoter region defined above. We used a similar 
classification to identify patterns of H4K16 acetylation. In this case, the promoter was 
defined as the region between the TSS and +500bp downstream, in order to 
accommodate shift in acetylation patterns towards the interior of genes compared 
with MOF-binding.  
 
Gene expression profiling 
Gene expression was measured using Affymetrix Drosophila2 GeneChips in at least 
triplicate for wt male and female 3rd instar larva salivary glands. Data analysis was 
performed using publicly available packages in the BioConductor Software Suite 
[PMID: 15461798]. Raw .CEL files were processed using GCRMA and probe sets 
were mapped to genes using annotation available from the Ensembl database (v57) 
[PMID: 21045057]. Expressed genes were identified as those outputting MAS5.0 
‘present’ calls in all available biological replicates. Microarray data will be available at 
ArrayExpress upon acceptance of the manuscript [PMID: 21071405]. 
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Figure Legends 
Figure 1. MOF is the major H4K16 specific HAT in the male and female genome. 
(A) H4K16ac is lost from all chromosomes in the absence of MOF. Immunostaining of 
polytene chromosomes from male and female third instar larva salivary glands, using 
antibodies against H4K16ac, MSL1 and HA (MOF) as indicated. DNA staining is 
shown in blue (Hoechst 322). (B) Western blot analysis of extracts prepared from wt, 
mof2 and FL-MOF expressing male and female 3rd instar larva showing the effect of 
MOF depletion on H4K16ac. (C) Number of eclosed mof2 adults compared to the 
control carrying the wt MOF allele. While males show full lethality, female number is 
reduced approx. two fold. Error bars represent the standard deviation from three 
independent experiments. (D) Lifespan of control, mof2, and FL-MOF expressing 
female flies after eclosion. Error bars represent the standard error of the mean. 
  
Figure 2. The chromobarrel domain is essential for MOF function. 
(A) Male lethality upon disruption of the chromobarrel domain. Male viability was 
assayed upon expression of various MOF transgenes in the mof2 background as 
indicated. Percentages refer to the number of mof2 males compared to the number of 
heterozygous mof2 females resulting from the same cross. (B-E) Immunostaining of 
polytene chromosomes from mof2 male third instar larvae salivary glands, expressing 
FL (B), ΔZn (C), Y416D and W416G (D), and ΔN MOF (E) transgenes. Antibodies 
against HA (MOF), MSL1 and H4K16ac were used as indicated in the figure. DNA 
staining is shown in blue (Hoechst 322).  
 
Figure 3. The MOF chromobarrel domain is required for MSL spreading. 
(A) MSL targeting is compromised without the MOF N-terminus. ChIP using MSL1 
and MSL3 antibodies in wt male 3rd instar larva as well as mof2 larva, or mof2 larva 
that express FL MOF or ΔN MOF transgenes. Binding to the X-linked high affinity 
sites at the roX2 gene and location 15A8, as well as the X chromosomal genes 
Rpl22, Klp3a, and Ucp4a is shown. PKA is used as a negative control. Primers were 
positioned at the promoter (P), middle (M), and end (E) of genes. The exact position 
of the primers is described in the Supplemental Data. ChIP is shown as percentage 
recovery of input DNA (% Input). Error bars represent standard deviation (StDev) of 
three independent experiments. (B) MSL spreading is lost upon disruption of the 
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chromobarrel domain. Same as in (A), using mof2 larvae that express FL MOF or 
Y416D MOF, respectively.  
 
Figure 4. The chromobarrel domain is required for H4K16ac. 
(A) Compromised MOF targeting of ΔN MOF. ChIP using MOF (upper panel), and 
H4K16ac (lower panel) antibodies in wt male 3rd instar larva as well as mof2 larva or 
mof2 larva that express FL-MOF or ΔN MOF transgenes. Binding to the autosomal 
genes bt, cg3937, cg6729, cg6884, cg31866, cg2709, cg7638, the X-linked high 
affinity sites at the roX2 gene and location 15A8, as well as the X chromosomal 
genes Rpl22, Klp3a, and Ucp4a is shown. Primers were positioned at the promoter 
(P), middle (M), and end (E) of genes. The exact position of the primers is described 
in the Supplemental Data. ChIP is shown as percentage recovery of input DNA (% 
Input). Error bars represent standard deviation (StDev) of three independent 
experiments. (B) H4K16ac is lost upon disruption of the chromobarrel domain, while 
promoter binding of MOF is retained. Same as in (A), using mof2 larvae that express 
FL MOF or Y416D MOF, respectively.  
 
Figure 5. The MOF chromobarrel domain functions after chromatin binding.  
(A) Bulk H4K16ac is lost upon disruption of the chromobarrel domain. Western blot 
analysis of extracts from mof2 male 3rd instar larva expressing the indicated MOF 
transgenes. (B) Acetylation assay on native nucleosomes. Each reaction contains 5.3 
nM of FL, Y416D or W426G MOF proteins, with or without MSL1 and MSL3, 
respectively, and 1.5 μg of native nucleosomes purified from MCF-7 cells. (C) Same 
as in (B), using FL and ΔN MOF proteins. (D) Acetylation assay on free histone 
octamers. 40 ng (21.3 nM) of the respective recombinant MOF-protein or trimeric 
complexes were incubated with C14 labeled acetyl coenzyme A and 1,5 µg of 
recombinant  (Xenopus) histone octamer, as indicated in the figure. The reaction was 
then applied on a P81 filter paper, air dried, washed and counted in scintillation 
liquid. (E) Disruption of the chromobarrel domain does not affect nucleosomal 
binding. Nucleosome pull down experiments are shown, using trimeric complexes 
containing FL, Y416D, W426G or ΔN MOF together with MSL1 and MSL3 proteins. 
Purified endogenous histone octamers from Drosophila embryos were wrapped with 
147 bp biotinylated DNA to assemble mononucleosomes and coupled to streptavidin 
beads. After incubation with trimeric complexes and stringent washing, MOF binding 
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was detected by western blot analysis using HA antibodies. 5% of the Input material 
(lanes 1-4), IP using empty streptavidin beads as a control (mock-IP) (lanes 5-8, and 
nucleosome IP (nuc-IP) (lanes 9-12) are shown. 
Figure 6. Several layers of regulation control genomewide H4K16ac in 
Drosophila.  
Our data suggests that in Drosophila MOF is responsible for the majority of H4K16ac 
at gene promoters in males and females, and for hyperacetylation along the male X 
chromosome. MOF activity is tightly regulated to achieve these diverse tasks. The N-
terminal region is required for targeting of MOF to gene promoters and for assembly 
the MSL complex. At the same time the N-terminus constrains the enzymatic activity 
of the MOF HAT domain, which is only unleashed in the context of the MSL complex 
to achieve hyperacetylation of the male X (blue arrows). The next layer of regulation 
is imposed by the chromobarrel domain (CD). Following binding of MOF to its 
chromatin target sites, nucleic acid interactions of the chromobarrel domain are 
required to trigger acetylation of the H4 tail (red arrows), which subsequently allows 
MSL complex spreading along the transcribed regions of genes. The chromobarrel 
domain thus acts as an “on-off switch” for H4K16ac. 
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Supplementary Methods 
 
Primers used in this study 
ChIP primers: 
F=Forward, R=Reverse, P=promoter, m=middle, 3’= towards the 3’ end of the gene. 
UCP4a P F:  CAA GTT GTC GCG AGT TGA AA 
UCP4a P R:  CAA TTG CTT CGC TCT AGC TG 
UCP4a m F:  CGC AAG GAG TTC ACA CAG AA 
UCP4a m R:  CTC CAT TTG GAT TTG CAC CT 
UCP4a 3’ F:  TTC ATG TTA CCC CGC CTT TA 
UCP4a 3’ R:  CTC CTG ACA TTT GGG CAT TC 
Rpl22 P F:  CAA TCC AAT GCG CAG TTA TG 
Rpl22 P R:  AAG GCC TTG TTC GCA TAT TG 
Rpl22 m F:  TAG CGG TAA GCT GGG CTA AA 
Rpl22 m R:  GTC GCT CTG ATG GCA GTG TA 
Rpl22 3’ F:  GGC TAG CCC GAA GTT TTC TT  
Rpl22 3‘ R:  AGC TGA TCC CTT CAG TGG AA 
Klp3a P F:  TTG GCT CTT GAA TAG CAG ATT T   
Klp3a P R:  GTG CAC AAA TCG TCC AAC C 
Klp3a m F:  GCA GCT CCT GTT TGA GAT CC 
Klp3a m R:  CAT TCC CAT TCG GAG GAG TA 
Klp3a 3’ F:  ATG GGC TGT CAG GCA TTT AG 
Klp3a 3’ R:  GAG GAG CAG CAA AAG AGG TG 
15A8 F:  TGA CGC CTT TGC TGA ATG T 
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15A8 R:  TGC GCT CCT ATC ACC CAG A 
roX 3’ F:  ACG GTG CTG GCT TAG AGA GA 
roX 3’ R:  GGC GGA AAT GTA TTT GCA GT 
CG6729 P F:  TATCCGGGTAAGTCCAGGTG 
CG6729 P R: CAATTTCCAGCGAAAATGTTG 
CG31866 P F: CGCAAACAGTTGGATTTTCC 
CG31866 P R: GGCCAGAACTCTGTCGGTAA 
CG6884 P F:  TGGGACGGAACTTGCTTATC 
CG6884 P R: GGCTTGTCCTGGAAAGATCA 
CG2708 P F:  GCAGCCGGTTCAATAGTCTC 
CG2708 P R: CGATCGCTCTCGAATACACA 
CG7638 P F:  ACACATTTTCTCGGCTCCAC 
CG7638 P R: TTTTCCGTCATGTCCACTCA 
CG3937 m F: AATCTTGGCATCCAGCTCAC 
CG3937 m R: AATTCATGGTCCGCAAGAAC 
Expression primers: 
roX2 exon3 F:  TCGCAATGCAAACTGAAGTC 
roX2 exon3 R:  AGGCGCGTAAAACGTTACC 
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Supplementary Figure Legends 
 
Figure S1. MOF acetylates promoters across the male and female genome 
(A) Genomic patterns of MOF-binding and H4K16 acetylation. Screenshots of the 
Integrated Genome Browser show the patterns (log2FC values) of MOF-binding (dark 
colour) and H4K16 acetylation (light colour) in male (blue colour shades) and female 
(red colour shades) salivary glands along a 20kb section of chromosome 3L (left) and 
a 25 kb section of the X chromosome (right). Genomic coordinates and the locations 
of annotated Refseq genes on the forward (+) and reverse (-) strands are indicated 
below. (B) Profiles of MOF-binding and H4K16 acetylation along genes. The plots 
show the average log2FC signal for MOF-binding (red) and H4K16ac (black) along 
genes in wt males (left) and females (right). Log2FC signals are shown for the region 
surrounding the TSS (-2000bp to +2000bp) and for the 3’-end of the gene (3’-end to -
2000bp upstream of the transcription termination site). Average log2FC values for X-
linked and autosomal genes are represented by solid and dashed lines, respectively. 
(C) Overlap in MOF-bound (left) and H4K16-acetylated (right) autosomal (top) and X-
linked genes (bottom) genes between males and females. (D) Overlap of MOF-bound 
with H4K16-acetylated genes in wt males and females. Autosomal (left) and X-linked 
(right) genes were divided into three categories showing full (full), promoter-only 
(prom) or no (not) binding by MOF. For each category, the stacked barplot specifies 
the number of genes showing full (full), promoter-only (prom) or no (not) H4K16 
acetylation. The numbers within each block indicate the percentage of genes within 
this block relative to all genes in the category. (E) Overlap of MOF-bound and 
H4K16–acetylated genes detected by the ChIP-chip analyses performed by Kind et 
al. (2008) from cell lines and our ChIP-seq analysis using third instar salivary gland 
samples. Both male and female samples are presented. 
 
Figure S2. Analysis of the MOF chromobarrel domain 
(A-C) MOF chromo-barrel domain structure. Ribbon diagram of the Drosophila MOF 
chromo-barrel domain (A). Residues Tyr416 and Trp426 are shown as sticks. 
Structure of the yeast Esa1 chromodomain (residues 17-89, B) in the same 
orientation as MOF. Structure of the extended chromodomain of yeast Esa1 
(residues 1-89, C). The N- and C- termini form a short β-sheet and a loop following 
Tyr56 changes its conformation. (D-F) Conservation of the chromobarrel domain 
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surfaces in MOF and MSL3. (D) Ribbon representation of the complex of MSL3, DNA 
and the H4 peptide (PDB code 3OA6). The structure of the MOF chromobarrel 
domain (PDB code 2BUD) is superimposed onto the one of MSL3. (E) Surface 
representation of the MSL3 chromobarrel domain in the same orientation as in (D) 
highlighting areas of conserved residues involved in DNA and H4 binding. The 
conservation of the surface is represented from gray to red (red is 100 % conserved) 
according to the color scale bar. The aromatic cage around Phe56 includes also 
Tyr31, Trp59 and Trp63. (F) Surface conservation of the MOF chromobarrel domain 
based on ortholog sequences ranging from human to nematodes. The conserved 
surface corresponding to the MSL3 DNA binding region includes Asn420, Arg422, 
Tyr314, Trp426 and Arg387. Tyr416 forms a floor of a cavity surrounded by Leu419, 
Leu423 and His393. 
 
Figure S3. MOF transgenes analyzed in this study 
(A) Schematic representation of the domain structure of the known MOF alleles mof1 
and mof2, as well as the MOF derivatives generated for this study. Globular domains 
in the MOF protein are the chromobarrel domain (chromo), the C-terminal HAT 
domain (HAT) containing a zinc finger (Zn). G691 is located in the catalytic center of 
the MOF HAT domain. Y416D and W426G reside in the chromobarrel domain and 
disrupt RNA binding. (B-I) MOF transgenes are expressed to wt levels. Western blot 
analysis using extracts from male adult fly heads expressing the indicated 
transgenes. Two to three independent lines were analyzed for each mutant variant. 
Tubulin (Tub) was used a loading control. 
 
Figure S4. Nuclear localization of the ΔZn MOF protein, and conservation of 
MOF 
Immunostaining of salivary glands from mof2 male third instar larvae expressing the 
FL-MOF or ΔZn MOF transgene, using antibodies against HA (MOF) and MSL1 as 
indicated. DNA staining is shown in blue (Hoechst 322).  
 
Figure S5. roX RNA levels are reduced upon removal of the MOF N-terminus 
(A) roX2 levels in mof2 male larva salivary glands expressing MOF transgenes as 
indicated. Transcript levels were normalized to roX2 DNA recovered from the same 
sample. (B) Alignment of the MOF amino acid sequence in different animal species. 
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Evolutionary distance between Drosophila melanogaster and virilis is approx. 55 mio 
years, melanogaster and sechellia approx. 2,5 mio years. Sequence conservation is 
indicated by darker greyscales.  
 
Figure S6. MOF chromatin targeting is lost upon deletion of the zinc finger 
(A) MSL targeting is compromised upon deletion of the MOF zinc finger. ChIP using 
MSL1 (upper panel) and MSL3 antibodies (lower panel) in wt male 3rd instar larva as 
well as mof2 larva, or mof2 larva that express FL MOF or ΔZn MOF transgenes. 
Binding to the X-linked high affinity sites at the roX2 gene and location 15A8, as well 
as the X chromosomal genes Rpl22, Klp3a, and Ucp4a is shown. PKA is used as a 
negative control. Primers were positioned at the promoter (P), middle (M), and end 
(E) of genes. (B) Compromised MOF targeting of ΔZn MOF. ChIP using MOF (upper 
panel), and H4K16ac (lower panel) antibodies in wt male 3rd instar larva as well as 
mof2 larva or mof2 larva that express FL-MOF or ΔN MOF transgenes. Binding to the 
autosomal genes bt, cg3937, cg6729, cg6884, cg31866, cg2709, cg7638, the X-
linked high affinity sites at the roX2 gene and location 15A8, as well as the X 
chromosomal genes Rpl22, Klp3a, and Ucp4a is shown. The exact position of the 
primers is described in the Supplemental Data. ChIP is shown as percentage 
recovery of input DNA (% Input). Error bars represent standard deviation (StDev) of 
three independent experiments. 
 
Figure S7. The MOF N-terminus is required for incorporation into the NSL 
complex 
Coimmunoprecipitations were performed from nuclear extracts obtained from SL-2 
cell lines stably expressing FLAG-tagged wt, Y416D and ΔN MOF. Input material and 
immunocomplexes were subjected to western blot analysis using the indicated 
antibodies for detection.   
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Sample # reads  # reads 
mapped
% reads 
mapped 
coverage
Male samples
MOF male wt 9,945,648 8915892 89.65 1.90
input male wt 7,143,508 6298158 88.17 1.34
H4 male wt 13,564,190 11892074 87.67 2.54
H4K16 male wt 12,567,533 11038368 87.83 2.36
H4 male mof2 18,391,608 15774286 85.77 3.37
H4K16 male mof2 18,033,157 14565538 80.77 3.11
input male mof2 9,934,408 8641131 86.98 1.84
Female samples
MOF female wt 9,935,297 7008690 70.54 1.50
Input female wt 15,784,565 13590676 86.10 2.90
H4 female wt 12,727,549 11094654 87.17 2.37
H4K16 female wt 10,476,721 8987154 85.78 1.92
Table S1: ChIP-seq samples analysed in the study. This table presents the total 
numbers of reads sequenced from each samples, the numbers and percentages of the 
reads aligned by Bowtie and selected as they were mapped on one of the D. melanogaster 
chromosome and did not contain any Ns, and the genome coverage obtained from these 
selected mapped reads.
X (%) Auto. (%) X exp (%) Auto exp (%)
Male wt
MOF 
Total bound 1,285 (57.65) 4,830 (41.19) 704 (92.63) 3,132 (81.48)
gene body 898 (40.29) 50 (0.43) 569 (74.87) 27 (0.7)
promoter 387 (17.36) 4,780 (40.77) 135 (17.76) 3,105 (80.78)
no MOF 944 (42.35) 6,895 (58.81) 56 (7.37) 712 (18.52)
Total 2,229 11,725 760 3,844
H4K16ac
Total bound 1,989 (89.23) 4,690 (40) 748 (98.42) 3,111 (80.93)
gene body 1,704 (76.45) 321 (2.74) 712 (93.68) 197 (5.12)
promoter 285 (12.79) 4,369 (37.26) 36 (4.74) 2,914 (75.81)
no H4K16ac 240 (10.77) 7,035 (60) 12 (1.58) 733 (19.07)
Total 2,229 11,725 760 3,844
Female wt
MOF 
Total bound 903 (40.51) 3,862 (32.94) 620 (74.79) 2,745 (65.02)
gene body 1 (0.04) 8 (0.07) 1 (0.12) 3 (0.07)
promoter 902 (40.47) 3,854 (32.87) 619 (74.67) 2,742 (64.95)
no MOF 1,326 (59.49) 7,863 (67.06) 209 (25.21) 1,477 (34.98)
Total 2,229 11,725 829 4,222
H4K16ac
Total bound 1,064 (47.73) 5,023 (42.84) 695 (83.84) 3,460 (81.95)
gene body 158 (7.09) 682 (5.82) 89 (10.74) 445 (10.54)
promoter 906 (40.65) 4,341 (37.02) 606 (73.1) 3,015 (71.41)
no H4K16ac 1,165 (52.27) 6,702 (57.16) 134 (16.16) 762 (18.05)
Total 2,229 11,725 829 4,222
Table S2. Numbers and percentages of MOF-bound and H4K16-acetylated genes. 
Numbers and percentages of MOF-bound and H4K16-acetylated genes on the X chromosome 
and the autosomes in wt males (top) and females (bottom). The numbers and percentages of 
expressed genes are indicated in the right end columns (X exp and Auto exp).
All genes Expressed genes
